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Abstract
Using enzyme linked immunosorbant assays (ELISA) we compared the suitability o f liver 
fluke homogenate (LFH), excretory/secretory products (ES) and cathepsin LI as a 
diagnostic agent for the serodiagnosis of human fasciolosis in the Bolivian Altiplano. 
Cathepsin LI (CL1) proved significantly better at the discriminating between seropositive 
and seronegative Fasciola hepatica infected individuals when compared to the other 
antigen preparations. The sensitivity of the CL1 -ELISA was further improved by using 
secondary antibodies directed against IgG4 only. This IgG4/CLl-ELISA was highly 
specific because sera obtained from individuals infected with other parasites were negative 
in the assay.
We also employed recombinant CL1 as antigen in this ELISA. A statistically 
significant correlation (r2 = 0.751; p<0.001) was observed between recombinant and 
native proteins making the standardisation of this assay possible. The difficulty of 
obtaining blood from the indigenous population prompted us to explore the method of 
collecting samples of blood onto filter paper after lancet-pricking of the finger (blood-filter 
samples). Statistical analysis revealed that there was significant correlation between the 
results obtained with serum and blood-filter samples (r2= 0.848; p<0.001). The collective 
serological data revealed that 44.3% of the 360 individuals in the Bolivian Altiplano tested 
were diagnosed as serologically positive. In addition, our data shows that fasciolosis has 
been endemic in this region for at least a decade.
Fasciola hepatica infection in mice was associated with a type II immune response 
which results in a generalised Th-subset imbalance polarising towards a Th2 cytokine 
profile. An established type I immune response in mice vaccinated with B. pertussis whole 
cell vaccine was significantly down-regulated, in an IL-4 dependent process, when these 
mice were subsequently infected with F. hepatica. We also demonstrated that 
intravenously administered F. hepatica ES products could induce the down-regulation of 
the type I immune response in these vaccinated mice. In addition, mice injected intra- 
peritoneally with ES exhibit a predominant Th2 cytokine profile. Peritoneal exudate cells 
secrete IL-10 in vitro when stimulated with ES suggesting that this cytokine may be the 
involved in the initial stages of inducing a type II response.
Abbreviations
ABTS 2,2-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid)
BCA Bicinchoninic acid
Bisacrylamide N,N-Methylene bisacrylamide
BP B. pertussis antigen
BSA Bovine serum albumin
CL1 Cathepsin LI
DTT Dithiothreitol
ELISA Enzyme linked immunosorbant assay
ES Excretory / Secretory products
FCS Foetal calf serum
IFNy Interferon-gamma
IL Interleukin
LFH Liver fluke homogenate
PAGE Polyacrylamide gel eletrophoresis
PBMC Peripheral blood mononuclear cells
PMA Phorbal, 12-myristate, 13 -acetate
PBS Phosphate buffered saline
pNpp p-nitrophenyl phosphate
RPMI Roswell Park Memorial Institute
SDS Sodium dodecyl sulphate
Temed N,N,N’ ,N’ -tetramethylethylenediamine
Th T helper cell
TNFß Tumour necrosis factor-beta
Tris Tris [hydroxymethylj-aminomethane
Tween 20 Polyoxymethylenesorbitanmonolaurate
Chapter 1 
Introduction
i
Fasciola hepatica, an obligate, endoparasitie trematode is the causative agent of 
fasciolosis, or liver fluke disease. The disease has a worldwide distribution but is 
located primarily in the temperate zones (Europe, the Americas and Asia) and the most 
common definitive hosts are sheep and cattle. In Ireland alone over 30 million pounds 
are lost annually by the agricultural community as a result of the disease. Infection in 
livestock results in weight loss, an increase in mortality (particularly in sheep) and a 
reduction in reproduction rates. In addition, a decrease in milk yield is found in dairy 
cattle and reduced wool production in sheep.
The disease in humans has been reviewed in several publications (Maurice, 
1994; Boray, 1981; Dawes and Hughes, 1970; Facey and Marsden, 1960). In 
particular an extensive review by Chen and Mott (1990), reported a total of 2594 cases 
from 42 countries over a period of 20 years. However, the incidence of the disease is 
believed to be much higher than that documented, particularly if one considers the 
number of cases misdiagnosed due to asymptomatic cases or incorrect diagnosis. In 
the review by Chen and Mott (1990) only 16 cases are documented in Iran compared 
to recent publications which estimate infection in some 30,000 individuals (Bahar et 
al., 1990; Massound, 1990; Pourtaghva el al., 1990). The number of cases reported 
does not therefore truly reflect the incidence of the disease in this region. In addition 
no reference has been made to Bolivia where a prevalence of 53% has been reported 
by Hillyer et al. (1992) in the Corapata community in the northwest Altiplano and an 
estimated 100,000 people are at risk of contracting liver fluke disease The morbidity 
and mortality in this region has yet to be assessed.
1.1 General introduction
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The life cycle of Fasciola hepatica is both cyclical and indirect, requiring a 
invertebrate intermediate host, the snail Lymnaea truncatula, and a definitive 
mammalian host (Fig. 1). The monoecious adult lives in the biliary tracts where it 
feeds on the lining of the bilary ducts. It is here that the sexually mature adult lays 
eggs which are carried by bile into the intestine. Although flukes are hermaphroditic 
and can self-fertilise, its preferred means of reproduction is by cross fertilisation. Eggs 
are passed with the faeces and embryonation will only occur in the presence of suitable 
conditions. Moreover eggs must be liberated from faecal matter as it inhibits 
embryonation.
In the absence of sufficient water eggs will desiccate rapidly. Precipitation of 
approximately 0.2mm in 24 hours (6mm per month) is a condition necessary for egg 
development. Eggs embryonate to form miracidia at temperatures greater than 10°C 
and less than 37°C (9-10 days at 26°C, 14-17 days at 22°C and 20 days at 20°C) 
(Rowcliffe and Ollerenshaw, 1960). Other important factors which influence 
embryonation are oxygen tension and pH. Low oxygen tension inhibits embryonation 
(Rowcliffe and Ollerenshaw, 1960) and pH 7.0 is optimum for egg development (Al- 
habbib, 1974).
Liberation of miracidia from the egg is coupled with the secretion of a 
"hatching enzyme" (Rowan, 1956) in the presence of sunlight (Roberts, 1950) and 
ambient temperatures (Gold and Goldberg, 1976). The free swimming phototropic 
miracidia must invade the secondary host within 24 hours (Hope Cawdery et al., 
1978). It is believed that this adaptation has developed in order that the miracidia have 
the advantage of always continually migrating to the edge of the water source where
1.2 Life cycle o f Fasciola hepatica
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Figure 1. Life cycle of Fasciola hepatica.
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the amphibious host resides. Once present in the host’s habitat it is attracted to the 
snail by chemotaxsis. Transmission into the intermediate host is active and may require 
proteolytic enzymes to penetrate the body wall.
On reaching the snail the miracidia attach to the intermediate host by its apical 
gland. Cilia are cast off after the initial attachment. The final penetration is by a young 
sporocyst which migrates via the lymph or blood vessels to the digestive gland. In 
favourable conditions one sporocyst develops into 5-8 first generation rediae. First 
generation rediae in turn give rise to 40 daughter rediae. Further development occurs 
and the rediae develop into 600 cercariae which are shed via the birth pore (Andrew, 
1998). The development of larval stages in the snail is temperature dependent. At 
environmental temperatures of 15°C, 20°C and 25°C development takes 82, 40 and 25 
days, respectively. The release of cercariae is stimulated by rainfall or a drop in 
ambient temperature (indicating a water source in which the cercariae can swim). The 
cercariae are not released at temperatures lower than 9°C and the snail dies at 
temperatures greater than 26°C; temperature is therefore an important limiting factor. 
In the absence of water, snails can burrow into mud and survive still infected for up to 
several months. Once in the presence of water and at suitable temperatures the snails 
will emerge and rapidly shed numerous cercariae (Schmidt and Roberts, 1989).
After the release of cercariae some will encyst at the waters surface but most 
attach to aquatic plants below the water level. The tail of the cecariae are shed and the 
cyst wall is secreted within two minutes to two hours to form metacercaria, the 
infectious stage of the life cycle (Smith and Halton, 1983). Transmission to the 
definitive host is passive, by the ingestion of aquatic plants or by drinking contaminated 
water. Survival of metacercaria is also dependent on moisture and temperature (Shaw,
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1932) and once encysted on herbage 50% can survive a typical Irish winter 
(Ollerenshaw, 1967).
Metacecariae excystment is initiated in the stomach of the mammalian host in 
the presence of high concentrations of carbon dioxide, reducing conditions and high 
temperatures (39°C) (Fried, 1994). Liberation of the newly excysed juvenile (NEJ) 
fluke is stimulated by bile salts secreted in the duodenum (Sukhedo and Mettrick, 
1986). The NEJ migrates through the intestinal wall into the peritoneal cavity, 
subsequently penetrating the gilsons capsule and migrating across the liver parenchyma 
to the biliary passages. This process takes almost two months in cattle and sheep 
(Dawes and Hughes, 1964). Once present in the bile duct the worms become sexually 
mature in four-five weeks and commence producing eggs. Adults can successfully live 
in the bile ducts of cattle for nine months to several years and up to 11 years in sheep 
(Pantelouris, 1965; Dan et ah, 1981).
1.3 Pathology and clinical manifestation of human fasciolosis
The clinical manifestation of liver fluke disease in man is similar to that exhibited by 
animals and for ease of reference can be divided into three stages; the invasive or acute 
stage, the prepatent stage, and the chronic or obstructive stage (Chen and Mott, 1990; 
Bjorland et ah, 1997; Mas-Coma and Bargues, 1997; Arjona el al., 1995). The 
invasive stage coincides with the migration of the juvenile flukes through the peritoneal 
cavity and across the liver parenchyma, where they mature on reaching the bile duct. 
The precise mechanism for reaching the liver is not known but once the liver capsule is 
penetrated it burrows through the liver parenchyma causing extensive haemorrhaging 
and inflammation. This stage is associated with the major pathology of the disease, the
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extent of which is dependent upon the number of flukes that invade the liver. The 
symptomology is due to the mechanical destruction of liver tissue and the initial 
symptoms include fever, sweating, abdominal pain and urticaria. The symptoms may 
be vague or absent in light infections. In addition, respiratory symptoms have been 
reported, the most common are bronchial wheeze, dysponea, dry cough and chest pain. 
Upon physical examination individuals present with hepatomeagly, splenomegaly and 
ascites. Ascites is yellow with high a leucocyte count and eosinophilia. Anaemia is 
common in the acute stage and individuals may be pale, dizzy and weak. The duration 
of this stage is approximately 6-8 weeks. Granuloma formation occurs around trapped 
flukes in the liver parcenchyma.
The prepatent or latent stage is the period when the mature fluke is laying eggs 
and the individual is asymptomatic. This stage commences 6-8 weeks after the initial 
infection. The chronic or obstructive stage occurs after several months to several 
years. The fluke feeds on the lining of the bile ducts causing hyperplasia and 
inflammation of the epithelium. Thickening and dilation of the bile ducts and 
gallbladder ensue. Dilation of the common bile duct is reported to have increased by 
2-3 fold (Chen and Mott, 1990). The occurrence of cholangitis or cholecystitis 
coupled with the presence of flukes may result in mechanical obstruction resulting in an 
enlarged and oedematous gall bladder. The clinical manifestations include right upper 
quadrant tenderness, epigastric pain, biliary colic, nausea, fatty food intolerance, 
jaundice and pruritus. Hepatic enlargement, splenomegaly and ascites are also 
common during this stage. The liver increases in size during the course of the disease 
and is more rigid on palpitation than in the acute stage. Splenomegaly occurs in a 
small number of individuals and ascites is more common in the acute stage. In the 
chronic stages individuals may appear jaundiced. Several reports of egg granuloma
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have been reported but this is not extensive and does not contribute significantly to the 
pathogenesis. Development of cirrhosis and liver failure was reported in only a small 
proportion of cases. Ectopic fasciolosis is possible with flukes migrating to organs 
other than the liver, but is not common (Arjona el ah, 1985). The disease is mainly 
associated with morbidity but some mortalities have been reported. There is no 
worldwide figures available on morbidity or mortality rates but an estimated 2.5 million 
individuals are believed to be infected with fasciolosis (Maurice, 1994).
1.4 Treatment of human fasciolosis
There are several drugs that are very effective in the treatment of human fasciolosis; 
table 2 summarizes the most effective drugs available. However some of these drugs 
are highly toxic causing serious adverse effects. Emetine is used widely and although 
its therapeutic effect includes elimination of infection and improved symptoms, it can 
be highly toxic. Dehydroemetine an analogue to emetine, has similar effects but is less 
toxic. There have been reported incidences of resistance to both drugs (Chen and 
Mott, 1990). In addition, they are administered by intermuscular (IM) or 
subcutaneous (SC) injection for a period of over one week. This is the principal 
disadvantage of dehydroemetine as self administration would be the preferred means 
particularly in rural areas such as the Bolivian Altiplano. Bithinol and hetol have a 
good therapeutic index; that is, they are very effective in the treatment of individuals 
and exhibit only mild gastrointestinal adverse effects. There have been numerous 
studies on the efficacious use o f both of these drugs in treatment o f this disease 
(Rakhmanov, 1987; Wang et ah, 1981; Bacq et ah, 1991; Espino et ah, 1994.) 
Metranidozole, a drug more commonly employed in protozoan infections has been
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used to treat faseiolosis but its success is dependent upon a high dosage and requires 
administration over a prolonged period of time. Small doses of the drug are not 
effective in eliminating an infection (Eckhardt and Heckers, 1981).
Table 2: Drug treatment of Human Faseiolosis.
Drug Dose
Mg/kg
Frequency Route of 
Administration
Side effects
Emetine 1 OD/IO days I M/SC Toxic effects, Cardiovascular 
changes, Hypotension
Hetol 50-60 TDS/7 days Oral Gastro Intestinal Complaints 
Dizziness
Bithionol 50 10 days Oral Anorexia, Nausea, Vomiting 
Abdominal Pain
Metronidazole 1.4g OD/13-28 days Oral Nausea, Vomiting, 
Anorexia
T riclabendazole 10 OD/1 -2  days Oral Fever, Nausea, 
Liver damage
OD=once daily, TDS= three times daily, IM = Intramuscular, SC= Subcutaneous.
Triclabendazole, a drug more commonly used in veterinary medicine is now 
prescribed for the treatment of human liver fluke disease. Several publications have 
reported successful treatment of the infection with only single or double oral doses of 
the drug (Apt et al., 1995; Laird and Boray, 1992). Toxic side effect are mild with 
some gastrointestinal adverse effect. Apt et al. (1995) reported the treatment of 24 
cases of asymptomatic F. hepatica infected individuals in Chile with a single oral dose 
of lOmg/kg of body weight of triclabendazole. Nineteen individuals were 
coprologically negative after two months while three of the remaining five received a 
second treatment and subsequently tested coprologically negative within a two month 
period. Tolerance of the drug was excellent in all cases as there was no alteration in 
liver function tests post-treatment. All successfully treated individuals were 
serologically negative within a six month period after treatment. Due to the limited 
number of human drug trials further investigation into its use in human faseiolosis is 
required before it can be recommended for therapuesis. Other drugs examined for the
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treatment of the disease include chloroquine, niclofolan, albendazole and praziquantel 
(Price et al., 1993; Laird and Boray, 1992; Chen and Mott, 1990). The use of these 
drugs are not recommended because of their toxic effect or limited therapeutic value.
1.5 Diagnosis of human fasciolosis
Clinically, human fasciolosis is primarily diagnosed by coprological or serological 
analysis particularly in large scale epidemiological studies. However, other methods of 
diagnosis (both invasive and non-invasive) are employed and will be briefly discussed.
Non-invasive and invasive techniques.
The majority of non-invasive diagnostic techniques are expensive and would not be 
employed in large epidemiological studies, particularly in countries where financial 
resources are limited. Radiological techniques employed in the diagnosis of fasciolosis 
include abdominal and chest X-ray (Han et al, 1993), cholangiography (Reidtmann et 
al., 1995) and endoscopic retrograde cholangiopancreatography (ERCP) (Price et al., 
1993; Hauser et al, 1984). Images obtained using these techniques show narrowing of 
the bile ducts, shadows and tracking in the liver tissue. Radioisotope scanning has also 
been employed as a useful tool in diagnosis (Han et al, 1993). It illuminates the 
presence of “cold areas” in the liver tissue where the liver fluke is present. Ultrasound 
is also useful in diagnosis, but has limited value as individual flukes are not visualized 
(Abdel el al., 1996). Computed tomography scans have diagnosed the disease by 
identifying multiple hypodense areas in the liver tissue. It is a particularly useful in 
monitoring an individual’s response to treatment (Kodama et al, 1991; Melero et al. 
1991).
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Invasive techniques for the diagnosis of fasciolosis include liver biopsy, 
laparoscopy and surgical intervention. Liver biopsy reveals eosinophilic abscess, 
granulation and charcot-leyden crystals. Eggs are sometimes present in the biopsy 
tissue (Kodama et al., 1991; Comse et al, 1990). Laparoscopy is performed by placing 
a scope through the abdominal wall facilitating examination of the abdominal and liver 
tissue. Lesions suggestive of liver fluke infection can be observed in the form of 
hepatic nodules of various shapes and sizes. Lesions may also be observed in Gilson’s 
capsule and the peritoneal cavity (Cosme et al., 1990; Croese et al 1982). During 
exploratory laparatomy eggs may be found in the bilary ducts. Finally, the symptoms 
of fasciolosis may be mistaken for cholecystitis, cholelthiasis or obstructive jaundice. 
During a cholecystectomy or choledochostomy, liver flukes or ova may be observed in 
the biliary ducts or the gall bladder (Angehrn el al, 1975; Moreau et al, 1995). In a 
case reported by Chen and Mott (1990) over fifteen flukes were drained from the bile 
ducts during choledochostomy.
Abnormal laboratory findings are extremely useful in the diagnosis of all stages 
of human fasciolosis. The haematological signs include results of elevated white blood 
cell counts (greater than 10,000/mm3) and eosinophilia. An eosinophilia count greater 
than 5% of total leucocytes is indicative of a helminth infection. Leucocytosis and 
eosinophilia are usually greater in the acute phase but remain elevated in all stages. 
Abnormal liver function has been reported in both the acute and chronic stages. In the 
acute stage patients have elevated glutamic pyruvic transaminase (GPT), glutamic 
oxalacetic transaminase (GOT) and raised alkaline phosphatase (AKP). Jaundice is 
prominent in the chronic stage of the disease resulting in high serum bilirubin, in 
addition to elevated GPT, GOT and AKP (Reidtmann et al., 1995). In all stages of the 
disease raised immunoglobulins to F. hepatica antigens are found. IgM is associated
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with early infection (Osman et al., 1995) whereas elevated IgG is observed in all stages 
of infection (Hillyer et al. 1992). Specific IgE is detected in 48% of individuals 
(Sampaio Silva et al., 1985).
Parasitological examinations.
Parasitological or coprological diagnosis is based upon the identification of Fasciola 
hepatica eggs in a patients stool and is widely employed for the diagnosis of human 
and animal fasciolosis. Fasciola hepatica eggs have a distinctive operculated shape 
and are 130-150(j.m in length and 63-90pm in width making it possible to distinguish 
them from other helminth eggs. Eggs are passed through the faeces only when flukes 
are mature which is approximately 2-3 months after initial infection. Coprological 
analysis is a rapid, reproducible and inexpensive means of diagnosis. However, there 
are several inherent flaws. Since eggs are released 2-3 months after infection, 
diagnosis of acute infection is impossible. Early diagnosis is imperative because it is at 
this stage that most of the pathogenicity of the disease occurs. In addition, eggs may 
be passed through the faeces from ingestion of raw or under cooked liver from infected 
livestock. Several stool samples are required on different times on different days as the 
release of eggs is sporadic.
There are numerous techniques to diagnose the presence of eggs in stool 
samples. However, the sensitivity of coprological analysis is dependent on the 
technique employed and its specificity is heavily dependent on the experience of the 
technician performing the technique. The most rudimentary technique is the simple 
direct smear, an insensitive but rapid means of diagnosis (Blagg et al., 1955). Egg 
concentration techniques include the sedimentation technique, the egg flotation 
technique (Stork et al., 1973) and the Kato-fCatz or cellophane faecal thick-smear
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technique (Katz et al., 1972). These latter methods are generally more accurate and 
sensitive. A comparative study was performed by Munoz et al. (1987) comparing 
three different coprologically analysis. The techniques employed were the Fast 
Sedimentation Method (FSM), the teleman centrifugation technique (TM) and the 
gravity sedimentation technique (GS). Using TM only 33% of individuals were 
diagnosed correctly compared to 100% for the remaining two techniques. Several 
studies have been performed reporting different sensitivities for different techniques. 
The most widely used is the Kato-Katz technique and rapid sedimentation technique. 
The latter is highly sensitive but is expensive and laborious. The former is rapid, 
reproducible and economically viable making it suitable for large epidemiological 
surveys.
Immunological examinations.
Immunological techniques are invaluable in the diagnosis of human fasciolosis 
particularly since the diagnosis of acute infection is possible. Moreover, most 
immunological techniques are inexpensive, rapid and sensitive. Immunological 
techniques exploit one of two immunological phenomena, a hypersensitivity reaction to 
antigen (skin test) or the formation of an antigen-antibody immune complex. The 
latter involves the detection of circulating liver fluke antigen, circulating immune 
complexes or the detection of specific antibodies to liver fluke antigen.
Skin tests were one of the first immunological tests to diagnose human 
fasciolosis. The antigen utilised was prepared from crude somatic liver fluke antigen. 
Although this method is simple and cheap it is not highly sensitive and therefore has 
limited use in diagnosis (Stork, et al., 1973; Smithers, 1982). The detection of 
circulating antigens (Ambroise-Thomas et al., 1980) or circulating immune complexes
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(CIC) (Sampaio Silva el al., 1985) has been utilised to diagnose fasciolosis but only 
incorporated as part of an experimental design in animal and human studies. Low 
sensitivity means it can only be employed in conjunction with other techniques to 
confirm diagnosis (Knobloch, 1985; Sampaio Silva et al. 1981.).
One of the earliest immunological methods is the immunufluorescence assay 
(IF A) (Stork el al., 1973; Wessely et al., 1987). A cross section of liver fluke tissue is 
mounted on a slide and probed with serum. While it is a sensitive assay it is not very 
specific as cross reactivity has been observed with other helminth infections 
particularly schistosomiasis, ascariasis and filariasis. In addition, this method is 
cumbersome and impractical for use in large surveys. Other techniques for diagnosis of 
human fasciolosis include indirect haematagglutination test (IHA), double diffusion 
(Garcia-Rodriguez et al, 1985), complement fixation (CF)((Stork et al., 1973; 
Wessely et al, 1987) and counter electrophoresis (CEP) (Hillyer, 1975). Enzyme 
linked immunosorbent assay (ELISA) and enzyme linked immuno-electrotransfer blot 
(ETIB) have been found to be the most sensitive and specific methods of diagnosis 
(Hillyer et al., 1992). However the ETIB method is cumbersome, time consuming and 
only allows the diagnosis of a limited number of patients at any one time. The degree 
of sensitivity of all these assays varies. Knobloch (1985) performed a study on 45 
human subjects parasitologically diagnosed for liver fluke disease. Their sensitivities 
for ELISA, IHA and circulating antigen where 98%, 56% and 20%, respectively.
1.6 F a sc io la  h ep a tica  cathepsin L proteinases
Proteases are a group of enzymes that cleave peptide bonds at specific locations in a 
polypeptide. They are a diverse group of enzymes that are involved in many
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proteolytic processes important in cellular function. Exopeptidases, cleave amino acids 
from either the amino (aminopeptidases, dipeptidases) or carboxyl terminus of proteins 
(carboxypeptidases) while endoproteinases, cleave internal peptide bonds. The 
International Union of Biochemistry classifies proteases according to their physical 
structure, chemical properties, active site and biological properties. Accordingly 
proteases are divided into four main classes, namely serine proteinases, aspartic 
proteinases, metalloproteinases and cysteine proteinases.
The cysteine class o f proteases include the plant proteinase papain, interleukin 
converting enzyme (ICE) and several mammalian lysosomal cathepsins (Cathepsin L, 
B, H and S). Catalysis proceeds via a thiol ester intermediate and is dependent upon 
an active cysteine residue site in the presence of reducing agents to stabilize or enhance 
its activity. The cathepsin L group of proteases are powerful lysosomal glycoproteins 
that can cleave extracellular matrix proteins such as collagen and elastin. In addition, 
they can cleave other biologically important proteins such as insulin B-chain, histones 
and haemoglobin. They are similar to that of papain and are believed to share a 
common evolutionary origin with this proteinase. This opinion is deduced from studies 
of their protein structure (particularly the catalytic site), amino acid sequence and 
biological properties. Papain-like cysteine proteases are synthesized as preproproteins. 
The enzyme is activated on cleavage of the N-terminal peptidase.
The molecular weight of a mammalian cathepsin L ranges between 21-28kDa. 
It’s enzyme activity is optimum between pH 4-6 and is irreversible above pH 7.0. 
Classification of cathepsin L cysteine proteinases can be made using synthetic 
substrates. Three synthetic substrates used for this purpose include Bz-arg-NN2, Z- 
lys-0PhN02 and Z-Phe-Arg-NHmec. Cathepsin L contains highly activated thiol 
groups and readily react with thiol blocking agents. Inhibitors therefore include
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phenylmethylsulfonylfluoride (PMSF), Iodoacetamide, Leupeptin and L-trans- 
epoxysuccinyl-leucylamido-(4-guanidino)-butane (E64) (Barret and Kirschke, 1981; 
Dalton and Brindley, 1997).
Papain-like proteases of parasites are reported to function in the destruction of 
host macromolecules, and in facilitating migration through the host tissue and in the 
acquisition of nutrients. In addition, they are involved in immune evasion mechanisms. 
An early publication by Howell et al. (1966) reported the presence of an enzyme in 
adult and juvenile fluke which had collagenase activity. Howell (1973) confirmed the 
proteolytic activity of the enzyme and demonstrated using incubating sections of fluke 
on photographic plates that the activity is restricted to the gut tissue. It is now 
generally accepted that the protease is secreted by vesicles in gut epithelium cells 
(Smith et al, 1993) and that the protease may function in tissue migration and feeding. 
However, several papers have reported that these proteases may have an additional 
vital role in immunoprotection as they cleaved immunoglobulin splitting the molecule 
at the hinge region into Fab and Fc fragments in a papain-like manner (Chapman and 
Mitchell, 1982; Heffeman and Dalton, 1989).
Heffernan and Dalton (1989) showed that when immature and mature Fasciola 
hepatica were maintained in culture media for 16 hours they released a proteolytic 
enzyme. This enzyme was classified as a thiol protease as it was deactivated by thiol 
protease inhibitors and exhibited enhanced activity in the presence of reducing agents 
(cysteine and dithiothreitol). Subsequent biochemical and characterisation studies 
revealed that this proteolytical activity was derived from two cysteine proteinases, 
termed cathepsin LI and cathepsin L2 (Smith et al, 1993; Dowd et al 1994). Both of 
these proteins accounts for 80% of the excretory-secretory products (ES) secreted by 
adult flukes (Dowd et al, 1993).
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Smith et al. (1983) was the first to purify and characterize the cathepsin LI 
proteinase from the media in which liver flukes were cultured. Cathepsin LI is a 27 
kDa proteinase with optimum activity at pH 4.5 and is inhibited by cysteine proteinase 
inhibitors. N-terminal sequence of cathepsin LI proteinase showed homology to 
cathepsin L proteinases of chicken liver (63%) and bovine (58%). Cathepsin LI is 
synthesized as a preproenzyme which are processed to the proenzyme form. Further 
processing gives rise to the mature form. Immunolocalisation studies at light and 
electron microscope level demonstrated that cathepsin LI was located in vesicles in the 
gut epithelial cells. This protein is secreted into the gut where it is regurgitated to the 
exterior by the fluke. It is postulated to be involved in three parasite functions, 
burrowing, feeding and immune evasion. In addition to cleaving host immunoglobulin, 
it was shown to prevent the antibody-mediated attachment of eosinophils to newly 
excysted juvenile (NEJ) flukes (Carmona et al., 1993).
A second proteinase, cathepsin L2, was purified and characterized by Dowd et 
al. (1994) and was found also to be a lysosomal proteinase belonging to the papain 
superfamily. It differs from cathepsin LI in its migration in zyograms, its affinity for 
binding to QAE-Sephadex, its enzyme specificity for various synthetic enzymes and N- 
terminal sequences. It was shown to hydrolyse a number o f substrates such as collagen 
and elastin. In addition, it cleaves fibrinogen producing a novel type of fibrin clot 
(Dowd et al., 1995). This may have evolved by the fluke to prevent haemorrhaging in 
the liver as the fluke migrate through the host. Both cathepsin LI and cathepsin L2 are 
believed to be good targets for immunoprophylaxis, or chemotherapy against 
fasciolosis. Both proteins have shown potential as vaccine candidates in studies 
performed in bo vines (Dalton et al., 1996).
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Mammalian immune systems have evolved to protect against infection from harmful 
microbes (viruses and bacteria) and parasites (protozoa and helminths). Such systems 
consist of a complex network of cells and molecules that recognise foreign antigens (or 
non-self antigens) as potential pathogens. The detective agents elicit such information 
concerning these pathogens and relay their discoveries through a number of complex 
interactions resulting in an immune attack that eliminates the source of the antigen. 
The immune system is classically divided into innate (non-adaptive) immunity and 
adaptive immunity.
Innate immunity
Innate immunity responds rapidly in a non-specific manner to a foreign antigen. In 
essence, defence strategies consist of physical/chemical barriers to infection, 
extracellular chemical defences (complement system, interferons) and cellular defences 
(leukocytes). The skin and mucous membranes, which line the alimentary, gut and 
respiratory tract, act as physical barriers to foreign antigens. In addition, they have 
chemical properties, such as the low pH on the surface of the skin and the secretion of 
lysozyme, which delimit bacterial survival. Such physical and chemical barriers are 
generally regarded as the primary line of defence against pathogens. However 
pathogens have developed mechanisms to bypass these barriers. In these 
circumstances the secondary line of defence is crucial for the early recognition and 
elimination of a foreign antigen.
The complement system consists of 20 plasma proteins which perform in an 
enzyme cascade manner. Its functions include regulation of inflammatory reactions,
1.7 General introduction to immunology
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clearance of immune complexes, leukocyte activation and microbial defence. The 
initiation of complement may proceed via two pathways, the classical or alternate 
pathway. The classical pathway is activated by the specific binding of IgG or IgM 
antibody. The initiation of the alternative pathway is by the reaction of 
polysaccharides in the cell wall of the pathogen or by the specific binding to IgA 
antibody with complement components. Regardless of the route the common terminal 
pathway is the formation of the membrane attack complex (MAC) which occurs via 
the convergence of the intermediate component C3 to C3b. The MAC complex is a 
cylindrical molecule which forms a pore in the cell wall causing osmotic disruption 
resulting in cell death. C3b activates complement by covalently binding non- 
specifically to micro-organisms or immune complexes. Damage limitation is curtailed 
by the simultaneous production of RCA (regulators of complement activation) 
proteins, ensuring the prevention of C3b binding to host antigens so only cells 
expressing foreign antigen are opoinised. Therefore, C3b has a vital role in the early 
recognition of foreign antigen. Other intermediate components also exercise important 
functions in innate immunity. C3a and C5a stimulate macrophages to release oxidising 
agents. In addition, C5a is a chemotatic factor (attracts white blood cells to migrate 
into the area of infection). Other extracellular defences include interferons and acute 
phase proteins. Interferons, released by white blood cells, bind non-specifically to 
virally infected cells while acute phase proteins are believed to enhance phagocytosis.
Cellular defences activated during innate immunity can be divided into three 
functional groups: cellular phagocytic cells (macrophages, neutrophils), cytotoxic cells 
(eosinophils, naturals killer, y5-T cells), and inflammatory cells (basophils, mast cells). 
Cellular phagocytic cells principally consist of macrophages and neutrophils. 
Phagocytes attach to the pathogen via opsonins (antibodies, acute phase proteins and
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complement). The pathogen is engulfed by phagocytosis and is eliminated by the 
release of powerful oxidising agents. Similarly cytotoxic cells eliminate pathogens by 
releasing powerful toxins, however this process does not necessitate phagocytosis, the 
cells merely attach directly to the pathogen. This occurs in the circumstance where the 
pathogen is of such volume and density as to render this option redundant. 
Eosinophils are cytotoxic cells which play an important role in the direct damage of 
parasitic worms. These cells consist of granules containing degradative enzymes which 
when released onto the surface of the parasite inflict damage. Although attachment to 
the worm can occur in an antibody-independent manner, cell attachment is substantially 
enhanced by the presence of antibodies. Other cytotoxic cells include natural killer 
cells which perform a significant role in immune responses to viral antigens and K-cells 
which are antibody dependent cell mediated cells. Inflammatory white blood cells 
release a number of active molecules provoking an acute inflammatory reaction at the 
infection site. These cells degranulate liberating biologically active molecules which 
cause an inflammatory reaction (swelling, redness and heat at the infection site). The 
degranulation of mast cells and basophils is augmented after IgE binding, to highly 
specific IgE surface receptors found on these inflammatory cells.
Adaptive/Acquired immunity
The acquired immune response differs from the innate response since it can specifically 
recognise a diverse antigen range. In addition, it exhibits immunological memory, 
ensuring a more effective immune response during subsequent infections. The 
acquired immune system consists of two main cell populations, T-cells and B-cells. 
Precursor B-cells and T-cells originate from lymphoid stem cells found in the bone 
marrow.
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B-cells
B-lymphocytes, or B-cells, mature and clonally expand in the presence of foreign 
antigen and activating signals from T-cells. Antigen adheres directly to B-cells via 
surface immunoglobulin (slg- approximately 105 are found on the surface of B-cells). 
Sites in the slg structure interact with complementary epitopes on the antigen. As 
soon as antigen-slg binding occurs, the antigen is internalised and it is in the endosome 
that the antigen is proteolytically cleaved into smaller peptides. Subsequently these 
peptides are presented on the cell surface in association with class II major 
histocompatibility complex (MHC). The antigen is presented to T-helper cells which 
in turn release cytokines activating B-cells and causes them to undergo clonal 
expansion into memory cells and plasma cells.
Plasma cells produced antibodies which can be classified by their respective 
structures and functions. There are five different classes o f antibody, IgG, IgA, IgM, 
IgD and IgE. All classes of antibody structures comprise o f similar basic Y-shaped 
immunoglobulin structures. IgG immunoglobulin class has the simplest structure. It 
may be cleaved into two identical Fab regions and a single Fc region. The Fc region is 
the constant domain which attaches to complement or various cell surface receptors. 
The Fab region is the antigen-specific region. This region varies between different 
antibodies which exhibit different antigen specificity.
IgM is composed of five units of the basic antibody structure. Although not 
highly specific it has ten binding sites ensuring its effectiveness in entrapping pathogens 
and producing large aggregates of antigen, thereby increasing the efficacy of 
phagocytic cells. In addition, it triggers the classical complement system and is 
important in the early recognition of antigen during a primary infection until the more 
specific IgG subclass can function effectively. IgG can be further subdivided into four
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isotypes, IgGl, IgG2, IgG3 and IgG4 (in humans). IgGl and IgG3 are effective in 
activating complement; and enhance phagocytosis by readily opsonising bacteria. The 
function of IgG4 in humans is unknown since it appears neither to activate complement 
nor binds immune effector cells. In helminth infections IgG4 is the predominant 
antibody produced, and is believed to benefit the parasite by blocking the attachment 
of IgGl and IgE and preventing IgGl activation of the complement cascade.
IgE is normally present in serum in low concentrations and is also found 
attached to the surface of cells which bear the IgE receptor. The serum IgE 
concentration greatly increases during helminth infections (and allergic disease). 
Bound IgE acts as opsonins for eosinophils on parasites increasing their cytotoxic 
effect. IgA is associated with pathogens of the gut and lung as it is predominantly 
found in secretions of the alimentary, respiratory and genito-urinary tract. IgD, which 
accounts for about 1% of serum is expressed on the surface of B-cells. The function 
of IgD is unknown.
T-cells
T-cells undergo maturation and differentiation processes in the thymus before 
migrating into the spleen and the lymph nodes. At this juncture cells commit 
themselves to one of two main T-cell populations, cytotoxic T-cells (Tc) or helper-T 
cells (Th). Unlike B-cells, T-cells do not recognise antigen directly, instead they 
recognise antigen presented by the major histocompatibility complex I or II. T-cells 
are distinguished phenotypically by CD markers. Both populations express CD3 which 
is situated in the T-cell receptor. CD8 is expressed on Tc-cells while CD4 is
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Figure 1.2 Overview of the immune response.
expressed on Th-cells. Tc-cells kill host cells that express foreign antigens. Cell killing 
is performed by the release of cytotoxic chemicals and pore forming molecules. 
Antigen recognition occurs via the Class I MHC molecule which is found on every cell 
in the body except activated leucocytes (macrophages, B-cells and T-cells). Activated 
leucocytes are unique in that they recognise antigens by utilising the Class II MHC 
molecule.
Th-cells can only bind to an antigen when it is coupled with a class II MHC 
molecule. Helper T-cells activate and enhance innate and acquired immunity by 
synthesising and secreting cytokines which act as immunoregulators. Direct cell to cell
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interactions between T-cells and B-cells also enable B-cells to undergo maturation and 
to secrete antibody. Th-cells can be further divided into two sub-populations, Thl and 
Th2 cells.
The Th-cell dichotomy
Mossman and Coffman (1980) were the first to identify and describe two functionally 
polarised Th-cell sub-populations in mice CD4+ T-cell clones. To date, no phenotypic 
difference has been identified. The cells can be differentiated by their secretion of 
distinct cytokine profiles. Thl cells secrete type I cytokine profile, IFNy, IL-2, IL-12 
and lymphotoxin. These cytokines are involved in the regulation of cell-mediated 
inflammatory reactions and in the induction of delayed type hypersensitivty reactions. 
The type I cytokine IFNy, controls the production of IgG2a by B-cells, which activates 
the classical complement pathway and hence phagocytosis. IFNy has a direct effect 
upon the regulation of nitric oxide production from macrophages. Th2 cells secrete 
type II cytokines, IL-4, IL-5, IL-6, IL-13, and IL-10 and are largely associated with 
responses to helminth infections and allergic diseases. Th2 cells augment the antibody 
response, particularly IgE and enhance eosinophil proliferation and function.
Both Thl and Th2 cells are derived from a common precursor, ThO. 
Environmental and genetic factors during antigen presentation influence ThO cells to 
clonally expand into either type I or type II CD4+ sub populations. Type I and Type II 
Th-cells counter regulate each other negatively. IFNy, which is secreted by Thl cells, 
selectively inhibits proliferation of type II CD4+ cells and IL-10, which is secreted by 
Th2 cells, inhibits cytokine synthesis by type I cells. Such counter regulation tends to 
invoke a polarisation of the immune response towards a type I or type II bias. 
Polarisation of the immune response influences the susceptibility of the host to an
24
infectious agent. Different pathogens require different immune responses for their 
elimination. In general, bacteria are eliminated by a type I immune response while gut 
parasites are eliminated by a type II immune response.
1.8 Immunological evasive strategies of F a sc io la  h epa tica :
In common with other successful parasites Fasciola hepatica has developed a number 
of immunological evasive mechanisms which are critical for it’s survival in the 
definitive host. In order to reach the bile duct the fluke must burrow through the 
mesenteric wall and migrate across the liver parenchyma thus exposing itself to the full 
force of the hosts immune response. Immune evasion strategies have been developed 
by Fasciola hepatica to counteract this immune attack and include, inter alia, such 
mechanisms as antigen switching, antigen shedding, parasite motility, destruction of 
innate immunity and modulation of the immune response. These mechanisms facilitate 
the completion of the parasites life cycle by allowing the subject to achieve sexual 
maturity. Survival in the host continues over the course of several years, causing 
morbidity rather than mortality; the former being more beneficial for its survival.
As the fluke migrates across the liver parenchyma towards the bile duct its 
glycocalyx undergoes antigen switching. This process occurs twice during fluke 
development. The first switch occurs when the newly excised juvenile (NEJ) burrows 
through the mucosal wall. During each switch the vesicles within the tegument wall 
secrete, synthesize and package antigenically distinct glycocalyx components 
transforming the cells from TO cells to T1 cells. The final transformation occurs when 
the fluke enters the bile duct (T1 cells to T2 cells) (Hanna, 1980; Dalton and Joyce, 
1987). This process is believed to avoid an immune attack at a time when the parasite
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is most immunologically vulnerable. In addition to antigen switching the glycocalyx is 
continuously sloughed off and quickly replaced every three hours thus hindering 
antibody binding (Duffus and Franks, 1981). The shed glycocalyx acts as a decoy 
mopping up circulating antibodies and effector cells. The final destination for the 
mature liver fluke is the immunologically safe environment o f the bile ducts (Dufliis 
and Franks, 1980). At this juncture, the turnover of the glycocalyx is much slower and 
accordingly there are diminished antibody responses.
The migration of the parasite acts as a mechanism to avoid the host immune 
response as it “leaves behind” the immune effector cells. Immunohistochemical studies 
of liver tissue have shown that migratory tunnels were infiltrated by immune leukocytes 
but the flukes were not surrounded by these cells (Meeusen et ah, 1995). In addition 
the flukes migration through these distinct anatomical regions was shown to influence 
the pattern of antibodies which were secreted from the local lymph nodes (mesenteric 
and hepatic lymph nodes) and the spleen in rats (Meeusen and Brandon, 1994). 
Expression of IgM isotype was found in the spleen whereas IgE and IgA were 
expressed in the hepatic and mesenteric lymph nodes respectively. The different 
isotype expression in different regions would suggest that cytokine secretion was 
regulated in each of these microenvironments. Migration through the tissue would 
expose the liver fluke to different immune responses rather than a single response that 
would become increasingly efficient during parasite migration (Meeusen and Brandon,
1994).
The alternative complement pathway is inhibited by the presence of sialic acids 
in the glycocalyx components (Baeza et al., 1994). Similarly antibody shedding is 
thought to prevent the activation of the classical pathway. Antibody cleaving by 
cathepsin L proteinases released by the fluke also blocks this pathway (Carmona el al.,
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1995). Newly exeysed juveniles are thought to be highly resistant to complement 
destruction as no deposition of the complement component C3 was observed on the 
surface of the glycocalyx, in studies performed in vitro or in vivo (Dufl'us and Franks, 
1980; Davies and Goose, 1981). The activation of both complement pathways is thus 
prevented. In addition both processes may be blocked by the release of decay 
accelerating factor (DAF), which regulates complement and is found on the surface of 
other helminths such as schistosomes (Pearce et al., 1990).
The neutralisation of the reactive oxygen products from the respiratory burst of 
leukocytes and macrophages is employed by liver fluke to evade the host immune 
attack. Studies performed in vivo have shown undamaged liver flukes in the liver of 
cattle surrounded by immune effector cells. An experiment performed by Piedrafleta 
(1995) demonstrated that NEJ cultured in vitro with macrophages exhibited resistance 
to reactive oxygen intermediates.
Experimental evidence in sheep suggest a lack of anamestic antibody response 
following challenge infection and a lack proliferative responses of lymphocytes during 
primary infection (Sandeman and Howell, 1981). This evidence suggests that liver 
flukes secrete factors that suppress or modulate the immune response. There are 
several molecules which are thought to be involved in immunoinodulation or 
suppression. Sloan et al. (1991) suggest that glyco-conjugates released from the 
glycocalyx may interfere with antigen processing by macrophages or suppress T- 
lymphocyte responses. A Kunitz-type (Fh-KTM) serine proteinase inhibitor expressed 
in the gut and tegument of adult liver fluke may have a role in inhibiting the activity of 
elastases released by neutrophils or may interfere with cytokine production (Bozas et 
al., 1995). Milbourne and Howell (1993) demonstrated that eosinophilia in mice and
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rats was observed two weeks after intravenous injection of ES products. They 
hypothesized that ES may have a similar activity to IL-5 cytokine.
1.9 Immunology to Fasciola hepatica infections, a general review
Cattle rarely die from fasciolosis and can habour an infection from several months to 
several years (Dan et al., 1981). The morbidity associated with disease in cattle 
includes weight loss, an increase in spontaneous abortion and a decrease in milk yields. 
In contrast, sheep frequently die during the acute stages of infection as a result of the 
pathological sequale. However, infection in sheep can also persist for many years, the 
longest duration reported being eleven years (Pantelouris, 1965).
Sheep and cattle are considered the natural host o f F. hepatica but other 
animals can become infected accidentally. In the accidental hosts such as pigs and 
horses liver flukes do not reach maturity as the flukes are trapped in the liver 
parenchyma. The ability of the host to inhibit fluke migration by its encapsulation in 
the liver tissue is believed to be an important factor in controlling infection. The 
susceptibility of sheep to fasciolosis may be explained by their failure to trap flukes in 
the liver parenchyma, thus extensive pathological damage occurs as the flukes migrate 
uninhibited.
Evidence suggests that resistance in cattle to fasciolosis is not completely 
immunologically based as the “self cure” is believed to be related to the calcification 
and thickening of the bile duct wall a phenomenon not observed in sheep. The level of 
acquired resistance in cattle following a primary infection is significantly high, ranging 
from 60%-84% (Boray, 1967; Doyle et al., 1971). Resistance to infection is observed 
following anti-helminth chemotherapy suggesting that the presence of liver flukes in
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the bile ducts is not a necessary requirement (Boray, 1967; Kendall el al., 1978). 
Hepatic fibrosis is believed to contribute to resistance of both a primary and secondary 
infection in cattle. During a challenge infection Doyle et al. (1973) established a 
correlation between the extent of resistance and the degree of pathological damage in 
the liver. In addition development of fibrosis was associated with resistance during 
primary infection (Ross el al., 1966). Cattle infected orally with a small (200 to 1300 
metacercariae) or large number (1500-2500) of metacecariae resulted in a 30% or 3% 
recovery rate of parasites in the bile duct, respectively.
Since sheep exhibit more extensive liver damage than cattle, one would 
hypothesize that there would be a higher degree of resistance during a challenge 
infection in sheep compared to cattle. In contrast to cattle the number of worms 
recovered during a challenge infection in sheep is the same as that recovered during a 
primary infection (Ross, 1967; Sinclair, 1962; 1970). However, during a challenge 
infection, egg production is reduced and fluke migration and development is retarded 
(Siclair, 1960; 1970; 1971). Therefore, sheep lack some other factor important in 
establishing resistance. Different levels of resistance and susceptibility have been 
reported in sheep with different genetic backgrounds. Japanese thin tailed sheep are 
highly resistant to infection with F. gigantica where other breeds of sheep are highly 
susceptible (Roberts el al., 1997).
Immunological evidence suggests that in both the natural host and laboratory 
host a type II immune response is associated with fasciolosis. Antibody responses in 
cattle are predominantly o f the IgGl isotype; levels peaking at eight-ten weeks post 
initial infection. The type of CD4+ cell type in cattle has yet to be determined, 
however Browne et al. (1994) isolated TH2 and TH0 clones but not TH1 clones in 
two chronically infected cattle. Clery et al. (1996) determined the cytokine profile in
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cattle infected with Fasciola hepatica by measuring mRNA from the hepatic lymph 
nodes during a chronic infection. Both IFNy and IL-4 mRNA was expressed in the 
month following initial infection but IFNy mRNA production declined after one month 
where IL-4 mRNA was detected throughout the course of the infection. The levels of 
IL-4 mRNA were several fold higher in the hepatic lymph node when compared to the 
precapsular lymph nodes. This data suggests that during the acute stages o f infection 
the CD4+ cells express both IFNy and IL-4 but as the infection progresses the cells 
differentiate and commit themselves to a more dominant type II profile (Clery et a l ,
1996).
Although sheep do not demonstrate immunological resistance to liver fluke, 
anti-fluke antibodies are detected in serum and are predominantly of the IgGl subtype. 
This immunoglobulin subtype peaks five-six weeks following initial infection (Sexton 
et a l, 1994; Chauvin el al., 1995). The lack of acquired immunity in sheep is thought 
to be related to the lack of cellular responses as ovine antibodies passed to rats 
passively transfer protection (Mitchell et al., 1981; Boyce et al., 1995). Sheep lack an 
anamnestic antibody response following challenge infection and peripheral blood 
lymphocytes from infected sheep are suppressed in infected animals when challenged in 
vitro with a mitogen (Chauvin et a l, 1995). In the acute stages o f disease type II cells, 
eosinophils and CD4+ T-cells are found in the liver tissue of sheep, in the chronic stage 
the cellular responses are quite different with infiltration of CD8+ and y8 TCR+ cell 
type (Meussen et a l, 1995; Chauvin and Boulard, 1996).
In the laboratory, both mice and rats can be experimentally infected with liver 
fluke. Rats may harbour an infection for as long as their natural life whereas mice die 
four-five weeks after an infection with more than a single parasite (Boray, 1969) The
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antibody isotype profile detected in serum from F. hepatica infected rats is 
predominantly IgE, IgGl, IgM and IgG2a subclasses (Pfister et ah, 1983; Poitou et 
ah, 1983). Immunoglobulin-E antibody responses are biphasic, peaking at five and 
nine weeks following initial infection. Titres of IgGl isotype increase over a period of 
five weeks whereas IgG2a increases gradually peaking at ten weeks following initial 
infection. This data suggests that both type I and type II cytokines are involved with 
primary infection of rats (Pfister et ah, 1984; Poitou et ah, 1993).
Eosinophilia is a characteristic feature of liver fluke disease in rats. Doy et ah 
(1978) reported eosinophil infiltration within the lamina propia. This study also 
demonstrated that the infiltration of eosinophils increased significantly during a 
challenge infection. The peritoneum of rats is infiltrated with eosinophils, neutrophils 
and lymphocytes when implanted with mature parasites. This data indicates that 
eosinophils and neutrophils may have an important role to play in the antibody- 
mediated immune protection against liver flukes at both the level of the gut and liver. 
Evidence of these cells being involved in parasite killing in vitro and in vivo has yet to 
be established. However, recent studies indicate that peritoneum lavage cells are able 
to mediate killing of NEJ in vitro by the production of nitric oxide (Spithill el ah,
1997).
Mueeusen and Brandon (1994) suggest that there are two sites of immune 
attrition in rats. Rats cured of a 10 day old infection by drug treatment resisted an 
oral, but not an intraperitoneal challenge with F. hepatica. If  rats were not drug 
treated and the primary infection allowed to develop, resistance to both oral and 
intreperitoneal challenge was observed. Resistance at the level in the liver must require 
the parasites to develop for a period of time within the hepatic tissue. In addition they 
investigated antibody secretion in serum and compared it to the antibody production in
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the local tissue. Antibody secreting cell probes were obtained from lymphocytes from 
mesenteric lymph nodes (MLN), hepatic lymph nodes (HLN) and the spleen. During a 
primary infection only the HLN are stimulated to secrete IgE. This stimulation occurs 
as the flukes migrate across the liver parenchyma. However during a challenge 
infection both the MLN and the HLN are stimulated to secrete IgA and IgE, 
respectively. In drug treated mice followed by challenge infection there was no 
antibody secretion observed in the HLN, MLN or the spleen, although serum 
antibodies were detected. Therefore, it was suggested that the responses in the HLN 
and the MLN are responsible for protection in the liver and gut, respectively.
Milboume and Howell (1990) reported an increase in peripheral blood 
eosinophils and an increase in production of eosinophils by bone marrow cells in vitro 
in both rats and mice. The onset of eosinophila in rats is more rapid compared to that 
observed in mice. Moreover, the eosinophil number in rats following primary and 
challenge infection was 32% and 45%, respectively, where eosinophil counts in mice is 
only 5% for both primary and secondary infection. The production of free radicals by 
rat peritoneal exudate cells is 3.5 more per cell and 30 times more per animal when 
compared to murine cells. Fadiel (1996) demonstrated that unlike rat intestines mice 
do not exhibit an increase in mast cells and eosinophils during infection. This data may 
explain why mice are more susceptible than rats to liver fluke disease and suggests that 
these cells may play a role in immune protection.
There is controversy as to whether mice can develop acquired resistance to F. 
hepatica infection. Mice infected with two liver fluke metacecariae demonstrated 
some resistance to re-infection and resistance differed between mice strains (Lang et 
al., 1967; Harness et al., 1976). This protection was dependent on exposure to the 
fluke rather than the stage of fluke development (Lang and Dronen, 1972; Lang,
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1974). In contrast, others have demonstrated that mice are susceptible to infection 
(Chapman and Mitchell, 1982).
There a few reports on immune mechanisms in mice. When adult flukes were 
implanted into the peritoneum of sensitised mice eosinophils, neutrophils and 
lymphocytes attached to their surface within 4 hours. Recently, a report by Van der 
Heijden et al. (1997) indicating the production of IL-5 and IL-4 mRNA but not IFNy 
in the lamina propia of mice infection with fasciolosis.
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Chapter 2 
Materials and Methods
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Aldrich-Sigma Chemical Company (Poole, Dorset, England)
Ammonium persulphate, avidin-alkaline phosphatase, avidin-peroxidase, 2,2-azino-bis (3- 
ethylbenzthiazoline-6-sulfonic acid)(ABTS), bovine serum albumin, dithiothreitol, 
Ethidium bromide, gentamicin, HEPES, 2-mercaptoethanol, peroxidase-conjugated anti- 
human immunoglobulin, peroxidase-conjugated avidin, biotin-conjugated anti-human 
monoclonal antibodies, phorbal,12-myristate, 13-acetate (PMA), p-nitrophenyl phosphate 
(pNpp), sodium dodecyl sulfate, temed (N,N,N ’ ,N ’ -tetramethylethylenediamine), triton X- 
100.
Amicon (Danvers, MA, USA)
8400 Ultrafiltration Unit.
Bachem (Bubendorf, Switzerland)
Z-phe-arg-AMC.
BioRad (BioRad Lab. GmbH, M ünchen, Germany)
Bradford assay.
Crompton Paddock Laboratories (Berkshire, UK)
Fasciola hepatica metacercariae.
2.1 Materials:
35
GibcoBRL, Life Technologies Ltd (Paisley, UK)
Roswell park memorial institute-1640 medium (RPMI-1640), fetal calf serum (FCS), 
penicillin/streptomycin (1000 IU/10000 ng), L-glutamine
Nuclon (Kamstrup, Roskilde, Denmark)
Microtitre plates.
Pierce and W arriner (Chester, England)
BCA (bicinchoninic acid), protein assay reagent kit.
Pharmacia LKB Biotechnology (Uppsala, Sweden)
QAE Sephadex A50, Sephacryl S-200HR
Pharminogen (San Diego, USA)
Alkaline phosphatase-conjugated rat anti-mouse IgGl, IgG2a, Ig2b and IgG3, biotin 
conjugated rat anti-mouse IFN y, IL-5, IL-4, IL-10 and IL-12, mouse purified IFN y, IL-5, 
IL-4, IL-10 and IL-12, purified anti-mouse IFN y, IL-5, IL-4, IL-10 and IL-12.
Reidel-de-Haen (Seelze, Germany):
Bromophenol blue, citric acid, dimethyl formamide (DMF), ethylenediaminetetraacetic 
acid (EDTA), di-sodium hydrogen phosphate, glucose, glycerol, glycine, hydrochloric
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acid, potassium dihydrogen phosphate, protogel, sodium acetate, sodium chloride, sodium 
dihydrogen phosphate, tris-HCl, glycin
Schliecher and Schull (Dassel, Germany)
Nitrocellulose paper.
Wallae (Turka, Finland)
BetaScint, fibre filter mats, microbeta scintillation counter.
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During three expeditions to Bolivia carried out by this laboratory serum samples were 
obtained from 29 individuals in the village of Chijipata Alta (February 1996). In addition, 
blood samples stored on filter paper were obtained from 10 individuals in the village of 
Chijipata Alta (February 1996) and from 67 individuals living in the village of Cutusuma 
(March 1997). Blood collected by venepuncture was allowed to clot and the serum 
obtained following centrifugation at 2000 x g  for 5 minutes, was subsequently stored at - 
20°C. Blood on filter paper was obtained by soaking drops of blood onto whatmann filter 
paper. Filter paper samples were stored at 4°C.
Serum samples were also obtained from the serum library of the Insitituto Nacional 
de Laboratorios de Salud (INLASA) in Bolivia. One hundred and forty four serum 
samples and 64 filter paper samples were obtained from individuals living in the village of 
Cutusuma (1987), 95 serum samples were obtained from individuals residing in Calasaya 
(December, 1991) and 32 serum samples from individuals residing in Santa Ana 
(December 1991). A summary of the serum samples obtained were shown in Table 2.1.
All samples were accompanied by data concerning the donor age, gender, location 
and date of sample collection. Coprological analysis for F. hepatica eggs was performed 
on faecal samples obtained from all individuals as outlined in section 2.4. Serum samples 
from patients infected with schistosomiasis (20), cysticercosis (15), hydatidosis (15) and 
Chagas disease (15) were obtained from the INLASA serum library. Five serum samples 
from patients infected with filariasis were donated by Dr. Alex Loukas at the Institute of 
Cell, Animal and Population Biology, University of Edinburgh. These samples were used
2.2 Subjects and serum samples
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to test for cross reactivity in the assay. Control serum samples were provided by eight 
volunteers at Dublin City University.
Table 2.1 Summary of serum samples obtained:
Location Year N u m b er c>f Sam ples Total 
Num ber 
of Samples
Serum
Y/N
Filter
Y/N
Coprolgical
analysis
Y/N
Source
<16 years >16 years
Cutusuma 1987 93 51 144 Y Y Y INLASA
Calasaya 1991 22 67 89 Y N Y INLASA
Santa Ana 1991 \ \ 32 Y N Y INLASA
Chijipata 1996 15 14 29 Y Y Y DCU EXPEDITION
Cutusuma 1997 66 \ 66 N Y Y DCU EXPEDITION
All studies performed with samples from humans were approved by the Ethics Committee 
of INLASA and by the Department of health, Bolivia. The nature of the study was 
explained to each individual and a signed document of consent was obtained prior to 
commencement of the studies. In addition, a record of each volunteers personal details 
were obtained. All individuals which were positive for fasciolosis were offered treatment 
with triclabendazole.
2.3 Elution o f human antibodies from filter paper
The method employed was previously described by Coltorti et al. (1988). Antibodies 
were obtained from blood stained filter paper by cutting one circle of 5 mm in diameter 
and soaking it in 250 (il of PBS for one hour at room temperature. An antibody dilution 
of 1:100 was assumed for all eluates.
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2.4 Coprological analysis o f human faecal sam ples
All coprological analysis was performed by Dr. Rene Angles (Unidad de Parasitología, 
INLSA, Bolivia) and by Dr. Jose Esteban (Faculty of Pharmacy, University of Valencia, 
Spain) using either the Kato-Katz technique or the MIF sedimentation method. The Kato- 
Katz technique (Katz el al., 1972) is a simple faecal thick smear technique. The faecal 
sample was smeared on a slide and a positive diagnosis made by the presence of F. 
hepatica eggs in the sample.
The MIF sedimentation Method (Esteban et al., 1997) was employed to determine 
egg number in addition to diagnosis. Two grams of faeces were suspended in water plus 
an emulsifying agent, merthiolate-iodine-formaldehyde (MIF). The eggs were separated 
by sedimentation. A standard technique of three series of repeated washing and 
sedimentation was employed.
2.5 Preparation of liver fluke antigens
2.5.1 Preparation o f liver fluke homogenate
Adult liver flukes were obtained from infected livers of condemned cattle at an abattoir in 
Ballyjamesduff, Co Cavan. In order to remove bile and debris the flukes were washed six 
times in sterile phosphate buffered saline (PBS) (0.14 M NaCl, 2.7 mM KCL, 8.1 mM 
Na2PO|H and 1.5mM KH2P 0 4), pH 7.3. Five mature liver flukes were homogenized in a 
Thyrister Regler TR homogenizer with 10 mis of sterile PBS. The liver fluke homogenate 
was centrifuged at 13,000 X g for 30 minutes. The supernatant containing soluble
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antigens liver fluke homogenate (LFH) was removed, aliquoted in 1 ml vials and stored at 
-20°C. Protein concentration of all liver fluke antigens was determined using BCA assay 
(section 2.6).
2.5.2 Preparation o f liver fluke excretory/secretory products
Excretory/secretory (ES) products were prepared as described by Dalton and Heffernan 
(1989). Briefly, adult liver flukes (approximately 40) were cultured in vitro for 24 hours in 
150 mis of RPMI-1640, pH 7.3, containing 2% glucose, 30 mM Hepes and 25 mg/ml 
gentamycin at 37°C. The culture media was changed eight hours later and the flukes were 
incubated for a further 12 hours. The culture media were pooled and centrifuged at 
13,000 X g  for 30 minutes to remove debris (particularly eggs). The ES products were 
filter-sterilised and concentrated to 10 mis using an Amicon 8400 Ultrafiltration Unit 
(Danvers, MA, USA) with a Ym3 membrane (3000 mw cut-off). Aliquots of 1 ml were 
then stored at -20°C.
2.5.3 Purification o f cathepsin L cysteine proteinases
Cathepsin LI was purified from ES products as described previously (Dowd et al., 1994; 
Smith et al., 1984). Culture media in which mature flukes were maintained in vitro were 
concentrated from 500 mis to 10 mis as previously described (section 2.2.2.). The 
concentrated ES was applied to a Sephacryl S200HR gel filtration column (2.6cm X 
74.5cm) equilibrated in 0.1 M Tris-HCl, pH 7.0, at 4°C. The column was eluted with 
0.1M Tris-HCl, pH 7.0, and after a void volume of 110 mis had passed, 5 ml fractions 
were collected. The column eluate was monitored for protein concentration at 280 ran
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using a LKB Uvicord monitor. Fractions were analyzed for cathepsin L activity using the 
fluorogenic substrate, Z-phe-arg-NHMec.
Fractions containing cathepsin L activity were pooled and applied to a 50 ml QAE- 
Sephadex column (2.5 cm X 10.0 cm) equilibrated in 1M Tris-HCl, pH 7.0. Cathepsin LI 
was collected in the column run-through. This was then passed over the column once 
more and the second run-through collected. The elution containing CL1 was concentrated 
using an Amicon 8400 Ultrafiltration Unit (Danvers, MA, USA) with a Ym3 membrane 
(3000 mw cut-off). Aliquots o f 1 ml were stored at -20°C. Cathepsin LI analyzed by 
sodium dodecyl sulfate (SDS)-PAGE for purity (section 2.8) and enzyme activity was 
measured using gelatin substrate (GS)-PAGE (section 2.9) and fluorgenic assay with Z- 
phe-arg-NHMec (section 2.7).
2.5.4 Purification of recombinant yeast-expressed cathepsin LI proteinase
The culturing of pFheCLlY29-transformed DBY746 yeast expressing active cathepsin LI 
cysteine proteinase was performed by Dr. Andrew Dowd as previously described (Dowd 
et al., 1997; Roche et al., 1998). Twenty mis o f concentrated yeast supernatant was 
provided and purified using gel filtration chromatography as described in section 2.5.3. 
Fractions were assayed for cathepsin L proteinase activity and the fractions containing 
activity, pooled and concentrated. The purity and activity of the recombinant cathepsin L 
was analysed by SDS-PAGE gel (section 2.8), GS-PAGE gel (section 2.9) and by assay 
using the fluorogenic peptide Z-phe-arg-NHMec (section 2.7).
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2.6 Measurement of protein concentrations
Protein concentrations of all liver fluke antigens were measured using bicinchoninic 
protein assay (Smith et a l, 1985). This assay was used to quantitatively determine protein 
concentrations within the range of 20 j_tg to 2,000 jig/ml. Bovine serum albumin at 
concentrations from 25 jig/ml to 2000 (ig/ml were used to plot a standard curve.
Concentration of all Bordetella pertussis antigens were measured using the 
Bradford assay (Bradford et a l, 1976). This assay was used to determine protein 
concentrations within the range of 10 jag-1000 p.g. The protein standards employed was 
bovine serum albumin at concentrations of 10 jig-1000 jig/ml..
2.7 Measurement of the cathepsin L activity using the fluorogenic 
substrate Z-phe-arg-NHMec
Proteinase activity was measured fluorometrically using Z-phe-arg-NHMec as substrate 
(Barrett and Kirschke, 1980). Assays (1 ml volume) were performed with substrate at a 
final concentration of 10 (jrn in 0.1 M, Tris-HCl, pH 7.0, containing 0.5 mM dithiothreitol. 
Each mixture was incubated at 37°C for 30 minutes and the reaction stopped by the 
addition of 200 [il of 1.7 M acetic acid. The activity of each sample was measured in 
duplicate and at three different dilution’s. The amount o f 7-amino-4-methylcoumarin 
(NHMec) released was measured using a Perkin-Elmer fluorescence spectrophotometer 
with excitation set at 370 nm and emission at 440 nm. One unit of enzyme activity was 
defined as that amount which catalyzed the release of one jimole of NHMec per minute at 
37°C.
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2.8 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS- 
PAGE)
All antigens were analyzed by one dimensional, 12% SDS-PAGE according to the method 
of Laemmli (1970). The running gel was prepared using 12% (w/v) acrylamide, 0.27% 
(w/v) bisacrylamide, 0.373 M Tris-HCl, pH 8.8, 0.1% (w/v) SDS, 0.03% (w/v) 
ammonium persulphate and 0.008% TEMED. The stacking gel contained 3% (w/v) 
acrylamide, 0.08% (w/v) bisacrylamide, 0.125 M Tris-HCl, pH6.8, 0.075% (w/v) 
ammonium persulphate, 0.1% (w/v) SDS and 0.023% (w/v) TEMED. Samples were 
prepared in non-reducing (0.12 M Tris-HCl, pH 6.8, containing 5% (w/v) SDS, 10% 
(w/v) glycerol and 0.01% (w/v) bromophenol) and reducing sample buffer (same as above 
except that 5% 2-mercaptoethanol was included, and the sample boiled for two minutes). 
Gels were run in a vertical slab gel apparatus in electrode buffer (25 mM tris-HCl, 192 
mM glycine and 0.1% SDS, pH 8.3) at 25 mA at room temperature. A voltage of 8V/cm2 
was applied and the gel was run until the bromophenol blue dye reached the bottom of the 
gel. Proteins were visualized by soaking the gel in a solution containing 0.1% (w/v) 
Coomassie Brilliant Blue R, 20% (v/v) methanol and 10% acetic acid for one hour at 
room temperature. The gel was destained with 20% (v/v) methanol and 10% (v/v) acetic 
acid.
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2.9 Gelatin-substrate polyacrylamide gel electrophoresis (GS-PAGE)
GS-PAGE was performed as described by Dalton and Heffeman (1989). The preparation 
of the gel was similar to that of SDS-PAGE except that 0.1% gelatin was added. Samples 
were applied in non-reducing sample buffer to maintain biological activity. After 
electrophoresis the gels were washed for 60 minutes in 0.1M sodium citrate, pH 4.5, 
containing 2.5% triton X-100 with one change to remove the SDS. The gels were 
subsequently incubated in 0.1 sodium citrate, pH 4.5 for 12 hours at 37°C, and stained in 
Coomassie Brilliant Blue R solution as previously described.
2.10 Enzyme linked immunosorbant assay (ELISA)
The optimal dilutions of antigen, serum and secondary antibodies for the ELISA method 
described below was determined using a chequerboard titration method. One hundred p.1 
of LFH, ES, CL1 or YCL1 antigen (50 jig/m], 20 (J-g/ml, 5 |ug/ml and 5 fJ-g/ml, 
respectively) was dispensed into wells of a microtitre plate which were subsequently 
incubated overnight at 37°C. Excess protein binding sites were blocked at 37°C for 30 
minutes by adding 200 f_il 2% bovine serum albumin (BSA) diluted in PBS/0.1% Tween 
20 to each well. After the wells were washed three times with PBS/0.1% Tween 20, 
human sera (diluted 1:125) were added and the plates incubated for 30 minutes at 37°C. 
Following another wash, 100 |xl of peroxidase-conjugated anti-human IgG (diluted 
1:4000) or 100 |xl of biotin-conjugated anti-human IgGl, IgG2, IgG3 or IgG4 monoclonal 
antibodies (diluted at 1:1000, 1:4000, 1:4000 and 1:1000, respectively) were added to
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each well and the plates incubated for a further 30 minutes at 37°C. The washing step was 
repeated. The binding of the biotin-conjugated antibodies was then detected by the 
addition of 100 pi of avidin-conjugated peroxidase (diluted to 1:4000) into each well. The 
binding of the secondary antibody was visualized by the addition of 100 \il o f ABTS (25 
mg/100 mis) in phosphate citrate buffer, pH 5.0 (0.2 M Na2HPC>4 0.1 M citric acid, mixed 
in a ratio of 25.7:24.3). After the colour had developed for 10 minutes the plates were 
read on a Titreteck multiscan at 405 nm. All samples were assayed in triplicate.
2.11 Preparation of formaldehyde treated sonic extract of B . p e r tu ss is  
antigen
Formalin treated B. pertussis antigen was prepared as previously described (Redhead et 
al., 1993). In brief, a bacterial suspension of B. pertusis at 5 X 107 - 5 X 109 was 
sonicated in sterile PBS. The sample was centrifuged at 10,000 X g  for 15 minutes at 
4°C. The supernatant was removed and the protein concentration determined using the 
Bradford assay. The concentration of sample was adjusted to 100 jxg/ml. Gelatin 
(0.02%) and Tween 20 (0.05%) were added before treating with 0.02-0.04% 
formaldehyde for 7 days. After 7 days the sample was exhaustedly dialysed against PBS 
for seven days at 4°C. The concentration was measured as described in section 2.6 and 
the sample stored at 4°C.
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A mixture of 500 (j.1 of ethidium bromide/acridine orange (ETBR) (10X stock; dissolve 10 
mg of ethidium bromide and 10 mg of acridine orange in 100 mis of sterile PBS) and 10 fil 
of cell suspension was made to count the number of viable spleen cells (1:10 dilution for 
lymph node cells). The number of viable cells (green) or non-viable cells (red) were 
counted by using direct microscopic counts with a haemocytometer and a Olympus T041 
fluorescent microscope.
2.14 Stimulation of murine spleen and lymph node cells with antigen
In vitro culturing of cells was performed as previously described (Redhead et al., 1993). 
Briefly, spleens from individual mice or lymph nodes pooled for four mice were removed 
aseptically and the cells crushed in a wire grid to form a single cell suspension in RPMI 
1640 medium containing 8% heat inactivated FCS (fetal calf serum), penicillin (100 U/ml), 
streptomycin (100 fig/ml) glutamine (2 nM) and 2-ME (5X105 M). Cell suspensions were 
then washed in RPMI medium and resuspended in 0.5 mis or 2 mis of RPMI for lymph 
nodes and spleen cells, respectively. The number of viable cells per ml were counted as 
described in section 2.13 and the concentration adjusted to 2 X 106 /ml for spleen cells and 
1 X 106 /ml for lymph node cells. The cells were stimulated in vitro in a 96 well plate by 
the addition of varying concentrations of antigen (LFH, 100 ng/ml -0.03pg/ml; ES 20-100 
fi.g/ml; BP 0.2-5 (-ig/inl). PMA/a-CD3 and RPMI was added to additional wells as a 
positive and negative controls, respectively. The cells were incubated in a CO2 incubator 
for three days at 37°C. After 24 hours 50 |il of supernatant was removed to measure IL-2
2.12 Assessment of cell viability
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production and after 72 hours supernatant was removed to measure all other cytokines. 
All tests were performed in triplicate.
2.14 Measurement of murine IL-2 by CTLL Bioassay
Cytotoxic T-cell lymphocytes (CTLL’s) were maintained in RPMI 1640 medium 
containing heat inactivated FCS, penicillin (100 U/ml), streptomycin (100 (ig/ml) 
glutamine (2nM) and 2-ME (5X105 M). Recombinant IL-2 was added to give a final 
concentration of 3 fig/ml to promote cell proliferation. Every 2-3 days when cell growth 
was confluent the cells were split by taking 2 mis of the cell suspension and adding it to 8 
mis of fresh media.
IL-2 was assayed by testing the ability of the supernatant from antigen stimulated 
T-cells to support the proliferation of a IL-2 sensitive, CTLL cell line. Nine mis of CTLLs 
were spun down at 1100 X g  for 6 mins at room temperature (the remaining 1 ml is added 
to fresh media and incubated for three days at 37°C before cryopreservation.) The 
supernatant was pipetted off and the cells were resuspended in 10 mis of fresh warm 
media in order to remove the recombinant IL-2. This washing step was repeated twice 
and the cells were placed in a CO2 incubator at 37°C. After 1 hour the washing step was 
repeated and the number of cells counted as described in section 2.13. The cell 
concentration was adjusted to a concentration of 1 X 105cells/ml. To each well containing 
CTLL’s 50 (j.1 of supernatant or standard were added and the plates incubated at 37°C 
overnight in a CO2 incubator. After 24 hours the cells were pulse labelled with 25 (j.l/ml of 
[3H]-thymidine, 25 |il per well (50 fil per 2.5 ml plate) and incubated for 4 hours at 37°C.
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The cells were subsequently harvested onto glass-fiber filter mats with an automatic cell 
harvestor. The filters were dried and sealed in sample bags with non-aqueous scintillation 
fluid, betascint. [3H]-thymidine incorporation was measured using a microbeta 
scintillation counter. The results were expressed as the mean counts per minute (cpm) of 
[3H]-thymidine incorporation for triplicate cultures. The concentration of each sample 
was determined using the standard curve and the concentration was expressed as 
international units per ml.
2.15 Measurement of murine cytokine by capture ELISA
The cytokines IL-5, IL-4, IL-10, IL-12 and IFNy were measured by capture ELISA as 
described by Barnard et al. (1996). Approximately 50 p,l of capture antibody at a 
concentration of 1 fag/ml was dispensed into each well of a microtitre plates which were 
subsequently incubated overnight at 4°C. Excess protein binding sites were blocked at 
room temperature for two hours by adding 200 pi of skimmed milk at a protein 
concentration of 1 mg/ml. After the wells were washed six times, 50 pi of supernatant or 
standard were added in triplicate and the plates incubated overnight at 4°C. The washing 
step was repeated and the biotin labeled detector antibody (1 pg/ml), was added to each 
well and the plates incubated at room temperature. After one hour the plates were 
washed and avidin-alkaline phosphatase at a 1/2500 dilution was added to each well for 30 
minutes at room temperature. Bound antibodies were detected by the addition of 100 (0.1 
pNPP (lmg/ml) in diethanolamine buffer, pH 9.8 (97mls of diethanolamine, 0.2g NaN2 
and 100 mg of MgCL2.6H20). The plates were allowed to develop in the dark until the
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top standard exhibited an absorbance of 1 absorbance unit at 405nm. Standard curves 
were used as a reference to determine concentration. Concentration of IL-5, IL-4, IL-10 
and IL-12 were expressed as pg/ml, whereas IFNy was expressed as ng/ml.
2.16 Culturing of murine peritoneal exudate cells
Peritoneal exudate cells were obtained from BALB/c mice by performing pertinoneal 
lavage with 10-15 mis of cold sterile serum free media. The cells were washed two times 
with serum free media, the cell number calculated and the concentration of the cells 
adjusted to 1 X 106 cells/ml. The cells were cultured in triplicate in the presence of 
varying concentrations of ES and LFH antigen (20-100 pg/ml) for 72 hours, then the 
supernatant was removed after 72 hours and the concentration of IL-10 present in the 
supernatant was measured.
2.17 Measurement of IgGl and IgG2a isotypes
Approximately 100 pi of ES (10 pg/ml) was dispensed into wells of a microtitre plate 
which were subsequently incubated overnight at 4°C. Excess protein binding sites were 
blocked for two hours at room temperature by adding 200 pi of skimmed milk (1 mg/ml) 
into each well. The serum samples were titred at a dilution of 1:100 - 1:218,700. After 
the wells were washed six times with PBS/0.1% Tween 20 the serum was added in 
triplicate and the plates incubated overnight at 4°C. After 24 hours the wash step was 
repeated and alkaline phosphatase conjugated rat IgGl and IgG2a, (diluted at 1:500, 
1:1000 respectively) were added to each well and the plates incubated for one hour at
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room temperature. After a final washing step, bound antibodies were detected by the 
addition of pNpp (1 mg/ml) in diethanolamine buffer, pH 9.8. The plates were read on a 
Titreteck multiscan at 405nm. The antibody titre was expressed as log titre.
2.18 Mice models
Mice were maintained under the guidelines of the Irish Department of Health. All mice 
were female and between 2-3 months old at the initiation of the experiment. (3.7.3).
2.19 Statistical analysis
Cluster analysis, regression analysis, chi-squared analysis and student t test were 
performed using SPSS for Windows™. K-Means Cluster analysis was carried out to 
separate the ELISA data into two sub-populations. Euclidian distances between pairs of 
data points were first calculated using the combined, unweighted absorbances due to two 
experimental groups. Two initial cluster centres were derived from the Euclidian distances 
and class assigned to clusters by a process o f iteration and classification using a maximum 
of 10 iterations, and a convergence criterion of 0.02. These parameters correspond to the 
default settings for the process in SPSS. The statistical analysis for the immunodiagnostic 
data was carried out in collaboration with Dr. Michael Parkinson.
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Chapter 3
Imimmodiagnosis of Fasciola hepatica infection 
(fasciolosis) in a human population 
in the Bolivian Altipiano.
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Several methods have been developed for the immunological diagnosis of human 
fasciolosis. Enzyme linked immunosorbant assay is both a sensitive and reliable means 
of diagnosing the acute and chronic stages of human fasciolosis (Hillyer et ah, 1992). 
Previously developed ELISA methods have employed crude somatic antigen or liver 
fluke excretory/secretory (ES) products to detect anti-fluke antibodies in serum 
(Knobloch el ah, 1985). These antigen preparations are complex and may result in 
reduced specificity of the assay since many parasites share similar antigens (Capron et 
ah, 1971). Previous work in this laboratory led to the isolation and characterisation of 
cathepsin LI, a major molecule of ES products. This molecule has been shown to be 
highly immunogenic in infected animals (Smith el ah, 1993; Dowd et ah, 1994).
In this study we analysed and compared the respective suitability o f liver fluke 
crude somatic antigen (LFH), excretory/secretory products (ES) and purified cathepsin 
LI cysteine proteinase (CL1) as coating antigens in an indirect ELISA for the 
serological detection of human fasciolosis. Initially, the detecting antibody employed 
was rabbit anti-human total immunolglobulin but since we discovered that the 
predominant IgG isotype elicited by liver fluke in humans is IgG4, an ELISA was 
developed with enhanced sensitivity based upon the detection of lgG4 responses to ES 
or CL1. Finally, the specificity of the assay was determined by assaying sera from 
individuals infected with other parasitic diseases.
3.1 Introduction
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Serum samples obtained on December the 16th, 1991, from 95 native Aymara (47 
males and 48 females) living in Calysaya, a small village northwest of La Paz, Bolivia, 
were used in this study. The age of the volunteers ranged between one and 85 years, 
with a mean +/- standard deviation (SD) age of 31.4+/- 19.9 years. Coprological 
analysis for F. hepatica eggs was available in respect to 58 individuals in this group. 
Serum samples from ninety one individuals were serologically analysed by enzyme 
linked immunosorbant assay for cysticercosis using soluble extracts of Taenia solium. 
The latter two tests were performed at the Instituto Nacional de laboratorios de Salud 
(INLASA) in 1991.
The serum samples were analysed by ELISA for total antibody responses 
against LFH, ES and CL1 and the absorbance data was statistically analysed. In order 
to increase the sensitivity of the immunodiagnostic assay we investigated the 
application of secondary antibodies directed against the different subclasses of human 
IgG antibodies namely anti-fluke total IgG, IgGl, IgG2, IgG3 and IgG4. The 
specificity of the ELISA for detecting fasciolosis was examined by testing sera 
obtained from patients with other infections including schistosomiasis mansoni (20), 
cysticercosis (15), hydatidosis (15) and Chagas disease (15).
3.2 Experimental design
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3.3.1 Analysis of human serum samples by ELISA using rabbit anti­
human total IgG as detecting antibody.
3.3.1.1 Comparison o f LFH, ES and CL1 in ELISA.
As previously noted serum samples were obtained in December (1991) from 95 
Aymarans living in the village of Calasaya in the Bolivian Altiplano. These samples 
were analysed by ELISA for total antibody responses against LFH, ES and CL1. The 
population was then examined by plotting the frequency of absorbancy measurements, 
grouped into blocks of 0.05 absorbance units, as histograms (Fig. 3.1 A, B and C). The 
frequency distribution of the absorbances obtained with all three antigens was bimodal. 
The largest mode situated to the left of the histograms represents the seronegative 
population and the second smaller mode located to the right represents the seropositive 
population.
The histogram displaying LFH absorbance shows a single broad peak at 0.175 
absorbance units (A) and a long tail stretching up to 0.7 A (Fig. 3.1 A). There is a 
second poorly defined peak at approximately 0.5A. In this histogram it is difficult to 
distinguish between the seronegative and seropositive population as there is no clear 
division between the peaks in the histogram. In contrast, the frequency distribution 
obtained with ELISA, using ES as antigen exhibits two peaks, at 0.175A and 0.675A, 
although a small peak at 0.375A may represent the points where these seronegative 
and seropositive populations bisect (Fig. 3.IB). ELISAs performed with purified CL1 
as antigen further discriminated between the seronegative and seropositive populations, 
with absorbance peaks at 0.15A and 0.475A (Fig. 3.1C). For both ES and CL1
3.3 RESULTS
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antigens, the low absorbance peak follows a bell-shaped curve characteristic of a 
normal distribution. In a normally distributed populations, 99.9% of all individuals 
should lie within 3.09 standard deviations of the mean. Therefore, a cut-off point that 
defines the seronegative from the seropositive population can be calculated. The 
calculated values for ES and CL1 antigens are 0.35A and 0.32A, respectively (dashed 
line in Fig. 3 .IB and C).
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ELISA reading @ 405nm (absorbance units)
F igu re 3 .1 . Analysis of sera obtained from 95 Aymarans by total IgG-ELISA utilising 
liver fluke homogenate, LFH (Panel A), excretory/secretory products, ES (Panel B) 
and purified cathepsin L I, CL.1 (Panel C) as antigen. The frequency of the absorbance 
readings obtained were grouped into 0.05  absorbance units and plotted as histograms.
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The vertical dashed lines in Panel B and Panel C represent the cut-off point between 
the seronegative and seropositive populations which were calculated as 3.09 standard 
deviations from the mean of the seronegative population.
3.3.1.2 Scattergram comparison o f ELISA results obtained with ES and CL1.
When the absorbances obtained for ES and CL1 antigens were plotted against each 
other in a scattergram a scatter of points centred at a low absorbance and another at a 
high absorbance was observed (Fig. 3.2A). The data was sorted into two clusters 
using K-means cluster analysis. This analysis provides an objective and unbiased 
method for separating the data into two sub-populations based on a range of measured 
parameters (in this case, antibody responses to ES and CL1). This analysis designated 
26 individuals in the high absorbance cluster as seropositive and 69 individuals in the 
low absorbance cluster as seronegative (Fig. 3.2A, indicated by solid and open circles 
respectively). While all of these 26 individuals were seropositive when ES alone was 
employed for detecting antibody, 20 were seropositive when CL1 was utilised (above 
horizontal dashed line in Fig. 3.2A). However, nine individuals determined as being 
seronegative by cluster analysis were deemed positive when ES was used as antigen in 
ELISA (open circles right of vertical dashed line, Fig. 3.2A).
3.3.1.3 Coprological analysis o fF . hepa tica  eggs.
Co pro logical analysis for F. hepatica was performed on 58 individuals in this 
population. Six individuals were diagnosed as being coprologically positive for F. 
hepatica by the Kato-Katz technique. Chi-squared statistical analysis of the observed 
and expected numbers revealed a very highly significant (P<0.001) over-representation 
of individuals with fluke eggs in the seropositive cluster (all 6 grouped with the
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seropositive cluster). Seven individuals that were coprologically negative were among 
the 26 serologically positive individuals. All remaining coprologically negative 
individuals were among the seronegative sub-population (Fig. 3.2A).
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Figure 3.2. Scatter graphs of the combined data obtained in the total IgG-ELISA 
(Panel A) and IgG4-ELISA (Panel B) using ES and CL1 antigens were plotted. K- 
means cluster analysis using the combined data obtained for ES and CL1 in the total 
IgG-ELISA separated the population into seronegatives (indicated by open circles) and 
seropositives (indicated by solid circles) sub-populations (Panel A). The performance 
of the individuals in these sub-populations in the IgG4-ELISA is also indicated by the 
open and closed circles (Panel B). The vertical and horizontal dashed lines indicate the 
calculated cut-off points for ES and CL1 antigens in the total IgG-ELISA and IgG4- 
ELISA.
3.3.1.4 ELISA for cysticercosis
Ninety one sera samples were also analysed for cysticercosis at the INLASA, La Paz 
using the ELISA technique. Fifteen individuals were found to be seropositive for 
cysticercosis using this method. These positive individuals were evenly distributed 
throughout the population. Chi-squared statistical analysis of the observed and 
expected numbers showed no significant over-representation in either cluster (Fig. 
3.3).
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Figure 3.3 This graph is identical to that shown in Figure 3.2. Panel B. However, the 
individuals in-this population who tested positive for cysticercosis are indicated by the 
closed circles. This graph illustrates that the cysticercosis positive individuals are 
evenly distributed throughout the population.
3.3.2. Analysis of isotypic responses of humans.
The 26 individuals deemed seropositive by cluster analysis using ES as antigen were 
selected for an analysis of the IgGl, IgG2, IgG3 and IgG4 antibody responses to LFH, 
ES and CL1 (Fig. 3.4A, B and C, respectively).
When LFH was used as a coating antigen in this ELISA the highest mean 
absorbance above the mean of the negative controls was obtained when anti-IgGl
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conjugated secondary antibody was employed (mean = 0.292). Similarly, high 
absorbances were also obtained with anti-IgG4 conjugated secondary antibodies (mean 
= 0.129). In contrast, the mean absorbances values obtained for IgG2 and IgG3 were 
low (0.004 and 0.009, respectively) (Fig. 3.4A). The lowest absorbance readings 
obtained against LFH with the seropositive sera overlapped with the highest 
absorbance readings obtained with sera from the negative controls.
When the coating antigen was ES, the highest mean absorbances were also 
obtained with anti-IgGl- (mean = 0.304) and anti-IgG4- (mean = 0.477) conjugated 
secondary antibodies, although the latter of the two exhibited the highest absorbance 
readings (Fig. 3.4B). With these two isotypes there was no overlap of the absorbance 
readings for the positive and negative controls.
Using CL1 as a coating antigen the highest mean absorbances were obtained 
with anti-IgGl- (mean = 0.262) and anti-IgG4- (mean = 0.540) conjugated secondary 
antibodies and similarly to ES antigen the latter of the two exhibited the highest mean 
absorbance readings. There was no overlap of absorbance readings for the positive 
and negative controls when CL1 was employed (Fig. 3.4C).
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Figure 3.4. Analysis of the isotypic responses of the 26 Aymaran individuals deemed 
seropositive by the K-means cluster analysis (Pos.). Sera were analysed by ELISA 
utilising LFH (A), ES (B) and CL1 (C) as antigen. Iso type responses were detected 
using avidin-conjugated rabbit anti-human IgGl, anti-human IgG2, anti-human IgG3 
and anti-human IgG4. Sera obtained from eight volunteers at Dublin City University 
served as background negative controls (Neg.).
3.3.3 Analysis of human serum samples by ELISA using rabbit anti­
human lgG4 as detecting antibody.
Since we established that IgG4 was the more effective isotype for distinguishing 
between seropositive and seronegative individuals, we measured the IgG4 responses of 
all 95 individuals to ES and CL1 by ELISA. The absorbance frequencies were then 
plotted as a histogram. The seronegative sub-population was represented by a bell­
shaped curve with a sharp single peak (Fig. 3.5A and B) for both antigens. The cut-olf 
point between the seronegative and seropositive sub-populations was calculated as
previously described (3.09 standard deviations of the mean); values o f 0.202A and 
0.169A were obtained for ES and CL1, respectively (vertical lines in Fig. 3.5). These 
cut-off values were much lower than those calculated for the total IgG ELISA (Section 
3.3.2.1; Fig. 3.IB and C). From this analysis it was observed that using CL1 allowed 
the identification of a more defined separation between the two populations than ES.
A comparison of scatter graphs of the absorbances obtained for total IgG- 
ELISA and IgG4-ELISA responses to ES and CL1 revealed that there is a more 
sharply defined difference between the seronegative and seropositive sub-population in 
the IgG4-ELISA (Fig. 3.2, compare A and B). In the IgG4-ELISA the seronegative 
sub-population formed a tight cloud in the low absorbancy region (Fig. 3.2B). 
Therefore, in ELISAs using ES as antigen 29 individuals were deemed seropositive 
(right of vertical dashed line in Fig. 3.2B). However, five individuals of the 26 
identified as seropositive in the total IgG-ELISA were seronegative using this analysis; 
and eight of the previously deemed seronegatives were now seropositive. When CL1 
was used as the antigen for IgG4-ELISA, 20 individuals were deemed seropositive. 
Eighteen of these were also deemed positive by total IgG-ELISA, while two had been 
previously deemed seronegative (above horizontal dashed line, Fig. 2B). Also, two 
individuals previously deemed to be seropositive were now seronegative.
Linear regression analysis of the ELISA results obtained for all the seropositive 
individuals detected with ES or CL1 showed a linear relationship between both 
antigens (Fig. 3.2B, r2 = 0.922, dotted line indicates regression).
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Figure 3.5. Analysis o f sera obtained from 95 Aymarans by IgG4-ELISA utilising ES 
(Panel A) and CL I (Panel B) as antigen. The frequency of the absorbance readings 
obtained was plotted as histograms. The horizontal lines represent the cut-off point 
between the seronegative and seropositive populations which were calculated as 3.09 
standard deviations from the mean of the seronegative population.
66
3.3.4 Analysis of serum from humans infected with other parasites in 
the IgG4-ELlSA for fasciolosis.
Sera obtained from individuals with schistosomiasis mansoni, cysticercosis, hydatidosis 
and Chagas disease were analysed by IgG4-ELISA and compared to sera from 
individuals that were serologically and coprologically positive for fasciolosis.
For both ES and CL1 antigens individuals seropositive for fasciolosis gave 
significantly higher absorbance readings than those obtained from individuals infected 
with other parasites (Fig. 3.6A and B, respectively). The absorbance readings obtained 
from the sera provided by individuals with these various infections did not significantly 
differ in comparison with the sera obtained from control individuals.
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Figure 3.6. Analysis of sera from individuals with various infections by IgG4-ELISA 
utilising F. hepatica ES (Fig. 3.6A) and CL1 (Fig. 3.6B) as antigen. Serum samples 
obtained from individuals with schistosomiasis (20), cysticercosis (15), hydatidosis 
(15) and Chagas disease (15) were compared to control sera obtained from volunteers 
at Dublin City University (negative controls, neg.) and with sera obtained from 
Aymaran individuals infected with F. hepatica (positive controls, pos.).
3.4 Discussion
Enzyme linked immunosorbent assay has been successfully employed for the diagnosis 
of many parasitic diseases (Cook, 1990). In ELISAs previously developed for 
diagnosing human fasciolosis crude antigen preparations, such as somatic antigen or 
excretory/secretory antigens, were employed (reviewed by Chen and Mott, 1990). The 
principal disadvantage of using such a heterogeneous mixture of antigens is that it 
compromises the specificity of the ELISA. Reduced specificity occurs because cross
reactivity with similar antigens expressed by other parasites is a common feature 
(Capron et a l, 1971). Several reports have identified and described common cross­
reactive antigens between trematodes such as F. hepatica and Schistosoma mansoni 
(Fagbemi and Obarisiagbon, 1991; Hillyer et al., 1995; Tendler et al., 1996). In 
addition, the use of crude antigen makes standardisation of the ELISA problematic 
since variation in antibody responses may be observed in different laboratories due to 
different methods of antigen preparation and storage conditions (Sampaio Silva et a l,
1996). Previous studies have reported an increase in the sensitivity and specificity of 
ELISA employing a single purified Schistosoma mansoni egg antigen (CEF6) in 
comparison to an ELISA using a more complex soluble egg antigen (SEA) (DoenhofF 
et al., 1993; Ghandour et al., 1997). In an attempt to enhance the specificity and 
sensitivity of the serological diagnosis of human fasciolosis we examined the use of a 
single antigen, cathepsin LI (CL1), in these ELISA assays and compared its 
performance with crude somatic extract (LFH) and with a less crude preparation, ES.
Cathepsin LI cysteine proteinase was initially purified from liver fluke ES 
antigens by Smith el a l  (1993). It is synthesised by the intestinal cells in the gut lining 
of the liver fluke and released by vesicles into the gut lumen where it is hypothesized to 
have a number of functions. Cathepsin LI is believed to function by assisting in the 
migration of the maturing fluke through the liver tissue. In addition it was shown to 
block antibody-mediated host immune responses by cleaving immunoglobulin into the 
Fab and Fc regions (Dalton and Heffeman, 1989; Smith et a l, 1993; Smith el al., 
1993; Dowd el a l, 1994). The enzyme was considered as a potential candidate for the 
serological detection of acute fasciolosis since it is secreted by all stages of fluke 
development in the mammalian host, including newly excysted juveniles. Also, the
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enzyme elicits a humoral response in cattle as early as two weeks post initial infection 
facilitating diagnosis during the acute stage (Dowd et al., 1994).
In this study we investigated the ability of ELISA for its ability to identify 
infected individuals in an endemic area. The serum samples employed were obtained 
from 95 Aymaran individuals residing in Calasaya, a region in the Bolivian Altiplano 
where a high prevalence of human fasciolosis has been previously reported (Hillyer et 
a l, 1992; Bjorland et a l,  1995). The performance of all three antigen preparations, 
LFH, ES and CL1, was compared in order to determine which antigen exhibited the 
most discrimination between those individuals that were seropositive and seronegative 
for fasciolosis.
The frequency of OD absorbances for all three antigens using total anti-human 
IgG were presented as histograms. In a given population when the absorbance 
readings are plotted, the presence of infection should be represented by two distinct 
bell shaped peaks reflecting the serologically negative (non-infected) and serologically 
positive (infected) individuals, respectively. ELISA analysis demonstrated that 
utilizing LFH antigen did not adequately discriminate between seronegative and 
seropositive individuals within the population because the peaks in the LFH histograms 
have a large region of overlap. When ES, a less complex antigen mixture, was 
employed the sensitivity o f the assay was improved because the seronegative and 
seropositive populations were more clearly defined. However, there was a marked 
similarity to the LFH histogram in that the peaks were broad. In contrast, to both ES 
and LFH antigens, the histogram generated using CL1 had more clearly defined bell­
shaped peaks and a more significant separation between the seropositive and 
seronegative sub-populations.
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A common problem when using ELISA as a diagnostic tool in a given 
population is that it is often difficult to determine the exact cut-off point in the 
absorbance readings separating the seronegative from seropositive individuals. In an 
ELISA previously developed by Hillyer et al. (1992) to diagnose human fasciolosis, 
the positive individuals were described as those samples from individuals with an 
absorbance value greater than the mean plus three standard deviations of 20 negative 
controls samples. In similar studies, such as that performed by Espino et al. (1994), an 
absorbance reading greater than four standard deviations o f the mean absorbance 
values obtained for 100 coprologically negative individuals was defined as the cut-off 
absorbance value. Clearly different parameters are defined by different laboratories in 
identifying the positive population. This creates the risk that they will not identify a 
number of individuals in the acute stages of infection. This would significantly alter the 
mean absorbance reading of the cut-off value. Espino et al. (1998) recently described 
the development of a sandwich ELISA that detects circulation F. hepatica antigen in 
serum. An absorbance value of 0.25 absorbance units was chosen as an arbitrary cut­
off point because it separates seropositives from seronegatives in the initial assay. 
Using this arbitrary value, the intra-batch variation resulting from different specificity 
of monoclonal antibodies, time of blood collection during the course of infection and 
species specific antigen, was not considered. Standarisation of an ELISA to diagnose 
human fasciolosis will require a statistically valid way of determining the cut-off 
absorbance value between seropositive and seronegative individuals rather than 
arbitrarily chosen ones. Accordingly, in this study the ELISA data was sorted by K- 
means cluster analysis, a method now widely used to identify distinct sub-populations 
within whole populations (Ferguson et al., 1995; Prokpowicz Bobrowsta et al., 1995; 
Shiddo et al., 1995).
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The primary objective of cluster analysis is to classify data into relatively 
homogenous groups or clusters based on the variables considered. Each cluster 
contains variables which tend to be similar in each cluster but dissimilar to variables in 
other clusters. The similarity of the cluster is determined by measuring the distance 
between the pair of variables. This is known as the euclidean distance and is defined as 
the square root of the sum of the squared difference in values for each variable 
(Malhotra, 1996).
This study employed K-means cluster analysis, a statistical method widely 
employed in a diverse number of applications. This statistical method can be employed 
to predict the survival of infants in the third world (Harrell el al., 1998) or determine 
the prevalence of antibodies against an infection, such as lyme disease, in non- 
symptomatic individuals in an endemic zone (Kimura et al., 1995). Using this method 
the number of clusters is pre-specified and in this study the absorbance data for 
seropositive and seronegative individuals is divided into two clusters based on the 
measure of similarity in terms of distance between the absorbance readings. When the 
data is divided into two clusters the cut-off points are calculated as 3.09 standard 
deviations from the mean of the low absorbance cluster which contains 99.9% of the 
seronegative individuals.
Using this statistical method the ELISA data obtained for ES and CL1 were 
combined and the seropositive and seronegative populations identified. This analysis 
revealed that 26 individuals out of 95 clearly separated into a distinct high absorbance 
cluster (27.3%). All six individuals coprologically positive for fasciolosis associated 
with this seropositive population, supporting the use of this method for identifying 
those individuals harbouring infection in the latent or chronic stage. Seven 
coprologically negative individuals were also associated with this seropositive
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population. These individuals may have harboured acute infections (i.e., parasites 
which had not yet entered and matured in the bile ducts) or alternatively, they were 
coprologically misdiagnosed. The remaining 45 coprologically negative individuals all 
associated with the seronegative sub-population supporting the use of our IgG4 
ELISA as a sensitive means of diagnosing human fasciolosis.
The K-means cluster analysis shows that the ES detected all 26 individuals in 
the seropositive cluster. However the nine individuals that were deemed seronegative 
by cluster analysis were identified as positive when ES was employed. In comparison, 
CL1 identified 20 of the 26 individuals in the seropositive cluster, all of which were 
well separated from the seronegative cluster. The higher proportion of individuals 
reacting to ES was possibly a reflection of its more complex antigenic make-up. 
Moreover, it is unsurprising that CL1 detects a subset of the individuals identified by 
the ES since CL1 is one of the major components of ES.
An analysis of the isotypic responses of the individuals to ES and CL1 revealed 
that the predominant antibodies elicited by infection with F. hepatica were IgGl and 
IgG4 isotypes. The highest mean absorbance was associated with IgG4 isotype. 
These observations led to the development o f an ELISA that specifically detects anti- 
IgG4 responses of humans to ES and CL1.
Histograms of the frequency of OD values obtained (using IgG4-ELISA 
employing either ES or CL1 as antigen) showed that the seronegative population 
formed a sharper bell-shaped curve than that obtained with the total IgG-ELISAs. In 
addition, the definition between the seronegative and seropositive populations was 
substantially sharper. This difference was particularly obvious when the data was 
compared in scatter graphs (see Fig. 3.2A and B). In the IgG4-ELISAs the 
seronegative sub-population was found to cluster tightly together at the low
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absorbance readings, whereas the individuals forming part o f the seropositive sub­
population was dispersed in a wide range of high absorbance readings. Consequently, 
the calculated cut-off points were much lower and the ratio of the positive/negative 
absorbance readings much higher in the IgG4-ELISA compared to the total IgG- 
ELISA. Therefore, by limiting the detection of the ELISA to IgG4 isotypic responses 
the sensitivity of the assay was increased.
Five of the 26 individuals deemed seropositive by total IgG-ELISA employing 
ES as antigen were deemed seronegative by the IgG4-ELISA. Conversely, eight of the 
seronegative individuals by total IgG-ELISA were deemed seropositive by IgG4- 
ELISA. The differences in the composition of the seropositive population observed in 
the two ELISA methods may again reflect the complexity of the ES as different 
immunogens would elicit different isotypic responses. In contrast the results obtained 
in both ELISA methods that employed CL1 antigen were more consistent. Eighteen of 
the 20 individuals deemed seropositive by total IgG-ELISA were also found to be 
seropositive by the IgG4-ELISA. These particular eighteen individuals were always 
found within the seropositive sub-population, even when LFH was used as antigen. 
However the clearest distinction between these and the seronegative population was 
obtained when CL1 was employed in the IgG4-ELISA assay. Therefore whilst CL1 
identifies fewer individuals as seropositive compared to ES, this antigen provides a 
more reliable and confident diagnosis of the individuals that have been exposed to liver 
fluke infection.
Fifteen individuals in our sample population were serologically positive for 
cysticercosis, a disease caused by Taenia solium, which is also highly prevalent in the 
Bolivian Altiplano. Chi-squared analysis revealed that these individuals did not cluster 
with those that were serologically positive for liver fluke disease but were randomly
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distributed throughout the entire population. Thus, our IgG4-ELISA assay using liver 
fluke ES or CL1 does not pick up false positives due to cross-reactivity with antibodies 
induced by cysticercosis infections.
In order to examine the issue of specificity further, we analysed sera obtained 
from individuals diagnosed with single infections, including schistosomiasis mansoni, 
cysticercosis, hydatidosis and Chagas disease, in the IgG4-ELISA tests. Hydatidosis 
and cysticercosis are prevalent throughout the region where schistosomiasis mansoni, 
and Chagas disease are more common in other regions throughout South America. 
There are several studies reporting cross reactive antigens between schistosomiasis 
mansoni and fasciolosis (Fagbemi and Obarisiagbon, 1991; Tendler et al., 1996). 
However none of the sera cross-reacted with ES or CL1 in these assays which 
provides support for their use in the specific diagnosis of fasciolosis particularly in 
schistosomiasis endemic regions.
The results outlined in this chapter demonstrate that both ES and CL1 antigens 
can be used for the specific diagnosis of human fasciolosis using ELISA. The 
sensitivities of these ELISA assays were greatly improved by the use of conjugated 
secondary antibodies that detect IgG4 rather than total serum antibodies. CL1 
provided a more conclusive diagnosis compared to ES as it discriminated more sharply 
between the seropositive and seronegative sub-populations. This assay also 
demonstrated a 100% specificity as no cross-reaction was observed with 
schistosomiasis mansoni, cysticercosis, hydatidosis and Chagas disease. Finally this 
study which identifies 20 of the 95 individuals positive for fasciolosis (21%, by CL1 
IgG4-ELISA) confirms the earlier reports (Hillyer el al., 1992; Bjorland et al., 1995) 
of the high prevalence of human fasciolosis in the Bolivian Altiplano.
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Chapter 4
Immunodiagnosis of human fasciolosis using 
recombinant Fasciola hepatica cathepsin LI cysteine
proteinase.
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4.1 Introduction
Results presented in Chapter 3 demonstrated that CL1 can be employed as an antigen 
in ELISA for the sensitive and specific diagnosis of human fasciolosis. The sensitivity 
of this ELISA was improved by the use of conjugated second antibodies that detect 
IgG4 anti-CLl antibodies rather than total IgG anti-CLl serum antibodies. Recently, 
in our laboratory functionally active recombinant F. hepatica CL1 was expressed in the 
yeast Saccharomyces cerevisiae. This recombinant protein exhibited similar molecular 
size and physicobiochemical properties to the native CL1 (Roche el al., 1997). In this 
chapter we examine the potential of this recombinant protein as a diagnostic reagent 
for human fasciolosis in our IgG4-ELISA and compare it’s performance with native 
CL1 antigen.
4.2 Experimental Design
In this study we used blood samples obtained in January 1987 from 64 native 
individuals residing in the village of Cutusuma and in February 1996 from 25 
individuals living in Chijipata Alta. IgG4-ELISA was performed on all serum samples 
using recombinant and native CL1 antigen. Coprological analysis for F. hepatica eggs 
was performed at INLASA on faecal samples obtained from all individuals using the 
sedimentation method in 1987 and the Kato-Katz method in 1996.
The specificity of recombinant CL1 was analysed by performing IgG4-ELISA 
on serum samples from individuals infected with schistosomiasis (20), cysticercosis 
(15), hydatidosis (15) and Chagas disease (15). These serum samples were obtained 
from the INLASA serum library. Serum samples obtained from individuals infected
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with filariasis (5) were also analysed. These latter samples were donated by Dr. Alex 
Loukas at the Institute of Cell, Animal and Population Biology, University of 
Edinburgh. Control serum samples were provided by eight volunteers at Dublin City 
University.
4.3 Results
4.3.1 Comparison of native and recombinant CL1 using IgG4 ELISA.
4.3 .1 .1  A n a lysis  o f  h um an  serum  sa m p les  from  C u tu su m a (1987).
IgG4-ELISA was performed on serum samples from 64 individuals residing in 
Cutusuma (1987) using recombinant and native CL1 antigen. The absorbance readings 
obtained were plotted as scattergrams (Fig. 4.1). Using cluster analysis we identified a 
compact low absorbance cluster which represents the seronegative individuals and a 
diffuse high absorbance cluster which represents the seropositive individuals. Cut-off 
points between the clusters were calculated at 3.09 standard deviations from the mean 
of the low absorbance cluster which contains 99.9% of the seronegative sub­
population and were 0.117A and 0.121A for the recombinant and native CL1, 
respectively. Using the cut-off points, thirty eight individuals (58%) were deemed 
seropositive and twenty six individuals were seronegative by IgG4-ELISA using both 
the recombinant and native CL1 (Fig. 4.1 and Table 4.1).
Twenty six of the 64 individuals were coprologically positive for F. hepatica 
eggs. These individuals were also seropositive in the IgG4-ELISA using either the 
recombinant or native CL1 as antigen. Chi-squared analysis showed that it was highly 
unlikely (p < 0.001) that the coprological and serologically positive individuals would 
group together by chance, thus reinforcing the designation of the high absorbance
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cluster as the seropositive sub-population. However, twelve coprologically-negative 
individuals were identified as seropositive. These individuals may harbour early (pre­
patent) infections, since the appearance of eggs in their faeces only follows the 
maturation of the parasite in the bile duct, approximately 12 weeks post initial 
infection. Importantly, the remaining twenty six individuals that were coprologically 
negative were also seronegative by our IgG4-ELISA (This data is summarised in Table
4.1). Using correlation analysis a statistically significant correlation (r2 = 0.898; p < 
0.001) was demonstrated between the absorbance readings obtained using the 
recombinant and native proteins.
4 .3 .1 .2  A n a ly sis  o f  h um an  serum  sam p les from  C h ijip a ta  A lta  (1996).
IgG4-ELISA was performed on 25 serum samples obtained in 1996 from individuals 
residing in Chijipata Alta (Table 4.1). The results obtained employing either native or 
recombinant CL1 were identical and statistical analysis revealed a significant 
correlation between recombinant and native CL1 (r2 = 0.81; p < 0.001). Sixteen 
(64%) individuals were identified as seropositive. Fifteen of these individuals were 
harbouring F. hepatica eggs in their faeces. There was only one individual that was 
coprologically positive but serologically negative. The remaining eight individuals that 
were coprologically negative were also seronegative by our IgG4-ELISA. A summary 
of the data obtained in Chijipata Alta is presented in Table 4.1.
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F igu re 4.1 Scattergram of IgG4-ELISA data obtained for the sera of 64 individuals 
from Cutusuma (1987) using yeast-expressed recombinant CL1 (YCL1) and native 
CL1 (NCL1) antigens. Cluster analysis, using combined data obtained for both 
proteins, separated the population into low-absorbance (seronegative) and high 
absorbance (seropositive) subpopulations. The vertical and horizontal dashed lines 
indicate the calculated cut-off points for each antigen. The closed circles represent the 
individuals that were coprologically positive and the open circles represent those that 
were coprologically negative. Chi-squared analysis on whether individuals were 
seronegative or seropositive showed a very high significant relationship between the 
two antigens (r2 = 0.898 with p<0.001)
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Table 4.1. Summary o f  the serological and coprological da ta  obtained for individuals
living in Cutusuma (1987) and Chijipata Alta (1997) in the Bolivian Altiplano.
Cutusum a '87 Chijipata A lta *97
G roup Recom binant Native R ecom binant Native
CL1 CL1 CL1 CL1
Copro+/Sero+ 26 (40.6%) 26 (40.6%) 15(60%) 15(60%)
Copro-/Sero+ 12 (18.7%) 12 (18.7%) 1 (4%) 1 (4%)
C opro+/Sero- 0 (0%) 0 (0%) 1 (4%) 1 (4%)
Copro-/Sero- 26 (40.6%) 26 (40.6%) 8 (32%) 8 (32%)
Total 64 64 25 25
Copro =  Coprologically; Sero =  Scrofogically
4.3.2 Analysis of serum from humans infected with other parasites 
using native and recombinant CL1.
Sera obtained from individuals infected with various parasites were analysed by lgG4- 
EL1SA and compared to results obtained from Aymara individuals that were both 
serological and coprological positive and nine healthy volunteers from Dublin City 
University. Sera from individuals infected with schistosomiasis mansoni, cysticercosis, 
hydatidosis, Chagas disease and filariasis were negative by IgG4-ELISA that employed 
either native (Fig. 4.2A) or recombinant CL1 (Fig. 4.2B). The mean absorbance for 
these sera was not significantly different from those obtained for the negative control 
sera. The serum samples from F. hepatica seropositive/coprologically positive 
individuals had significantly higher absorbance readings than those obtained from 
individuals infected with other parasites (p<0.05).
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F ig u re  4 .2 . Analysis of individuals with various infections by IgG4-ELISA using 
Fasciola hepatica native (Panel A) and recombinant (Panel B) CL1 antigens. Serum 
samples were obtained from individuals with schistosomiasis mansoni (Sch.), 
cysticercosis (Cys.), hydatidosis (Hyd.), Chagas disease (Cha.) and filariasis (Fil.) and 
compared with control sera obtained from volunteers at Dublin City University 
(negative controls, neg.) and sera obtained from Aymara individuals, serologically and 
coprologically positive for F. hepatica infection (positive controls, pos.).
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In the previous chapter it was demonstrated that the CL1 antigen in an IgG4-ELISA 
discriminated between seropositive and seronegative individuals for fasciolosis to a 
markedly greater extent than crude antigens such as LFH or total ES products. This 
antigen was also highly specific and sensitive and was useful in diagnosing both acute 
and chronic fasciolosis. The fact that a single antigen is useful for the diagnosis of 
human fasciolosis allows the development of an ELISA method employing 
recombinant protein. The principal advantage of using recombinant protein is that 
large quantities of antigen can be produced. In addition, the ELISA can be 
standardised facilitating the comparison of diagnostic data from different regions.
Several studies have reported the use of recombinant proteins for the 
serodiagnosis of parasitic diseases in humans such as schistosomiasis mansoni, 
onchocerciasis, toxoplasmosis and amebiasis (Klinkert et al., 1988; Ogunrinade et al., 
1993; Martin et a l, 1998; Myung et al., 1992). The assays employed have functioned 
with varying degrees of success. Ogunrinade et al. (1993) developed a diagnostic 
assay for the specific and sensitive diagnosis of onchocerciasis. The development of a 
recombinant assay was essential because of the difficulty in obtaining sufficient 
quantities of native antigen; since previously employed native antigens were found to 
be highly non-specific. This study evaluated the use of two recombinant Onchocerca 
volvulus antigens, OC 3.6 and OC 9.3, in an assay based on the measurement of total 
IgG or IgG4 antibodies with sera from patients with onchocerciasis. Similarly to the 
findings in our study the sensitivity of the assay was significantly improved by the use 
of second conjugated antibodies that detect IgG4 anti-onchocerical antibodies (OC 
3.6, 95% sensitive; OC 9.3 83%, sensitive). This assay was also highly specific as no
4.4 Discussion
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cross reactivity was observed when these recombinant antigens were tested by IgG4- 
ELISA with sera from individuals with other parasitic diseases (bancroftian filariasis, 
brugian filariasis, loiasis, ascariasis, schistomiasis and dracunculiasis).
Many of the recombinant ELISAs developed have limited use in the clinical 
field given the common factors of reduced specificity and sensitivity. The development 
of a recombinant ELISA to diagnose schistosomiasis, using two cDNA sequences from 
the C-terminus of the Schistosoma mansoni heat shock protein (HSP 70), was only 
useful in detecting the chronic stages of infection. Using this assay cross-reactive 
antibodies were elicited in donors with other parasitic disease such as filariasis and 
malaria (Moser et al., 1990). In contrast, the development o f an ELISA to diagnose 
toxoplasmosis with recombinant polypeptides termed H4/GST and HI 1/GST was only 
useful when diagnosing individuals in the acute stage of infection. Using this assay, 
only 14% of 159 individuals tested in the chronic stage of infection were diagnosed 
correctly (Tenter and Johnson, 1991).
This study assesses the value of utilising recombinant CL1 antigen in the IgG4- 
ELISA for the specific and sensitive diagnosis of human fasciolosis. The development 
of a recombinant ELISA was possible because large quantities of functional 
recombinant CL1 were expressed in the yeast S. cerevisiae in our laboratory (Roche et 
al., 1997). Serum samples obtained from the villages o f Cutusuma (1987) and 
Chijipata Alta (1996) were analysed in an IgG4-ELISA against both native and 
recombinant CL1. Statistical analysis revealed a significant correlation between the 
native and recombinant CLl in both Cutusuma and Chijipata Alta (r2 = 0.898, p <
0.001; r2 = 0.81, p<0.001, respectively).
Using cluster analysis the populations were divided into seronegative and 
seropositive individuals. All coprologically positive individuals with the exception of
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one in the Chijipata Alta region, were also serologically positive in the IgG4-ELISA 
when either native or recombinant CL1 was employed. Therefore, the sensitivity of 
the ELISA for both recombinant and native antigen was 97.6%. Recombinant CL1 
appears to be useful in diagnosing acute infections, as twelve individuals in Cutusuma 
(18.7%) and one individual in Chijipata Alta were serologically positive and 
coprologically negative. All seronegative individuals, with the exception of one in 
Chijipata Alta were also coprologically negative which adds support to the use of 
recombinant CL1 in the sensitive diagnosis o f human fasciolosis.
A higher percentage of individuals (18.7%) were seropositive/coprologically 
negative in the Cutusuma survey when compared with individuals with a similar 
diagnosis in the Chijipata Alta survey (4%). These individuals are most likely to be in 
the acute stage of infection but some of these individuals may be in the chronic stage of 
infection where coprological analysis failed to detect F. hepatica eggs in their stool. 
Accurate diagnosis by coprological analysis is highly dependent upon the technique 
employed. In Cutusuma (1987) only one stool sample was obtained for each individual 
and coprological analysis was performed using the less sensitive sedimentation method. 
In contrast, in Chijipata Alta (1996) the more sensitive Kato-Katz method was 
employed to analyse the stool samples and two stool samples were analysed for each 
individual in this group.
In order to examine the specificity of the recombinant protein we analysed sera 
obtained from individuals with single infections, including schistosomiasis mansoni, 
cysticercosis, hydatidosis, Chagas disease and filariasis. Sera from these individuals 
did not react with either the native or recombinant CL1 in the IgG4-ELISA supporting 
its use for the specific diagnosis of human fasciolosis.
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In summary the IgG4-ELISA using recombinant CL1 as antigen is highly 
sensitive and specific in the diagnosis of human fasciolosis. In addition, this assay is 
useful in diagnosing both at the acute and chronic stages o f disease. This recombinant 
protein was not only functionally active in S. cerevisiae but also exhibited similar 
physico-chemical properties to the native CL1, sharing similar molecular size, pH 
profile of activity, stability and substrate specificity. It is not overly surprising that the 
recombinant antigen performed similarly to the native antigen in the IgG4-ELISAs 
described in this study. However, the important development in this study was the 
demonstration of the possibility of producing sufficient quantities of antigen to provide 
all diagnostic centres with a standardised serological test for human fasciolosis. 
Finally, the incidence of infection in Cutusuma (1987) and Chijipata Alta (1996) 
determined by IgG4-ELISA was 59% and 64%, respectively, confirming reports o f the 
high incidence of infection in the Bolivian Altiplano.
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Chapter 5
Diagnosis of human fasciolosis: detection of anti- 
cathepsin L antibodies in blood samples collected on 
filter paper and analysis of serological and 
coprological data from individuals 
between 1987-1997.
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5.1 Introduction
The studies presented in Chapter 3 and Chapter 4 using the CLl/IgG4-ELISA 
confirmed earlier reports of the high incidence of human fasciolosis in the Bolivian 
Altiplano. Further studies to examine the extent of disease in this region were 
hampered by the reluctance of the indigenous Aymaran population to provide blood by 
venepuncture. This difficulty prompted us to explore a simpler and less invasive 
method of collecting samples onto filter paper after lancet-pricking of the finger. This 
innovation has already been successfully employed by the Nacional de Laboratorios de 
Salud, (INLASA) for obtaining blood for the serological diagnosis of Chagas Disease. 
In the present study, we employed IgG4-ELISA to analyse blood samples obtained on 
filter paper in the following three surveys a) Cutusuma (1987), samples obtained from 
INLASA, b) Chijipata Alta (1996) during an expedition by our laboratory and c) 
Cutusuma 1997 during a final expedition by our laboratory. Finally in this chapter we 
collated and analysed the data obtained by our laboratory and INLASA using serum, 
blood-filter samples and faecal samples during the period from 1987 to 1997.
5.2 Experimental Design
In this study serum and faecal samples were obtained from three separate surveys. In 
1987, 57 serum samples and blood/filter samples were obtained from the region of 
Cutusuma. Coprological analysis was performed on all individuals using the 
sedimentation technique. In February 1996, serum samples and blood filter samples 
were obtained from 11 individuals residing in Chijipata Alta. Coprological diagnosis
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was performed using the Kato-Katz method. In 1997 blood/filter samples were 
obtained from 67 children (all under 13 years old) residing in Cutusuma. Faecal 
samples were also obtained and tested for F. hepatica eggs by the Kato-Katz method. 
All serum and blood/filter samples were analysed by IgG4-ELISA which employed 
purified native CL1 antigen. All coprological analysis was performed at 1NLASA.
5.3 Results
5.3.1 A comparative analysis of serum and blood/filter samples in 
Cutusuma (1987) and Chijipata Alta (1996) using the CLl/IgG4 
ELISA.
5 .3 .1 .1  C u tu su m a (1987).
Serum samples and blood/filter samples obtained from 57 individuals residing in 
Cutusuma in 1987 were analysed by IgG4-ELISA using purified CL1 as antigen. The 
absorbance readings obtained were plotted against each other on a scattergram (Fig.
5.1). Cluster analysis revealed that the scatter of points divided into two clusters, one 
compact cluster of low absorbance and a diffuse cluster of high absorbance. The cut­
off points were set at 3.09 standard deviations from the mean of the low absorbance 
readings and were 0.2035 and 0.1733 for the serum and blood/filter samples, 
respectively. Using these cut-off points 41 individuals were deemed seropositive for 
fasciolosis and 16 individuals deemed seronegative when following sera analysis (Table
5.1). lgG4-ELISA using blood deposited onto filter paper identified 36 individuals as 
seropositive and 21 individuals as seronegative (Table 5.1). A highly significant 
relationship was observed between the results obtained with serum and blood/filter 
samples (r2=0.848, p <0.001). Chi-squared analysis showed that it is highly unlikely
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that such a coincidence in results using the two methods occurred merely by chance 
(P< 0.001).
All coprologically positive individuals, with the exception of two, associated 
with the seropositive cluster (Fig. 5.1, indicated by solid circles). Chi-squared analysis 
verified that the individuals with a positive coprological diagnosis were significantly 
(P< 0.001) concentrated in the high absorbance cluster reinforcing the designation of 
this group as the infected individuals. On the other hand, 22 (38.6%) and 17 (29.8%) 
individuals that were coprologically negative proved positive by IgG4-ELISA using the 
serum and blood-filter samples, respectively (Table 5.1).
5.3.1.2 Chijipata Alta (1996).
Serum and blood-filter samples were obtained from eleven individuals at Chijipata Alta 
and analysed by IgG4-ELISA against CL1. There was a highly significant relationship 
between the two sampling methods for these patients (r2 = 0.983, p > 0.001, Fig. 5.2). 
Five individuals were identified as seropositive using both serum and blood-filter 
samples (Table 5.1). Three of these were also coprologically positive for F. hepatica 
eggs, but no faecal samples were obtained from the remaining two individuals. Of the 
six coprologically negative individuals, five were also serologically negative and the 
remaining individual did not provide a faecal sample. The results are summarised in 
Table 5.1.
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Kato/Katz analysis on individuals
S eru m  R e a d in g s
O Kato/Katz Negative
  F ilter Paper cutoff
•  Kato/Katz Positive
 Serum cutoff
Figure 5.1. Seattergrams of the data obtained by IgG4-ELISA using serum and 
blood/filter samples obtained from individuals from the village of Cutusuma (1987). 
Cluster analysis using the combined data obtained with serum and blood-filter samples 
separated the Cutusuma population into low absorbance (seronegative) and high 
absorbance (seropositive) sub-populations. The vertical and horizontal lines indicate 
the calculated cut-off points for the serum and blood/filter samples, respectively. 
Closed circles represent individuals that were coprologically positive and open circles 
represent those that were coprologically negative. The triangles represent the five 
individuals that were seropositive by analysis with serum and seronegative by analysis 
with blood/filter samples. The results are summarised in Table 5.1.
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Fig. 5.2. Scattergrams of the data obtained by IgG4-ELISA against CL1 using serum 
and blood-filter samples obtained from individuals from the village of Chijipata Alta 
(1996). The vertical and horizontal lines indicate the calculated cut-off points for the 
serum and blood/filter samples, respectively. Closed circles represent individuals that 
were coprologically positive and open circles represent those that were coprologically 
negative. The squares represent the three individuals for which no coprological 
analysis was available
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Table 5.1. Summary of coprological and serological (serum and blood/filter samples) 
data for individuals from Cutusuma (1987), Chijipata Alta (1996) and Cutusuma 
(1997).
Cutusum a '87 Chijipata Alta *96 Cutusum a '97
Group Serum
sam ple
Filter
sam ple
Serum
sample
Filter
sam ple
Filter
sample
Copro+/Sero+ 19(33%) 19(33%) 3 3 34(51.5%)
Copro-/Sero + 22 (38.6%) 17(29.8%) 0 0 8(12.1%)
Copro+/Sero- 2 (3.5%) 2 (3.5%) 0 0 0 (0%)
Copro-/Sero - 14 (24.6%) 19(33.3%) 5 5 24 (36%)
Total 57 57 8 8 66
Copro = Coprologically; Sero =  Serologically.
5.3.2 Analysis of blood/filter samples obtained in Cutusuma (1987).
Blood/filter samples obtained from 67 individuals residing in Cutusuma 1997 were 
analysed by IgG4-ELISA against native CL1. Using cluster analysis the population 
was divided into seropositive and seronegative individuals. All coprologically positive 
individuals were also serologically positive. Eight individuals were identified as being 
serologically positive and coprologically negative. The remaining twenty four 
individuals were coprologically and serologically negative. A summary of the data 
obtained is presented in Table 5.1.
5.3.3 Collated data on the incidence of human fasciolosis in the 
Bolivian Altiplano from 1987-1997.
Analysis of the sera obtained from the Altiplano region from 1987 to 1997 revealed 
that 44.3% of the entire sample population tested were serologically positive for 
fasciolosis (Table 5.2). The seropositive individuals, represented 54.2% at Cutusuma
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(1987), 20.2% at Calasaya (1991), 34.4% at Santa Ana (1991), 69.0% at Chijipata 
Alta (1996) and 63.6% at Cutusuma (1997). The coprological examinations, which 
detect only chronic infections, were positive for 36.4% of the total population tested. 
The coprologically positive individuals for each region were 31.7% at Cutusuma 
(1987), 11.5% at Calasaya (1991), 64.0% at Chijipata Alta (1996) and 49.2% at 
Cutusuma (1997) (Table 5.2).
The age of the individuals in our population sample ranged between 1-85 years, 
with a mean of 21+/-17 (Santa Ana was excluded as the age and gender of all 
individuals were not recorded). The number of serologically and coprologically 
positive individuals in different age groups were examined. In all communities there 
was no statistical relationship between the proportion of infected individuals and the 
age of these individuals. However, if the entire population is divided into two age 
groups (excluding Cutusuma 1997 since all individuals were children under 13 years)
i.e. individuals above and below 16 years, it was shown that using both serological and 
coprological analysis there is an over-representation (P<0.001) of infected individuals 
in the <16 years old group compared to the >16 years old group. In this study the 
proportion of males infected was not significantly different from that of females 
infected for any age range studied (data not shown).
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T ab le  5 .2 . Summary of coprological and serological data from the indigenous 
population residing in the Bolivian Altiplano from 1987-1997.
Year
Cutusum a
1987
Calasaya
1991
Santa Ana 
1991
C hijipata Alta 
1996
Cutusum a
1997
Tota l
Serology <16 years 57\93 7\22 \ 10\15 42/66 116\196
61.3% 31.8% \ 86.7% 63.6% 55.8%
>16 years 21\51 11\67 \ 7\14 39\132
41.2% 16.4% \ 50.0% 29.5%
Total 78M44 18\89 11\32 17\29 42/66 166\360
54.2% 20.2% 34.4% 69.0% 63.6 44.3%
Coprology <16 years 24\68 5M3 \ 9\12 34/66 72\159
35.3% 38.5% \ 75.0% 51.5% 44.3%
>16 years 2\14 1\39 \ 7\13 10\66
14.3% 2.6% \ 53.8% 15.2%
Total 26\82
31.7%
6\52
11.5%
\
\
16\25
64.0%
34/66
51.5%
82\225
36.4%
5.4 Discussion
Our IgG4-ELISA is a specific and sensitive method of serologically diagnosing human 
fasciolosis. In order to develop the ELISA further it was hypothesized that a less 
invasive means of obtaining blood samples, by lancet-pricking of the finger with 
subsequent collection of blood onto filter paper and elution of antibodies, would be as 
empirically accurate as using serum samples.
Serum and blood/filter samples were obtained from individuals in Cutusuma 
(1987) and Chijipata Alta (1996) and were analysed by IgG4-ELISA using CL1 as 
antigen. Using cluster analysis the seropositive and seronegative individuals were 
identified for both communities. In the Cutusuma population the same 19 individuals
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were identified as coprologically and serologically positive by both methods. Similarly 
two individuals were diagnosed as serologically negative and coprologically positive. 
Using the blood/filter samples, 17 individuals were serologically positive/coprologically 
negative and 19 individuals were coprologically negative/serologically negative 
compared to 22 and 14 individuals when serum samples were employed. The long 
term storage of the sera and blood-filter samples (10 years) may have contributed to 
the differences observed in diagnosis between both methods of sample collection; the 
blood/filter samples were stored at 4°C whereas the sera samples were stored frozen at 
-20°C. Nevertheless, our analysis of blood/filter samples from Cutusuma (1987) 
reveals that blood samples taken onto filter paper can be stored for up to ten years at 
4°C without much deterioration. In the Chijipata Alta survey the IgG4-ELISA using 
either serum and blood/filter samples provided a similar diagnosis for all individuals. 
Statistical analysis revealed that there was significant correlation between the results 
obtained with serum derived from whole blood samples or eluates from blood samples 
dried onto filter paper (r2 = 0.848, p < 0.001 for Cutusuma; r2 = 0.983, p < 0.001 for 
Chijipata).
The method of collecting blood onto filter paper for the serological diagnosis 
o f human fasciolosis is an excellent innovation. It could prove a useful tool for a large 
scale epidemiological study to determine the extent of human fasciolosis in the Bolivian 
Altiplano and in other countries where a high prevalence is reported. This method is 
not only cost effective, an important consideration with such a study, but also allows 
large scale screening within a relatively short time. However there are several 
disadvantages associated with this method for example, there is a limit to the number 
of assays that can be performed and blood titres cannot be measured accurately using
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this method (data not shown). Therefore the depletion of circulating anti-fluke 
antibodies following chemotherapy cannot be monitored.
The development of this method of collecting blood onto filter paper made it 
possible for a survey to be performed in Cutusuma in 1997 to compare the incidence of 
human fasciolosis with that which existed in 1987. Using the IgG4-ELISA with native 
CL1 as antigen the prevalence of fasciolosis in this region was calculated to be 63.6%. 
The proportion of serologically positive similarly-aged (<16 years) children in 
Cutusuma in 1987 was 61.3%. These results indicate that human fasciolosis has been 
endemic in Cutusuma for at least 10 years. This survey also underlines the advantages 
of using the blood/filter method as a means of obtaining blood samples in a large 
epidemiological study.
Hillyer et al. (1992) and Bjorland et al. (1995) have argued that the incidence 
of human fasciolosis in the Bolivian Altiplano occurs in sporadic outbreaks. However 
the collective coprological and serological data collated from INLASA and this 
laboratory suggests that human fasciolosis has been endemic in the Bolivian Altipalno 
for at least a decade. The studies performed by our laboratory using serological 
analysis reveal a high prevalence of human fasciolosis of approximately, 54.2% at 
Cutusuma (1987), 20.2% at Calasaya (1991), 34.4% at Santa Ana (1991), 69% at 
Chijipata Alta (1996) and 56% at Cutusuma (1997). Over a period of ten years in the 
entire region 44.3% of all individuals tested were diagnosed as serologically positive.
Coprological analysis, which can detect only chronic infections, was positive 
for 36.4% of the total population tested. Therefore it provides a false picture of the 
actual prevalence of human fasciolosis in this region. In this study approximately 8% 
of individuals diagnosed using coprological analysis were not detected using this 
method. Therefore in the entire region where an estimated 100,000 individuals are at
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risk of infection, an estimated 8,000 individuals would not be correctly identified. This 
is the principal disadvantage of using coprological analysis in large epidemiological 
surveys.
In this study, the greater risk from human fasciolosis was statistically associated 
with children under 16 years. This may be related to an increased exposure to 
infection as children commonly work in the fields minding livestock where the intensity 
of transmission is expected to be higher. Children may also be more likely to consume 
aquatic plants which are contaminated with F. hepatica metacecariae. Alternatively, 
our data could indicate the development of an age related immunological resistance to 
infection as observed for schistosmiasis haematobium infection in Kenya (Hagan et al., 
1991).
In conclusion, analysis o f both serum and faecal samples showed a high 
incidence of human fasciolosis in all communities studied. The highest incidence of 
infection was observed in the Cutusuma and Chijipata Alta region (Table 5.2). When 
we consider only those individuals for which we have both serological and 
coprological data 78% were similarly diagnosed (either as infected or non infected) by 
both techniques. Seventeen percent were serologically positive but coprologically 
negative (individuals that may be acutely infected) and the remaining five percent (11 
individuals) were coprologically positive but serologically negative. Collectively this 
IgG4-ELISA employing CL1 as antigen is 95% sensitive which further supports the 
use of this assay in a large epidemiological survey.
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Chapter 6
Cytokine and antibody profile in wild-type and 
knockout mice infected with F. hepatic a.
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6.1 Introduction
We have demonstrated that anti-fluke antibodies circulating in humans infected with F. 
hepatica are predominantly of the IgG4 subtype. This immunoglobulin subtype is 
regulated by type II cytokines. To date there have been no reported studies quantitatively 
measuring cytokine secretion from T-cells in human or animal models infected with 
fasciolosis. The Bolivian Altiplano is an ideal location to study the immunology of 
fasciolosis on a human population but this was not logistically possible because of the 
reluctance of the indigenous population to donate blood. Accordingly, we considered that 
the utilisation of the murine model would afford us some insight into the immune 
responses associated with fasciolosis.
6.2 Experimental design
Three to four month old female BALB/c, C57BL/6 and 129SV/EV wild-type mice and 
IFNyR''  and IL-4‘/_ knockout mice were employed in this study. The IL-4'' knockout 
mice cannot synthesize any IL-4 cytokine therefore it cannot drive a Th2 response. The 
wild-type mouse for the IL-4'/' knockout mice is the C57BL/6 strain. The IFNy"" 
knockout mice lacks the IFNy receptor and accordingly while it can produce IFNy this 
cytokine cannot drive the Thl response. The wild-type mouse for the IFNy' " knockout is 
the 129swev strain.
In the first experiment four mice from each group were infected orally with five F. 
hepatica metacercariae. Two non-infected mice from each group served as controls.
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Three weeks post infection all mice were sacrificed by cervical dislocation and the spleens 
removed. Isolated spleen cells were stimulated in vitro with LFH. Supernatant samples 
were removed after 24 hours to measure IL-2 whereas IL-4, IL-5 and IFNy were 
measured after 72 hours. Serum was obtained via cardiac puncture and circulating anti­
fluke IgGl and IgG2a antibodies were measured.
In the second experiment, eight mice of each strain were infected with 15 F. 
hepatica metacercariae. In addition, two mice from each group were included in the study 
as controls. Three weeks later all mice were sacrificed, and the spleen cells isolated and 
stimulated in vitro with LFH. Similar to the previous experiment IFNy, IL-2, IL-4 and IL- 
5 cytokines in supernatant were quantified and circulating anti-fluke IgGl and IgG2a 
antibodies were measured.
In the third experiment, four BALB/c mice were infected with 10 metacercariae. 
Four additional mice were included in the study as controls. Three weeks post initial 
infection all mice were killed and their spleens, hepatic lymph nodes (FILN), mesenteric 
lymph nodes (MLN) and superficial lymph nodes (SLN) removed. Cells isolated from 
these tissues were then stimulated in vitro with LFH and then IFNy, IL-2, IL-4 and IL-5 
cytokines in the supernatant measured.
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6.3.1 Cytokine production by spleen cells of mice infected with five 
metacercariae of F. hepatica.
Four female, C57BL/6, 129SV/EV, BALB/c, IFNyR knockout and IL-4'/' knockout mice 
were infected with five F. hepatica metacercariae. Three weeks later all mice were 
sacrificed and their livers examined for signs o f infection i.e. migratory tracts and 
pathology. Spleen cells were isolated and stimulated with LFH in vitro. Subsequently, 
the amount of Thl cytokines, IFNy and IL-2, and Th2 cytokines, IL-4 and IL-5, secreted 
into culture supernatants were quantified (Fig. 1A -D).
Spleen cells from C57BL/6 mice produced IL-5, IFNy and low levels of IL-2 and 
IL-4 cytokines. Cells of 129SV/EV mice produced higher levels of IL-4, IL-5 and IL-2 
cytokines but no significant levels of IFNy. The cells from BALB/c mice produced high 
levels of IL-4, medium levels of IL-5, low levels of IL-2 and no significant IFNy (Fig. 1A- 
D). As expected, the cells from IFNyR'/_ knockout mice secreted medium levels of IL-4, 
high levels of IL-5 but low levels of IL-2 and IFNy. In contrast, and also as expected, the 
cells of IL-4"/' knockout mice produced IFNy and IL-2 cytokines but low levels of IL-5 
and no IL-4 (Fig. 1A-D).
When spleen cells from mice infected in 5 F. hepatica metacercariae were 
stimulated in vitro with PMA/anti-CD3 there was no generalised polarisation of the 
immune response towards a Thl or Th2 response in the C57BL/6, 129SV/EV, BALB/c or 
IFNyR"'' (1 29sv/ev) knockout mouse strain. However, when spleens cells from IL-4_/
6.3 RESULTS
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(C57BL/6) knockout mice were stimulated in vitro with PMA/anti-CD3 the cytokine 
response was skewed towards a Thl cytokine response.
For all groups o f mice, the in vitro cytokine production by spleen cells was higher 
when the cells were stimulated with 100 (ig/ml LFH as compared with 20 pg/ml. Spleen 
cells obtained from non-infected mice of each strain did not produce cytokines in response 
to stimulation with LFH.
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Fig. 6.1A IL-4
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C57/BL 129sv/ev BALB/c IFN R-/- IL-4-/-
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■  PMA/anti-CD3
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F ig . 6.1Cytokine release from spleen cells after in vitro stimulation with 20  and 100 pg/ml 
of LFH and a positive control PMA/anti-CD3. IL-4 (Panel A), IL-5 (Panel B), IFNy 
(Panel C) and IL-2 (Panel D) were measured in supernatants following stimulation of 
spleen cells from five different strains of mice (BALB/c, C57BL/6 and 129sv FV, IFNyR" " 
and IL-4" mice strains) infected three weeks previously with 5 F. hepatica metacercariae. 
The bars represent the standard error o f the means of four mice.
6.3.2 Cytokine production by spleen cells of mice infected with 15 F. 
hepatica metacercariae.
Spleen cells were isolated from eight female C57BL/6, 129SV/EV, BALB/c, IFNyR" ', IL-4 
mice three weeks post infection with 15 F. hepatica metacercariae. The cytokines 
released in vitro following stimulation with LFH were then quantified. The most striking 
difference observed in the cytokine production by spleen cells obtained from these mice as 
compared to cells from those infected with five metacercariae was the almost complete 
lack of secretion of the type I cytokines, IL-2 or IFNy. This suppression was apparent in 
all mouse strains used but was particularly evident in the IL-4‘/" mice which are only 
capable o f producing these cytokines. Moreover, the suppression of type I cytokine 
production was observed even when the spleen cells were stimulated with the mitogen 
PMA/anti-CD3. While the higher infection dose also suppressed the production of IL-4, 
this suppression was less marked than that observed for IL-2 or IFNy. In contrast, 
production of the type II cytokine IL-5 by the spleen cells of mice given a high infection
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dose was not significantly different from that modulated by cells of mice given a low-dose 
infection.
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Fig. 6.2 Cytokine production was assessed in the supernatants of spleen cells derived from 
five different strains of mice (BALB/c, C57BL/6 and 129SV/EV, IFNyR'/_ and IL-4"') 
infected three weeks previously with 15 F. hepatica metacercariae. IL-4 (Panel A), IL-5 
(Panel B), IFNy (Panel C) and IL-2 (Panel D) cytokines were measured from supernatant 
from spleen cells stimulated in vitro with 20 and 100 |J.g/ml of liver fluke homogenate and 
a positive control PMA/anti-CD3. The bars represent the standard error of the means of 
eight mice.
6.3.3 IgGl and IgG2a responses in F. hepatica-infected mice
The titres of IgGl and IgG2 antibodies were measured in all mice three weeks after 
infection with 5 or 15 F. hepatica metacercariae. Antibodies of the IgGl subtypes were 
detected in all mouse strains with the exception of the IL-4‘/_ knockout mice which cannot 
produce IgGl because they lack IL-4. There was no IgG2a antibodies detected in the 
serum of any mouse strain (Figure 3). The IgGl titres observed in the groups infected with 
five metacercariae (Fig. 3A) were similar to those observed in mice infected with 15 
metacercariae (Fig. 3B).
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Fig. 6.3 Serum IgGi and IgG2a antibodies specific for liver fluke excretory /secretory 
products, in mice infected with F. hepatica. Antibodies were measured three weeks after 
infection with a dose of 5 (6.3A) or 15 F. hepatica metacercariae (6.3B). A minimum of 
four mice trom the low dose experiment and eight mice from the high dose experiment 
were assayed.
Fig. 6.3B
108
6.3.4 In vitro production of cytokines by T-cells of the peripheral lymph 
nodes and spleens of BALB/c mice infected with F. hepatica.
Cells were isolated from the spleens, HLN, MLN and SLN of BALB/c mice three weeks 
after an infection with 10 F. hepatica metacercariae. Isolated spleen cells were stimulated 
in vitro with LFH and PMA/anti-CD3 and the secretion of cytokines IL-4, IL-5 and IFNy 
in the supernatant were quantified. Spleen, HLN and MLN cells secreted a predominant 
Th2 cytokine profile i.e. high levels of IL-4 and IL-5 and no secretion of IFNy was 
observed. The amount o f IL-4 cytokine secreted was significantly higher (p > 0.5) in the 
HLN and MLN when compared to the amount secreted by spleen cells also, HLN 
produced almost a nine-fold greater amount of IL-4 than the MLN. In contrast, cells from 
the MLN secreted significantly greater amounts of IL-5 when compared to that secreted 
by cells from the HLN and spleen. When spleen and lymph node cells were stimulated in 
vitro with PMA/anti-CD3 a predominant Th2 cytokine profile was exhibited. There was 
no significant cytokine production observed in the SLN in response to stimulation with 
LFH or PMA/anti-CD3.
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Fig. 6.4. Liver Fluke specific production of cytokines measured from supernatant 
stimulated in vitro with 4 jig/ml, 20 jag/ml and 100 ¡ag/ml o f liver fluke homogenate and 
PMA/anti-CD3. IL-4 (Panel A), IL-5 (Panel B), and IFNy (Panel C) were measured in 
supernatants following stimulation of spleen or lymph node cells from BALB/c mice 
infected three weeks previously with 10 F. hepatica metacercariae. The spleen cells from 
each mouse were assayed individually, whereas lymph node cells were pooled.
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In most helminth infections a type II immune response predominates with the secretion of 
IL-4, IL-5, IL-6, IL-10 and IL-13 cytokines. The associated immunological elements 
include eosinophilia, masocytosis, elevated sera IgE antibodies and IgG4 (Humans) /IgGl 
(Rodents) (Mulcahy, Joyce and Dalton, in press; Pearce et al., 1996). In the murine 
model evidence supporting the association of a Th2 cytokine profile with fasciolosis is 
limited to a few studies. Van de Heijden et al. (1995) reported a type II cytokine response 
in lamina propria lymphocytes of mice infected with F. hepatica. In this study secretion of 
type II cytokine profile, IL-4 and IL-5, was associated with elevated total IgE antibodies 
in serum. However, cytokine secretion was not quantitatively measured and was limited 
to the study of local gut mucosal tissue. Other studies have identified eosinophilia in both 
the peripheral blood and bone marrow cells in F. hepatica infected mice (Milbourne and 
Howell, 1990; 1993). In addition, eosinophil attachment was observed on the surface of 
adult flukes in mice within four hours after implantation into the peritoneum (Rajasekariah 
et al. 1979). Since a Th2 class of CD4+ T-cells are involved in eosinophil differentiation 
and maturation, these studies indicate that a Th2 cytokine response would be associated 
with F. hepatica infection in mice.
Type II CD4+ T-cells produce IL-4, IL-5, IL-13 and IL-10 resulting in a strong 
antibody-mediated immune response. In contrast, type I T-cells produce IL-2, IFNy and 
lymphotoxin resulting in a delayed hypersensitivity reaction. These two subsets counter- 
regulate each other through cytokines unique to each subset. The Thl cytokine, IFNy
6.4 Discussion
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inhibits the proliferation of Th2 cells whereas IL-10 inhibits the synthesis of Thl 
cytokines. In the present chapter five different groups of mice (BALB/c, C57BL/6 
129sv , v, IFNyR‘A and IL-4 ' mice strains) were infected with 5 and 15 F. hepatica 
metacercariae to determine the immune response associated with fasciolosis. In addition 
we compared local and systemic immune responses in BALB/c mice infected with 10 F. 
hepatica metacercariae.
Spleen cells from both BALB/c and 129SV/EV mice infected with five mctacercariae 
elicited a strong Th2 cytokine response when stimulated in vitro with LFH. When spleen 
cells from infected C57BL/6 mice were stimulated in vitro with LFH a cytokine profile 
characteristic of a ThO cytokine response was observed (high IL-4, IL-5 and IFNy). 
C57BL/6 mice have been described as a “type I mouse” whereas BALB/c mice have been 
described as a “type II mouse” because each mouse strain was shown to be genetically 
predisposed to produce a more type I or type II immune response, respectively. Therefore 
it is unsurprising that BALB/c mice secreted the greatest amount of IL-4 cytokine or that 
C57BL/6 mice exhibit a ThO cytokine profile. When spleen cells from all three strains of 
infected mice were stimulated in vitro with PMA/anti-CD3 there was no generalised 
polarisation of the immune response towards a predominant Th2 cytokine profile.
Spleen cells from all three wild-type mice infected with 15 F. hepatica 
metacercariae elicited a strong Th2 cytokine response; secretion of IL-2 and IFNy 
cytokines from these cells was totally inhibited. Spleen cells from these mice also 
exhibited a generalised suppression of IL-4 secretion but no significant difference in the 
secretion of IL-5 was observed. Mitogen stimulated spleen cells from these infected mice 
exhibited a generalised polarisation of the Th-subset towards a Th2 cytokine profile.
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These observation may indicate that F. hepatica secretes molecules that down-regulate a 
Thl response. This would explain the difference observed in the cytokine profile released 
by spleen cells of mice that received 5 metacercariae as compared to those cells o f mice 
that received 15 metacercariae. The increase in the number of flukes present correlates 
with increased suppression of Thl cytokines. Moreover, the spleen cells from the “type 
I” C57BL/6 mice switched from producing a mixed ThO cytokine in the lower infection 
dose to a predominant Th2 cytokine profile in the higher infection dose.
IFNyR" ’ mice, which cannot drive a Thl response, were infected and the cytokine 
profile quantified. As expected these mice produced IL-4 and IL-5, but the level of these 
cytokines did not differ from the wild-type 129sv/ev controls. This was observed when mice 
were infected with 5 or 15 F. hepatica metacercariae. However, when the spleen cells of 
the mice that were given the high infection dose were stimulated with PMA/anti-CD3 we 
observed that they produced significantly higher levels o f the Th2 cytokines than the wild- 
type controls. These observations are as expected in an infection that causes Th2 immune 
responses.
In a reciprocal-like experiment we infected IL-4'/‘ knockout mice that are unable to 
synthesize IL-4 cytokine. As anticipated there was no production of IL-4 cytokine by 
these mice and reduced levels of IL-5, compared to wild-type controls, were produced. 
This result was in agreement with experiments performed by Pearce et al. (1996) and 
Lawrence et al. (1994) which showed that whilst IL-5 production is not dependent on IL- 
4, it’s production is enhanced when this cytokine is present. Moreover, it stresses that 
Th2 responses are not totally dependent on IL-4. The other interesting observation was 
the fact that IFNy production in the IL-4 /‘ knockout mice was significantly higher than in
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the wild-type when these were infected with five F. hepatica metacercariae suggesting 
that a down-regulation of Thl responses is dependent upon IL-4.
When the infection dose was increased to 15 F. hepatica metacercariae we 
observed total inhibition of IFNy and IL-2 cytokine production. Therefore, liver fluke 
may secrete immunosuppressive molecules that protect it from immune attack. The 
secretion of immunosuppressive molecules that block lymphocyte population was 
previously reported by Chauvin et al. (1995) and Chervi and Masih (1997). However, it is 
clear that infection had no effect on IL-5 production suggesting that this cytokine may be 
produced by cells other than those cell populations that produce IFNy, IL-2 and IL-4 
(which are produced by CD4+ cells). Several reports have demonstrated that non-CD4+ 
cells can secrete either Thl or Th2 cytokines and can contribute to the nature of the in 
vivo immune response. An IL-5 response which is Th2-like may result from activation and 
expansion of other cell populations such as CD8+ cells, B-cells and eosinophils (Reiner 
and Locksley, 1993). The significance of the lack of IL-5 blocking is not yet understood 
but it is interesting to note that this cytokine is involved in eosinophil production. To date 
there has been no clear demonstration in fasciolosis of the susceptibility of parasites to 
eosinophils and therefore suppression of these cells may not be necessary.
The regulation of immunoglobulin subclasses by subsets o f antigen specific helper 
T-cells has been previously reported by Stevens el al. (1988) and Purkerson and Isakson 
(1992). Studies performed in the murine model infected with helminth parasites such as 
schistosomiasis (Caulada-Benedetti el al., 1991) and filariasis (Lawrence et al., 1994) 
have demonstrated that IL-4 is associated with the secretion of IgGl and IgE whereas 
IFNy is associated with secretion of IgG2a. In agreement with these studies we found that
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all mice exhibiting a predominant Th2 cytokine response had anti-fluke IgGl antibodies 
present in their serum. There was no significant difference in the antibody production in 
mice that received 5 or 15 F. hepatica metacercariae.
In our final experiment we investigated if the immune response in the local lymph 
nodes is different from that found in the spleen cells of mice infected with F. hepatica. 
We chose to examine both HLN and MLN nodes since newly excysted juvenile liver 
flukes burrow through the gut wall, which is drained by the MLN, before migrating across 
the liver parenchyma for several weeks, which is drained by the HLN. We found that 
HLN, MLN and spleen cells all secreted Th2 cytokines. The induction of Th2 cytokines is 
highest at the intestine and hepatic tissue site as the draining lymph nodes (MLN and 
HLN, respectively) secrete significantly higher amounts of IL-4 and IL-5 when compared 
to that secreted by spleen cells. However the HLN produced a nine-fold greater amount 
of IL-4 when compared to the MLN. In contrast, cells from the MLN produces 
significantly greater amounts of IL-5. Therefore, as the liver fluke progresses through its 
developmental stages it may secrete molecules that induce a Th2 cytokine profile in the 
draining lymph nodes, although the pattern of the cytokines produced by these differs. 
This difference may reflect the secretion of different antigens as the parasite matures and 
develops. It is well known that changes takes place in the surface tegument as the parasite 
migrates. The main tegumental secretory antigens which make up the surface glycocalyx 
are derived from TO cells in the newly excysted juvenile flukes whereas the glycocalyx is 
synthesised by T1 cells in the juvenile fluke during the hepatic stages. It would be of 
future interest to take MLN and HLN at various times during infection and determine at 
what point these lymphoid cells are stimulated to produce a Th2 cytokine profile. In this
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study we only examined the cells at a single time point (i.e. 21 days after infection) and 
therefore we were looking at the “composite” response in the lymph nodes.
Studies on other helminth parasites have investigated the responses in the lymph 
nodes that are close to the infection or antigen-immunisation site. Pearce et al. (1996) 
demonstrated that the injection of S. mansoni egg antigen into the foot pad of mice 
induced a Th2 response in the local popliteal lymph node. Furthermore infection of mice 
with B. malayi induced Th2 responses in the lymph nodes close to the injection site, 
although a ThO response was observed in the spleens (Pearlman et al., 1993). These 
studies suggest that the early induction of Th2 responses in the local lymph nodes may be 
important in dictating the overall response to infection. In this study we found that once a 
Th2 response has developed the spleen cells respond in a Th2-like fashion even to the 
mitogen PMA/anti-CD3.
The role of type II cells in the protection of the host against helminth infections is 
controversial. A type II response is important for the control of the intestinal nematode, 
Trichuris muris, in mice (Bancroft et al., 1998), whereas Type I CD4 T-cells are involved 
with protection in mice vaccinated with irradiated schistosoma larvae (Pearce et al., 
1996). The functional role of type II cells in fasciolosis has yet to be identified. However, 
recent evidence from a vaccine study performed in cattle has described the involvement of 
IgG2 antibody subtypes in protection while IgGl secretion has been linked to 
susceptibility (Mulcahy et al., 1997). Therefore the study of Mulcahy et al. (1997) 
provides evidence that a type I response may have an important role in the protection of F. 
hepatica infected cattle (refer to section 9.1).
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In conclusion, this investigation is the first to quantitatively measure cytokine 
production of spleen cells, lymph node cells and circulating IgG subtypes in the murine 
model infected F. hepatica metacercariae. We have observed that a liver fluke infection 
induces a Th2 response in mice. The molecules involved in inducing this type II response 
has not been identified but we hypothesis that molecules of ES products may be important. 
In the following chapters we have exploited the murine model for fasciolosis to investigate 
this hypothesis.
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Chapter 7
The effect of an infection with Fasciola hepatica on the 
Thl responses induced in mice vaccinated with 
Bordetella pertussis.
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The control of disease and the efficacy of vaccines is dependent upon the type of CD4+ 
subset response induced. Protection in humans and animals against bacterial, viral and 
unicellular parasitic diseases is primarily associated with the induction of a type 1 immune 
response whereas helminth infections are predominantly associated with a type II immune 
response. Several reports have demonstrated that, in both human and animal studies, a 
prior infection which induces a strong type II cytokine profile has an impact on the 
immune response elicited against a non-parasitic antigen (Kullberg et ah, 1992; Sabin el 
ah, 1996). A corollary o f this observation could be that helminth infections which involve 
type II responses can effect the immune responses to vaccines that require type I 
responses.
In Chapter 6 we demonstrated that spleen cells from mice infected with F. 
hepatica secrete the type II cytokines, IL-4 and IL-5, on stimulation in vitro with LFH 
antigen. In contrast, T-helper cells from mice vaccinated with B. pertussis vaccine secrete 
the type I cytokines, IFNy and IL-2, on stimulation with B. pertussis antigen (BP) in vitro 
(Mills et ah, 1993; Redhead et ah, 1993). In this chapter we investigated the effect of an 
F. hepatica infection on an established type I response in mice vaccinated with B. 
pertussis whole cell vaccine. Since IL-4 is a key cytokine that promotes type II cytokine 
secretion we investigated the role of IL-4 by repeating this experiment in IL-4 knockout 
C57BL/6 mice.
7.1 Introduction
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7.2 Experimental Design
7.2.1 Experimental design 1
D a y  0 Day 14 Day 42 Day 63
G r o u p  1 B. pertussis
W C V / F h  g roup  W C V II*
(4  B A L B / c  m ice ) (0 .6 iu  p e r  m se)
G r o u p  2
W C V  g roup  
(4  B A L B / c  m ice )
G r o u p  3
F h  g roup  
(4  B A L B / c  m ice )
G r o u p  4
C o n tro l g roup 
(4  B A L B / c  m ice )
B. pertussis 
W C V  IP 
(0 .6 iu  p e r  m se)
B. pertussis 
W C V  IP 
(0 .6 iu  p e r m se)
B. pertussis 
W C V  IP 
( 0 .6 iu  p e r m se)
In fe c tio n  w ith  10 
Fasciola hepático 
m etaceca riae
In fe c tio n  w ith  10
Fasciola hepático 
m etaceca riae
A l l  m ic e  w ere  
s a c r if ic e d  by 
ce rv ica l 
d is lo ca t io n
In this experiment eight 3-4 month old female BALB/c mice were vaccinated with an 
intra-peritoneal injection of B. pertussis whole cell vaccine on day 0 and day 14 (0.8 IU/ 
mouse). On day 42, four of these mice were infected with 10 F. hepatica metacecariae 
(Group 1) while the other four mice were left uninfected (Group 2). Four additional mice 
did not receive any vaccinations but were infected on day 42 with F. hepatica (Group 3). 
Four mice acted as background controls, receiving no vaccination and no liver fluke 
infection (Group 4). All mice were sacrificed on day 63 and their spleens removed. 
Isolated spleen cells were stimulated in vitro with LFH and BP and the cytokines secreted 
into the supernatant quantified.
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7.2.2 Experimental design 2
Wild-type controls: Day 0 Day 14 Day 42 Day 63
C57BL/WCV/ 
(4 mice)
C57BLAVC 
(4 mice)
IL-4 knockout mice:
IL-4WCV/Fh 
(4 mice)
I1-4AVCV 
(4 mice)
B. pertussis 
W C V IP  
(0 .6 iu  per rase)
B. pertussis 
W C V IP  
(0 .6 iu  per rase)
B. pertussis 
W C V IP  
(0 .6 iu  per rase)
B. pertussis 
W C V IP  
(0 .6 iu  per m se)
B. pertussis 
W C V IP  
(0 .6 iu  per m se)
B. pertussis 
W C V  IP 
(0 .6 iu  per m se)
B. pertussis 
W C V  IP 
(0 .6 iu  per m se)
B. pertussis 
W C V IP  
(0 .6 iu  per m se)
Infection w ith 10 
Fasciola hepatica 
m etacecariae
Infection with 10
Fasciola hepatica 
m etacecariae
In this experiment eight C57BL/6 IL-47' knockout mice and their wild-type controls were 
vaccinated with an intra-peritoneal injection of B. pertussis whole cell vaccine (0.8 
IU/mouse) on day 0 and day 14. On day 42, four mice from each group were infected 
with 10 F. hepatica metacercariae. All mice were killed by cervical dislocation on day 63 
and their spleens removed. Isolated spleen cells were stimulated in vitro with LFH and 
BP and the cytokines released into the supernatant quantified.
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7.3.1 In vitro cytokine production by spleen cells of BALB/c mice 
previously vaccinated with B. pertussis whole cell vaccine and infected 
with F. hepatica.
To examine whether an infection of F. hepatica had an effect on an established type I 
response in mice, we vaccinated 3-4 month old female BALB/c mice with B. pertussis 
whole cell vaccine and followed it with an F. hepatica infection. Mice were sacrificed 21 
days following a challenge infection and isolated spleen cells were stimulated in vitro with 
LFH or BP antigen and the amount of IL-4, IL-5, IL-2 and IFNy cytokines that were 
secreted into the culture media measured.
Spleen cells from naive mice (Controls, Group 4) did not secrete either TH1 (IL-2, 
IFNy) or TH2 (IL-4, IL-5) cytokines in response to stimulation with LFH or BP antigen 
(Fig. 7.1A-D and Fig. 7.2A-D, respectively). Spleen cells of BALB/c mice that only 
received liver fluke infection (Group 3) exhibited a predominant type II response to LFH 
antigen, where significant amounts of IL-4 and IL-5 cytokine were secreted and there was 
no secretion of IFNy or IL-2 cytokines (Fig 7.1A-D). Spleen cells of these mice did not 
secrete any cytokines in response to stimulation with BP antigen (Fig. 7.2A-D).
Spleens cells from the mice that received the B. pertussis whole cell vaccine only 
(Group 2) did not secrete any cytokines following stimulation with LFH (Fig. 7.1A-D). 
However, these mice secreted IL-2 and IFNy cytokines with no significant amount of IL-4 
and IL-5 cytokine in response to BP antigen (Fig. 7.2A-D).
7.3 Results
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Spleen cells of mice that were vaccinated with B. pertussis whole cell vaccine and 
then infected with F. hepatica (Group 1) showed no statistical difference in their cytokine 
production following stimulation with LFH antigen to that of spleen cells from mice that 
were infected with F. hepatica only (Group 3) (i.e. high IL-4 and IL-5 production and no 
IFNy or IL-2, Fig. 7.1A-D). However, most importantly, the spleen cells of these B. 
pertussis whole cell vaccinated and fluke infected mice (Group 1) showed a significant 
reduction (P < 0.05) of type 1 cytokines, IFNy and IL-2, following stimulation with BP 
antigen when compared to spleen cells from mice that received the vaccine only (Group 2) 
(Fig. 7.2A-D). When spleen cells from vaccinated infected mice were stimulated in vitro 
with PMA/anti-CD3 a predominant Th2 cytokine profile was observed.
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Figure 7.1 Measurement of the cytokine production of spleen cells from four diiferent 
groups of BALB/c mice following stimulation with LFH (Group 1: mice that were 
vaccinated with B. pertussis whole cell vaccine and infected with F. hepatica (WCV/Fh); 
Group 2: mice that received B. pertussis whole cell vaccine only (WCV); Group 3: mice 
that were infected with F. hepatica only (Fh); Group 4: mice receiving neither B. pertussis 
whole cell vaccine or F. hepatica infection (Control)). Spleen cells were cultured with 
LFH (4 (.ig/ml, 20 |a,g/ml, 100 |ig/ml) and PMA/anti-CD3. IL-2 was measured after 24 
hours and IL-5, IL-4 and IFNy were measured after 72 hours. Results are the means of 
assays from four individual mice.
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Figure 7.2 Measurement o f the cytokine production of spleen cells from four different 
groups of BALB/c mice following stimulation with BP (Group 1: mice that were 
vaccinated with B. pertussis whole cell vaccine and infected with F. hepatica (WCV/Fh); 
Group 2: mice that received B. pertussis whole cell vaccine only (WCV); Group 3: mice 
that were infectcd with F. hepatica only (Fh); Group 4: mice receiving neither B. pertussis 
whole cell vaccine or F. hepatica infection (Control)). Spleen cells were cultured with BP 
(0.2 pg/ml, 1 (.ig/ml, 5 pg/ml) and PMA/anti-CD3. IL-2 was measured after 24 hours and 
IL-5, IL-4 and IFNy were measured after 72 hours. Results are the means of assays from 
four individual mice.
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7.3.2 Cytokine production by spleen cells of wild-type and IL-4 knockout 
C57/BL mice vaccinated with B. pertussis whole cell vaccine and infected 
with F. hepatica.
We have demonstrated in the first experiment that a type I response elicited in mice by 
vaccination with B. pertussis whole cell vaccine is suppressed by a subsequent infection 
with F. hepatica. To investigate the role of IL-4 in the up-regulation of type II immune 
responses, we repeated the experiment in wild-type and IL-4 knockout C57BL/6 mice. In 
this study we vaccinated eight IL-4 knockout mice and eight wild-type controls with B. 
pertussis whole cell vaccine. Four mice in each group were then subsequently infected 
with 10 F. hepatica metacecariae. All mice were sacrificed 21 days after challenge 
infection and their spleen cells cultured in vitro with LFH and BP antigen. Cytokine 
production in the supernatants was quantified. Interleukin 2 cytokine was measured after 
24 hours whereas IL-4, IL-5 and IFNy cytokines were measured after 72 hours.
Spleen cells o f wild-type and IL-4 knockout C57BL/6 mice that received the BP 
vaccine only did not produce any cytokines in response to stimulation with LFH (Fig. 7.3 
A-D). The wild-type C57BL/6 mice that were vaccinated with BP and then infected with 
F. hepatica displayed a type II response to LFH antigen i.e. production of IL-4 and IL-5 
and no production of IFNy and IL-2. The IL-4 knockout mice that were vaccinated and 
infected, as expected, did not produce IL-4, but did produce IL-5; these mice did not 
produce IFNy or IL-2 (Fig. 7.3A-D).
Spleen cells of wild-type and IL-4 knockout C57BL/6 mice that received the B. 
pertussis whole cell vaccine only, produced no IL-4, low levels of IL-5 but high levels ol
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the Thl cytokines IFNy and IL-2 in response to stimulation with BP (Fig. 7.4A-D). Wild- 
type C57BL/6 mice that were vaccinated with B. pertussis whole cell vaccine and then 
infected with F. hepatica produced significantly higher levels of IL-4 (P < 0.05) and about 
the same levels of IL-5 as the group that received the vaccine only (Fig. 7.4A and B). 
However, these mice produced no IFNy and reduced amounts of IL-2 compared to the 
vaccine only group (Fig. 7.4 C and D). When spleen cells from vaccinated infected 
C57BL/6 mice were stimulated in vitro with PMA/anti-CD3 a predominant Th2 cytokine 
profile was observed. The spleen cells of IL-4 knockout mice that were vaccinated with 
B. pertussis whole cell vaccine and infected with F. hepatica did not produce IL-4 as 
expected, and did not show any significant differences in the amount of IL-5, IFNy or IL-2 
production compared to the mice that received the vaccine only (Fig. 7.4A-D). When 
spleen cells from vaccinated infected IL-4 knockout mice were stimulated in vitro with 
PMA/anti-CD3 a cytokine profile similar to mice that were vaccinated only was observed.
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Figure 7.3 Cytokine production by spleen cells of wild-type (C57) and IL-4 knockout 
C57BL/6 mice (IL-4) that were vaccinated with B. pertussis whole cell vaccine (WCV) or 
vaccinated and then infected with F. hepatica (WCV/Fh). Spleen cells were stimulated in 
vitro with LFH antigen (4 ¡ig/nil, 20 (.ig/ml, 100 fxg/ml) and PMA/antiCD3. Samples of 
supernatant were removed for measurement of IL-4, IL-5, lFNy and IL-2 cytokines (7.3 
A-D). Results were expressed as the mean cytokine concentration of four mice per group 
tested in triplicate.
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F ig u re  7 .3  Cytokine production by spleen cells o f wild-type (C57) and IL-4 knockout 
C57BL/6 mice (IL-4) that were vaccinated with B. pertussis whole cell vaccine (WCV) or 
vaccinated and then infected with F. hepatica (WCV/Fh). Spleen cells were stimulated in 
vitro with BP antigen (0.2 (J.g/ml, 1 pg/ml, 5 (¿g/ml) and PMA/anti-CD3. Samples of 
supernant were measured for IL-4, IL-5, IFNy and IL-2 cytokines (7.4 A-D). Results 
were expressed as the mean cytokine concentration of four mice per group tested in 
triplicate.
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Empirical evidence gleaned from the previous chapter demonstrates that spleen cells o f F. 
hepatica infected mice secrete a cytokine pattern characteristic of a Th2 cytokine profile 
(high IL-4 and IL-5); but do not secrete IFNy and IL-2 cytokines which are characteristic 
of a Thl cytokine profile. Furthermore, the same cytokine secretion pattern was elicited 
when spleen cells of infected mice were stimulated in vitro with non-specific mitogens 
such as, PMA/anti-CD3. This is perhaps indicative of a general imbalance in Th-cell 
subset response, an immunological phenomenon observed with other trematode infections 
(Bassily et al., 1992; Sabin et al., 1995). This provoked an interest in elucidating if this 
Th-cell subset imbalance would influence the outcome of the immune response to a Thl 
inducing antigen.
Brito et al. (1976) was the first to report the immunosuppressive effects o f a 
trematode infection in mice vaccinated with tetanus toxoid. In this study, mice infected 
with S. mansoni were unable to mount the same antibody response to the vaccine when 
compared with uninfected control mice. Moreover, the immunosuppression of antibody 
response was only observed during the patent stage of infection (six to eight weeks after 
initial infection when mature females produce eggs). It is now well established that 
oviposition in mice infected with S. mansoni is the major stimulus for the induction of Th2 
cytokine producing CD4+ cells (Grzych et al., 1991). However, in the pre-patent stage of 
infection spleen cells from S. mansoni-infected mice produce Thl cytokines in response to 
SWAP antigen (Schistosoma Worm Adult Protein). The secretion of Thl cytokines 
declines after egg production commences. This confirms that egg production is associated
7.4 Discussion
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with the down regulation of Thl cytokine secretion in schistosomiasis (Vella and Pearce,
1992).
In an experiment performed by Kullberg et al. (1992) it was demonstrated that the 
generalised imbalance of Th-cell function during an infection with S. mansoni alters the 
Thl cytokine response elicited in BALB/c mice vaccinated with sperm whale myoglobulin 
(SwMb). Immunisation of mice eight weeks after an infection with S. mansoni cercariae 
resulted in the reduction of IFNy and IL-2 secretion (79% and 71%, respectively) by 
spleen cells stimulated with SwMb when compared with uninfected animals. In the same 
group of mice the secretion of IL-4 from cultured spleen cells was three times as high as 
that observed in non-infected animals. The production of Thl and Th2 cytokines was 
CD4+ cell dependent and the addition of IL-10 antibodies to the cultured spleen cells 
restored the down-regulation of IFNy to SwMb observed in the infected and vaccinated 
mice.
Several other studies such as that by Actor et al. (1993) reported similar findings. 
In this study BALB/c mice were vaccinated with the vaccinia virus, a Thl inducing 
antigen, and then were co-infected with S. mansoni. In comparison to vaccinated mice 
only, spleen cells o f infected and vaccinated mice exhibited a reduction in the secretion of 
Thl cytokines. More importantly, there was a down-regulation of virus specific CD8+ 
cytotoxic T-cells. When these mice were challenged with vaccinia virus there was delayed 
clearance of the virus for up to three weeks in mice infected with S. mansoni. This 
observation indicates that helminth infections may influence the immune response to 
concurrent infections.
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This present study employed mice vaccinated with B. pertussis whole cell vaccine 
as a model to study the effects o f F. hepatica on an established Thl immune response. B. 
pertussis is a gram-negative bacterium that causes whooping cough, a respiratory disease 
that accounts for 300,000 deaths of young children annually. The whole cell vaccine is 
effective in preventing disease in children and Thl cells are believed to play a role in 
protective immunity generated following infection with B. pertussis (Ryan et al., 1997). 
The pathogenicity and immunology of B. pertussis infection in mice has been widely 
studied (Redhead et al., 1993; Barbie et al., 1997). Similar to investigations in humans, 
cell mediated immune responses are associated with clearance of a challenge infection and 
subsequent protection against recurrent infections (Redhead et al., 1993). Immunisation 
of mice with whole cell vaccine induces a high level o f protection against respiratory 
challenge and this protection is associated with a type I immune response (Barnard et al., 
1996).
In the present study mice were vaccinated with B. pertussis whole cell vaccine (a 
type I inducing antigen) (Redhead et al., 1993) and then infected with F. hepatica to 
identify if an established type I immune response is altered by a dominant type II response. 
The data presented in this chapter for mice infected with F. hepatica only or vaccinated 
with B. pertussis whole cell vaccine supports results previously reported. Spleen cells 
from BALB/c mice infected with F. hepatica is associated with a predominant type II 
immune response when stimulated in vitro with LFH antigen (Chapter 6). As previously 
described by Redhead et al. (1993) spleen cells from BALB/c mice vaccinated with B. 
pertussis whole cell vaccine exhibited a predominant type I response to BP antigen. Spleen 
cells of vaccinated and liver fluke infected mice when challenged with LFH antigen
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exhibited no significant differences in cytokine production when compared to mice 
infected with F. hepatica infection only. In contrast, spleen cells from these vaccinated 
and infected mice when stimulated in vitro with BP antigen exhibited a significant down 
regulation of Thl cytokine production (IFNy and IL-2) compared to immunised 
uninfected control mice. Furthermore, in this group there was a significant increase in IL- 
5 although no difference was observed in amount o f IL-4 cytokine secretion.
This observed down-regulation in Thl cytokines with the simultaneous increase in 
Th2 cytokines in vaccinated and infected BALB/c mice may be due to the cross-regulation 
of Th-subsets (Grzych el al., 1991; Pearce et al., 1991). Mice infected with F. hepatica 
induce spleen cells to secrete IL-4 and perhaps another important regulatory cytokine, IL- 
10. Interleukin-10 was not measured in this study but was shown to be secreted in F. 
hepatica infected mice (data not shown). Interleukin 4 is a growth factor of Th2 cells and 
therefore is important in regulating Th2 cytokine production while 1L-10 inhibits the 
synthesis of IFNy, IL-2, IL-3, lymphotoxin and granulocyte/ macrophage - CSF by Thl 
cells (Mosmann and Moore, 1991). In this present study the role of IL-4 was investigated 
by repeating the previously described experiment in wild-type and IL-4 knockout 
C57BL/6 mice.
In agreement with the data presented for BALB/c mice, wild-type C57BL/6 mice 
vaccinated with B. pertussis whole cell vaccine and then infected with F. hepatica, 
exhibited a Th2 response to LFH antigen. Spleen cells from IL-4 knockout mice that were 
vaccinated and then infected with the liver fluke did not secrete any IL-4 to LFH antigen 
as expected but did produce significant levels of IL-5. In agreement to that described in
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Chapter 6 IL-4 knockout mice exhibited a significant decrease in IL-5 production when 
compared with their wild-type controls.
Similar to that reported for BALB/c mice, spleen cells o f wild-type and TL-4 
knockout C57BL/6 mice vaccinated with B. pertussis whole cell vaccine secreted high 
levels of IL-2 and IFNy, low levels of IL-5 and no IL-4 when stimulated with BP antigen. 
Spleen cells from vaccinated and infected wild-type C57BL/6 mice stimulated with BP 
antigen produced no IFNy and reduced amounts o f IL-2 compared to the vaccine only 
group. In contrast to the BALB/c mice, spleen cells from these mice produced higher 
levels of IL-4 but the same levels of IL-5. The spleen cells of vaccinated and infected IL-4 
knockout mice did not show any significant difference in the amount of IL-5, IFNy or IL-2 
production compared to mice that received vaccine only (as expected these mice did not 
produce any IL-4). These results indicate that a down regulation of Thl cytokines by 
spleen cells from vaccinated and infected mice is dependent upon the production of IL-4.
In agreement with the data presented in Chapter 6, when spleen cells of F. 
hepatica infected BALB/c and C57BL/6 mice were stimulated with a non-specific mitogen 
(PMA/anti-CD3) a predominant Th2 cytokine subset was exhibited. The predominance of 
Th2 cytokines in mitogen-stimulated spleen cells was also observed when mice were 
vaccinated with B. pertussis whole cell vaccine and infected with F. hepatica. This again 
illustrates the generalised imbalance in the Th-cell subsets associated with F. hepatica 
infection. When spleen cells from vaccinated and infected IL-4 knockout mice are 
stimulated with mitogen a ThO cytokine profile was exhibited. This indicates that the Th- 
subset imbalance observed in F. hepatica infected mice is a IL-4 dependent process.
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Interleukin-4 is a positive growth factor for Th2 cells, in addition it suppresses the 
development of IL-2, a positive growth factor for Thl cells. The levels of IL-4 and IL-2 
determine both the levels of effector cells developed in response to mitogen or antigen and 
the patterns of lymphokines they secrete when stimulated in vitro (Swain et a l, 1990). 
Kullberg et al. (1992) suggested that IL-4 produced in vivo in S. mansoni infected mice 
may promote the outgrowth of Th2 precursor cells in these animals immunised with a 
foreign antigen. In this study the number of units of IL-4 secreted per CD4+ cell in 
response to SwMb, from S. mansoni-infected mice was measured. These CD4+ cells 
produced over three times as much IL-4 as did cultured CD4+ cells from uninfected 
animals. This indicates that either higher levels of IL-4 are produced by cells or that there 
is an increase in the number of Th2 cells in infected mice. This hypothesis may also 
explain the down regulation of BP stimulated spleen cells from F. hepatica infected mice 
vaccinated with B. pertussis whole cell vaccine.
In conclusion, this is the first study to demonstrate the down regulation of Thl 
cytokines to a non-parasitic antigen in F. hepatica infected mice. These results merit an 
examination of the efficacy of immunisation programs in the Bolivian Altiplano where 
human fasciolosis is endemic (Bjorland et al., 1992). Infection with F. hepatica may make 
individuals susceptible to other infections that require Thl responses to resist them. 
Polyparasitosis was described in the Amaryan population of the Bolivian Altiplano and a 
positive correlation was observed between individuals with fasciolosis and the protozoan, 
Giardia intestinalis (MasComa et al., 1999). Finally the molecules responsible for the 
induction of Th2 response or the down-regulation of Thl response have yet to be 
identified. The experimental system described in this chapter would be an excellent model
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to identify these molecules; and possibly investigate the role of another important Th2 
regulatory cytokine, IL-10.
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Chapter 8
Down-regulation of type I responses in BALB/C mice to 
B. pertussis whole cell vaccine elicited by a co-injection 
of F. hepatica ES products.
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In the previous chapter we demonstrated that an established type I immune response in 
mice vaccinated with B. pertussis whole cell vaccine was down regulated when these mice 
were subsequently infected with F. hepatica. This was an IL-4 dependent process 
because when this experiment was repeated in IL-4 knockout mice this down regulation 
was not observed. Since F. hepatica ES products are actively secreted by the parasite we 
hypothesize that these molecules may have a vital role in the suppression of type I immune 
responses by actively enhancing the production of Th2 like cytokines. In the following 
study we have performed both in vitro and in vivo studies to investigate this hypothesis.
8.1 Introduction
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8.2.1 Experimental design 1
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Four 3 to 4 month old female BALB/c mice were administered 100 (in 100 fil) of F. 
hepatica ES products intravenously via the tail vein (Group 1). One hour later these four 
BALB/c mice and an additional four mice that did not receive ES products (Group 2) 
were vaccinated with B. pertussis whole cell vaccine (0.8 iu/mouse). Four untreated 
BALB/c mice were included in the study as controls (Group 3). On day 14 all mice were 
sacrificed by cervical dislocation and the spleens removed. Isolated spleen cells were 
stimulated in vitro with BP antigen and IFNy, IL-2, IL-4 and IL-5 cytokines in the 
supernatant measured.
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8.2.2 Experimental design 2
Spleen cells obtained from mice vaccinated with a single dose of B. pertussis whole cell 
vaccine were stimulated in vitro with BP (0.1 ixg/ml, 2 jig/ml and 5 fag/ml) in the presence 
or absence of 100 (ig/ml o f ES antigen. The spleen cells were cultured at 37°C and 
supernatant samples removed after 24 hours to measure IL-2 and after 72 hours to 
measure IL-4, IL-5 and IFNy.
8.2.3 Experimental design 3
Spleen cells and peritoneal exudate cells from BALB/c mice were cultured in vitro with F. 
hepatica ES products (4 pg/ml, 20 (xg/ml and 100 p.g/ml). Spleen cells were cultured at 
37°C and supernatant samples were removed after 24 hours to measure IL-2 and after 72 
hours to measure IL-4, IL-5, IL-10, IFNy and IL-12. Peritoneal exudate cells were 
cultured at 37°C and the supernatant samples removed after 48 hours to measure IL-10 
and IL-12.
8.2.4 Experimental Design 4
Four BALB/c mice were administered F. hepatica ES products by intra-peritoneal 
injection (20 p.g/mse) on alternate days. Four untreated BALB/c mice were included in the 
study as controls. On day 10 all mice were sacrificed by cervical dislocation and the 
spleens removed. Isolated spleen cells were stimulated in vitro with ES antigen and IFNy, 
IL-4 and IL-5 cytokines in supernatant were measured after 72 hours.
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8.3.1 Cytokine production by spleen cells of mice injected intravenously 
with F. hepatica ES products vaccinated with B. pertussis whole cell 
vaccine.
To identify the molecules involved in the down regulation of Thl cytokines as described in 
the previous chapter, BALB/c mice were first injected intravenously with ES antigen and 
then vaccinated with B. pertussis whole cell vaccine. Mice were sacrifice 14 days later 
and the spleens removed. Isolated spleen cells stimulated in vitro with BP antigen and IL- 
4, IL-5, IL-2 and IFNy cytokines secreted into culture media were measured.
Spleen cells of mice that received B. pertussis whole cell vaccine only (Group 2) 
produced the type I cytokines, IFNy and IL-2, when stimulated with BP antigen (8.1 A and 
B); no secretion of either IL-4 or IL-5 was observed (data not shown). Spleen cells of 
mice that received an intra-venous injection of ES products, previous to vaccination with 
the B. pertussis whole cell vaccine (Group 1) produced significantly reduced levels of 
IFNy and IL-2 (p<0.0001) when compared to cells of the vaccinated mice only (Group 2) 
(8.1 A and B). Similarly, in group 2 there was no secretion of either IL-4 or IL-5 
cytokines (data not shown). Spleen cells of control mice (Group 3) did not secrete any 
cytokines in response to stimulation with BP.
8.3 Results
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Fig. 8.1 Measurement of IFNy (Panel A) and IL-2 (Panel B) cytokine production of 
spleen cells from three different groups of BALB/c mice following stimulation with BP. 
(Group 1 : mice that were injected with ES products intravenously and vaccinated with B. 
pertussis whole cell vaccine (WCV/ES); Group 2: Mice that received B. pertussis whole 
cell vaccine only (WCV); Group 3: untreated control mice (Control)). Results were the 
mean of four individual mice for triplicate cultures of spleen cells stimulated with BP 
antigen and PMA/anti-CD3.
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8.3.2 Cytokine production by spleen cells o f m ice vaccinated with B. 
pertussis whole cell vaccine in response to stimulation in vitro with BP  
antigen in the presence or absence o f F. hepatica ES products.
It was demonstrated in the first experiment (section 8.3.1) that a Thl cytokine response 
elicited by mice vaccinated with B. pertussis whole cell vaccine was blocked when these 
mice received a prior injection of ES antigen. We investigated if this down regulation can 
be observed in vitro. To this end spleen cells from mice vaccinated with B. pertussis 
whole cell vaccine were stimulated with BP in the presence and absence of ES antigen.
Spleen cells of BALB/c mice that were vaccinated with B. pertussis whole cell 
vaccine secreted IFNy and IL-2 cytokines when stimulated with BP antigen (Fig. 8.2C and 
D); a low level of IL-4 and IL-5 secretion was also observed (Fig. 8.2A and B). When 
these spleen cells were stimulated with BP antigen in the presence of F. hepatica ES 
products a significantly lower level of IFNy was produced (P< 0.05) (Fig. 8.2C); no 
significant changes in the production of IL-2, IL-4 and IL-5 were observed (Fig. 8.2A, B 
and D).
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Fig. 8.2 Cytokine production by spleen cells of mice vaccinated with a single dose of B. 
pertussis whole cell vaccine. Spleen cells were stimulated in vitro with BP antigen in the 
presence (WCV/ES) or absence (WCV) of ES antigen (100 |J.g/ml) and PMA/anti-CD3.
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Supernatant samples were removed after 24 hours to measure IL-2, whereas IL-4, IL-5 
and IFNy cytokines were quantified after 72 hours. Results were the mean of four 
individual mice for triplicate cultures.
8.3.3 Cytokine production by spleen cells and peritoneal exudate cells 
stimulated in vitro with ES antigen.
This experiment investigated if ES antigen can directly stimulate cytokine production of 
naive spleen and peritoneal exudate cells, by stimulation of these cells in vitro with ES 
antigen. We found that spleen cells from BALB/c mice did not secrete IL-4, IL-5, IL-10, 
IFNy or IL-12 cytokines when stimulated in vitro with ES (data not shown). Peritoneal 
exudate cells from BALB/c mice were also stimulated with ES antigen and the production 
of IL-12 and IL-10 quantified, while these cells did not produce any IL-12 (data not 
shown) they did secrete significant amounts of IL-10 cytokine (Fig. 8.3). The 
concentration of IL-10 cytokine produced correlated with the concentration of ES antigen 
present in the culture medium.
□  0 ug/ml
□  20 ug/ml 
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Fig. 8.3 Measurement of IL-10 production by peritoneal exudate cells from BALB/c mice 
stimulated in vitro with ES antigen (0 |J.g/ml, 20 pg/ml and 100 p,g/ml) and PMA/anti- 
CD3. Results were expressed as the mean cytokine concentration of a pool of peritoneal 
exudate cells from four mice tested in triplicate.
8.3.4 Cytokine production by spleen cells from mice vaccinated on 
alternate days with ES antigen.
To examine whether ES products can induce a Th2 cytokine response, 3-4 month old 
BALB/c mice were injected intraperitonally with ES antigen on alternate days. Mice 
were sacrificed after 10 days and isolated spleen cells were stimulated in vitro with ES. 
The amount of IL-4, IL-5 and IFNy present in culture media was measured.
Spleen cells from control BALB/c mice did not secrete either Thl (IFNy) or Th2 
(IL-4 and IL-5) cytokines in response to stimulation with ES antigen (data not shown). 
Spleen cells of mice that were injected with ES exhibited a predominant type II response 
when stimulated in vitro with ES, with significant secretion of IL-4 and IL-5 cytokines; no 
secrction of the Thl cytokine, IFNy, was observed.
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QOug/ml 
□  20 ug/ml 
H 100  ug/ml 
■  PMA/anti-CD3
□  0 ug/ml 
□ 2 0  ug/ml 
0 1 0 0  ug/ml 
■  PMA/anti-CD3
□  0 ug/ml
□  20 ug/ml 
H 100 ug/ml
■  PMA/anti-CD3
Fig. 8.4 Measurement of cytokine production by spleen cells from BALB/c mice that were 
injected intraperitoneally with F. hepatica ES products on alternate days. Spleen cells 
were stimulated in vitro with ES antigen (0 pg/ml, 20 p-g/ml, 100 pg/ml) and PMA/anti- 
CD3. After 72 hours supernatant samples were obtained and IL-4, IL-5 and IFNy were 
quantified. Results were expressed as the mean cytokine concentration of four mice per 
group tested in triplicate.
151
Information gleaned from the previous chapter suggested that fasciolosis is associated 
with a generalised Th-subset polarisation towards a Th2 cytokine profile. Antigen 
stimulated spleen cells from infected mice secrete a predominant Th2 cytokine profile. 
More importantly an infection with F. hepatica, down-regulates a type I immune response 
to a bystander non-parasitic antigen. Similar to other parasites, these processes are 
dependent upon IL-4 (Sabin and Pearce, 1995; Mac Donald et ah, 1998). The molecules 
of ES products involved in the induction a type II immune response or in the suppression 
of Thl cytokines has yet to be identified. Since F. hepatica continuously secretes ES 
products throughout all stages o f development in the definitive host we hypothesise that 
these molecules may function by inducing the secretion of the cross-regulatory cytokine, 
IL-10 or the Th2 cell growth factor, IL-4. The early induction of Th2 cytokines would 
inhibit the development of a type I immune response. In this present chapter a number of 
preliminary studies were performed to investigate these matters.
Successful infection of a potential host by parasites requires the release of 
molecules which disarm the host defence system. The release of immunomodulatory 
molecules is not unique to parasitic infections. The Epstein-Barr virus genome encodes a 
homologue of IL-10 which shares many of the cellular cytokine’s biological activities. It 
plays a central role in the host-virus interactions by down-regulating the protective type I 
immune response (Moore et al., 1990). Similarly, the bacterium B. pertussis inhibits the 
development of cell mediated immunity by down-regulating 1L-12 cytokine production 
(McGuirk et ah, in press).
8.4 Discussion
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Several studies have been performed to determine the immunomodulatory role of 
ES products in parasitic infections such as that reported by MacDonald et al. (1998), 
Fukumoto et al. (1997) and Ramaswamy et al. (1995). When mice were infected with the 
larval and adult stages of Brugia malayi high levels of parasite-specific IL-4 were 
produced by spleen cells on stimulation in vitro (Lawrence et al., 1994). Both stages of 
infection are capable o f inducing profound peritoneal exudate cell mediated suppression. 
The development of this proliferative suppression is dependent upon IL-4 and could not 
be reversed by the addition of nitric oxide inhibitors. In these studies there was no 
apparent defect in either antigen-specific processing or co-stimulation. In contrast, when 
mice were infected with B. malayi microfilariae, which induces a Thl response, a 
moderate suppressive effect that can be fully reversed with inhibitors o f nitric oxide was 
observed (MacDonald et al., 1998). In a subsequent study they investigated whether the 
molecules of excretory/secretory products were involved in the generation of these 
suppressor antigen presenting cells. ES was found to generate suppressive peritoneal 
exudate cells as effectively as the live parasite itself. Moreover, this process was also 
dependent upon IL-4 and could not be reversed by the addition of nitric oxide inhibitors. 
The molecules present in ES which are involved in augmenting these suppressor cells have 
not been identified. In this experiment it was also demonstrated that ES from Toxocara- 
and Nippostronylus-infected mice also generate a suppressive peritoneal exudate cell 
population. These results indicate that the immunomodulaory phenomenon may be a 
common feature of the Nematode phylum (Allen and MacDonald, 1998).
Fukumoto et al. (1997) investigated the anti-inflammatory properties of ES 
products of plerocercoids of Spirometra erinacei. In this experiment murine peritoneal
153
exudate cells were stimulated with IFNy and/or lipopolysaccharides (LPS) in the presence 
or absence of ES products. Both IFNy and LPS stimulate the expression of iNOS 
(inducible nitrous oxide synthase) and JE mRNA. The release of nitrate oxide from 
mononuclear phagocytes is important in host defence functions, whilst JE, a chemokine, 
exhibits chemoattractant properties triggering leukocyte trafficking and migration. This 
study demonstrated that ES products of plerocercoids suppressed iNOS and JE mRNA 
expression. In addition nitrate production of macrophages was inhibited in a dose- 
dependent manner. These may explain why plerocercoids found in the peritoneal cavity of 
infected animals are not harmed by bound inflammatory leucocytes. Similar to filarial 
worms the molecules present in ES involved in these processes have not been identified.
Schistosomulae of S. mansoni actively penetrate the skin to gain entry into the 
definitive host by releasing a number of proteinases in their excretory/secretory products 
(Dalton and Brindley, 1998). The ES products of schistosomulae also exhibit anti­
inflammatory properties. Ramaswamy et al. (1995) demonstrated that ES products 
induced the anti-inflammatory cytokine IL-lra, from human keratinocytes. This IL-lra 
inducing molecule was identified as a 16.8 kDA protein (SM16.8). Addition of SM16.8 
to cultured spleen or lymph node cells also results in a significant reduction in cell 
proliferation and IL-2 secretion.
In this chapter we performed several experiments to determine if the ES products 
of F. hepatica contained molecules that could modulate immune responses. Spleen cells 
from B. pertussis whole cell vaccinated mice exhibit a predominant type I immune 
response (high IFNy and IL-2) when stimulated in vitro with BP antigen. When these 
mice received a co-injection of intravenous ES antigen one-hour prior to vaccination there
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was a significant decrease in both IFNy and IL-2 production (P < 0.001); no significant 
secretion of IL-4 or IL-5 cytokines was observed. Therefore, molecules of ES products 
can down-regulate the production of the Thl cytokines, IFNy and IL-2.
In contrast to results obtained in the previous chapter there was no generalised Th- 
subset imbalance associated with an intravenous injection of ES products. When spleen 
cells of mice co-injected with B. pertussis whole cell vaccine and ES products were 
stimulated in vitro with PMA/anti-CD3 there was no significant difference in the cytokine 
profile observed when compared to that of control mice or o f mice that received vaccine 
only. A single dose of ES antigen may be enough to down-regulate the Thl response but 
is not sufficient to induce a strong Th2 response which would result in this generalised Th- 
subset imbalance. This may explain why spleen cells from co-injected mice when 
stimulated in vitro with ES did not secrete either Thl (IFNy and IL-2) or Th2 (IL-4 and 
IL-5) cytokines (data not shown).
To identify the mechanism involved in blocking Thl cytokines it would be 
advantageous to develop an in vitro model to illustrate the effects o f F. hepatica ES 
products on Thl cells. To this end, spleen cells from B. pertussis vaccinated mice were 
stimulated in vitro in the presence or absence of ES products. As previously reported 
spleen cells from B. pertussis whole cell vaccinated mice when stimulated in vitro with BP 
antigen, secrete high levels of IFNy and IL-2 but very low levels of IL-4 and IL-5 
cytokine. When these cells were stimulated with BP in the presence of ES there was a 
significant down-regulation of IFNy; no significant difference in the secretion of IL-2, IL-4 
or IL-5 cytokines was observed when compared to cells stimulated with BP only. 
However, the suppression of IFNy secretion by ES was only statistically significant when
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spleens cells were stimulated with the highest concentration of BP antigen. The molecules 
of ES products may inhibit IFNy secretion in vitro by several different mechanisms such as 
a) the induction of IL-10 secretion, b) the blocking of IL-12 secretion or c) by directly 
cleaving IFNy. The inability to down-regulate IL-2 may reflect the concentration of ES 
employed. However the amount added to the cultured spleen cells was the same as the 
dose administered in vivo by intravenous injection. Therefore these results may indicate 
that parasite derived factors act in concert with host immune components that are not 
present in the in vitro system.
When peritoneal exudate cells of naïve BALB/c mice were stimulated in vitro with 
ES a significant production of IL-10 was produced. Interleukin-10 is a multifunctional 
cytokine that was first described as the synthesis inhibitory factor because it inhibits 
proliferation, effector function and development of Thl cells. In the murine model IL-10 
is expressed by mouse CD4+ Th2 clones, T-cells, activated mast cell lines, activated 
macrophages, keratinocytes and Ly-1 B-cells. It is an important cross regulatory cytokine 
inhibiting Thl cytokines at the mRNA and protein level. In vitro it exhibits a number of 
immunostimulatory properties as it enhances the growth and differentiation of B-cells, 
thymocytes, peripheral T-cells, mast cells and cytotoxic T-cells. Thus, the early 
production of IL-10 in infected mice may inhibit the synthesis of Thl cytokines allowing 
the type II immune responses to develop. The cellular components present in the 
peritoneal exudate which secrete IL-10 in response to ES antigen in vitro have not been 
identified. Peritoneal exudate cells from naïve mice consist primarily of macrophages, 
neutrophils and lymphocytes (predominantly Ly-1 B-cells). Both macrophages and Ly-1
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B-cells are a rich source of IL-10. It is possible that these cells are the early source of IL- 
10 during the initial stages of infection.
The production of IL-10 by CD4+ T-lymphocytes was shown by Sher et al. (1991) 
to down-regulate Thl cytokine secretion. In their experiments spleen cells from 
chronically infected mice were stimulated for 24 hours with soluble egg antigen (SEA). 
The supernatant was then tested for its ability to alter IFNy synthesis by a Thl cell line. 
Spleen cells from infected mice inhibited the production of IFNy by Thl cells. This 
inhibition was totally neutralised by the addition of IL-10 monoclonal antibodies. In our 
experiment we have demonstrated that the down regulation of Thl cytokines is exhibited 
in mice infected with liver fluke and vaccinated with B. pertussis whole cell vaccine. 
Although this process was shown to be dependent upon IL-4, IL-10 may also be 
important. IL-10 may mediate it’s effects by the induction of early IL-4 production. The 
use of monoclonal antibodies to inhibit IL-10 molecules in these vaccinated infected mice 
may help elucidate the role of this cytokine.
Velupillai and Ham (1994) have identified a carbohydrate ligand LNFP-III on S. 
mansoni eggs which induces B-cells to secrete IL-10 and Prostaglandin E2, two molecules 
known to down-regulate Thl. In addition this molecule induces the proliferation of 
splenic B-cells but not CD4+ cells. The nature of the LHFP-III interaction with B-cells is 
unknown. F. hepatica and S. mansoni are both digenic trematode worms that share 
similar physiological and morphological characteristics. Several experiments have 
demonstrated that these worms express similar molecules. It is possible that F. hepatica 
secretes structurally and functionally related oligosaccarides to LHFP III. Unlike 
schistosomiasis the induction of a type II immune response by F. hepatica is not
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associated with egg production. The production of Th2 cytokines by spleen and lymph 
node cells of infected mice was detected as early as one week post initial infection (data 
not shown). These LNFP-III-like oligosaccharides may be present in the glycoprotein rich 
surface glycocalyx. When liver flukes are cultured in vitro these oligosaccharides could be 
released into the culture media on antigen shedding, explaining their presence in ES 
products. Further work is necessary to determine if this hypothesis is correct.
In our final experiment mice were injected with ES antigen (20 n-g/mse) on 
alternate days for 10 days. Spleen cells from these mice exhibited a predominant type II 
response when stimulated in vitro with ES. Previously in our laboratory we showed that 
spleen cells of mice that received only one intra-peritoneal injection of ES secreted neither 
Thl or Th2 cytokines when stimulated in vitro with ES (data not shown). Therefore, a 
continuous injection of ES was necessary to induce the Th2 response. This would reflect 
the in vivo situation as liver flukes continuously secretes ES products. It was estimated by 
our laboratory that each fully mature liver fluke can secrete approximately 16-32 jig/hour 
of ES products. This is in an agreement with an experiment by Allen et al. (1998) who 
demonstrated that the suppressive effects of filaria ES antigen was only observed when 
mice received several injections.
In conclusion, the data from these preliminary studies demonstrates that F. 
hepatica ES down-regulates a type I immune response to a bystander non-parasitic 
antigen. More importantly, ES induces peritoneal exudate cells to secrete IL-10 in vitro. 
Intra-peritoneal injection of ES on alternate days for 10 days induced a predominant Th2 
cytokine profile.
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Chapter 9 
General Discussion
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Human fasciolosis is becoming recognised as a major public health problem, particularly in 
such diverse countries as Bolivia and Iran. In this study the region of interest is the 
Bolivian Altiplano, a high plain region situated between two Andean mountain ranges, 
approximately 3,700 metres above sea level. The Altiplano is the largest expanse of arable 
land in the Andes and is principally inhabited by the indigenous Amaryan population. The 
subjects in this study reside in a region located between the capital city, La Paz and lake 
Titicaca where a high prevalence of human fasciolosis was previously reported by Hillyer 
el al. (1992) and Bjorland et al. (1995). The contributory factors causing this high 
regional prevalence include, inter alia, climatic conditions, human dietary habits, life style, 
presence of intermediate host and animal reservoirs.
The appearance of liver fluke disease is influenced by climatic factors. In Europe 
the disease generally appears in late summer and early Autumn (Ripert et al., 1988). 
Although human infection is rare in Europe it is also at this time that cases appear. In 
contrast, the Bolivian climate appears to promote transmission of the disease all year 
round (Stork et al., 1973). Temperature does, not vary significantly in this region 
averaging from 18°C to 22°C during the day and dropping at night from 0°C to 6°C in the 
wet (October-July) and dry seasons (May-September), respectively. Accordingly, 
temperature would not appear to be an important limiting constraint in disease 
transmission in this region. However, during the period of May to August the drop in 
temperature can retard the development of the larval stages in the molluscan host (Fuentes 
etal., 1998)
The bar chart in Fig. 9.1 displays the monthly precipitation in the Altiplano over a 
period of three years (data provided by INLASA). The minimal rainfall for successful
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transmission is six mm per month. The bar chart illustrates that in the Bolivian Altiplano 
during a typical year sufficient rainfall occurs for eight months o f the year. During the 
height of the rainy season lake Titicaca and its tributaries overflow and subsequent 
extensive flooding producing optimum conditions for transmission. A positive relationship 
can be observed between the proximity to the lake and the prevalence of the disease in 
cattle (Buchon et al., 1997). During the dry season successful completion of the life cycle 
is still possible because animals and humans tend to collect around water sources. The 
Lymanaeidae snail introduced to the region during colonization by Spanish explorers has 
adapted to the climatic conditions in the Bolivian Altiplano. This snail is reported to 
reside almost wholly sub-aqua in comparison to its European counterpart; therefore they 
are not dependent to the same extent upon the amount of precipitation levels per month. 
In addition, they are observed on aquatic plants during the dry season (Oviedo et al.,
1995). The incidence of infection is believed to be clustered in particular regions, 
depending upon the distribution of the molluscan host which is predominantly found in the 
north west of the Altiplano.
Over the course of the last two decades local health care officials have become 
increasingly aware of the problems associated with the high incidence of human fasciolosis 
in the Bolivian Altiplano (Angles et al., 1992). Esteban et al. (1997) published a review 
focusing upon the incidence of human liver fluke disease from 1962 to 1992. The earliest 
paper published by Hartmann and Patino (1962) featured a clinical report concerning two 
medical cases. A further 26 years elapsed before subsequent papers were published by 
Vela Pacheco (1988) and Flores Serna and Estevez Martini (1988). In common with the 
initial reports, these papers focused upon clinical cases and did not report on the
161
prevalence of the disease in the region. Caceres Vega (1989) marked a new departure by 
reporting upon the incidence of disease in four different locations in the Bolivian Altiplano 
(Table 9.1). Several epidemiological surveys have been published since 1989 and Table 1 
summarizes the reported recorded incidence of the disease in humans in this region over 
the last 17 years.
Figure 9.1: Official rainfall from Battalas (2km from the city of La Paz) from 1988-1989. 
The minimal rainfall required for transmission is 6 mm per month (black bars).
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Fig. 9.2 A map of the Bolivian Altiplano illustrating the zones and communities where 
cattle were surveyed for F. hepatica infection (Buchon et al. 1997). A total of 107 
communities were surveyed (89 communities numbered on the map) in this study. The
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communities where bovine fasciolosis was present were indicated by closed circles 
whereas communities where fasciolosis was not detected were indicated by open circles.
The majority of the studies performed by this laboratory and by others were 
carried out in the Pucarani and Tambillo region (Fig. 9.2). In the village of Cutusuma four 
surveys were performed in Cutusuma between the period of 1984-1989. Each survey 
reported a high incidence of infection in this region. Our laboratory surveyed serum 
samples obtained in Cutusuma (1997) and demonstrated that human fasciolosis was 
present in this region in 1986 and 1997. These results and the data presented in this table 
supports our findings which highlights that fasciolosis has been prevalent in these regions 
for over a decade.
The prevalence of liver fluke disease varies throughout the Altiplano (Table 9.1). 
In the south of la Paz and in the Tiwanaku corridor the incidence of infection is relatively 
rare compared to the highly prevalent zones in the north west of La Paz (Fig. 9.2). Our 
hypothesis postulates that this is due to the proximity of the southern region from Lake 
Titicaca. In addition, the distribution of the molluscan host is mainly restricted to the 
north west of the Altiplano and has not yet been found in the Timanaku corridor.
In our study we found that one of the highest reported incidence of human 
fasciolosis was in a small village, Chijipata Alta, situated north of the city La Paz. In this 
random study performed on 29 individuals 69% tested serologically positive in our 
IgG4/CLl ELISA. A similar study was performed by Esteban et al. (1997) one year later. 
This study was performed on school children who were diagnosed by coprological 
analysis. In agreement with our results 67% of individuals tested were positive for liver 
fluke disease. In the study performed by this laboratory we observed that coprological
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incidence of infection in this survey may be as high a 72%.
analysis underestimated the number o f  infected individuals by 8%. Therefore the true
T able 1: The incidence of human fasciolosis from 1981 - 1998.
No. Y ea r T ow n N u m b er
E xam ined
%  In fec ted
C op ro . Sero.
C F ELISA IFA ID R
1 1981 Tambillo 12 0
2 1984 Guaqui 126 0
3 1984 Battalias 92 3
4 1984 Pucarani 73 3
5 1984 Cutusuma 92 21
6 1986 Rio Seco 816 0
7 1986 Taúca 93 1
8 1987 Cutusuma 144 31.7 54.2
9 1987 Santiago de Huata 71 0
10 1987 Viacha 272 0
11 1987 Cutusuma 183 37 92 80
12 1987 Tauca 79 0 18
13 1987 Batallas 164 7 58
14 1989 Kallutaca 90 47.7
15 1989 Cutusuma \ 55.6
16 1989 Cutusuma \ 92.2
17 1989 Cullucachi \ 13.5 71.9
18 1991 Calasaya 89 11.5 20.2
19 1991 Calasaya 71 21 49
20 1991 Santa Ana 32 34.4
21 1992 Coropata 100 27 53
22 1992 Huacullani 123 38.2
23 1993 Huacullani 256 31.2
24 1993 Quinpajo 43 20.9
25 1993 Calería 51 5.9
26 1993 Coropata 85 17.6
27 1996 Chijipata 29 64 69
28 1997 Chijipata 48 66.7
29 1997 Cutusuma 67 46 49.2
Cf=Complemenl fixation, IFA=Indirect immunofluorecencc, IDR=intradermal reaction to fasciolosis.
Copro. =  coprological analysis, Sero. =  Serological analysis.
(Angles el at.. 19921'7,9' 13; Caceres Vega. 19891417; Bjorland et a t.  199518; Hillyer et a t  199221; Esteban et at. 19 9 7 22 Jil'28; O ’ Neill et 
a t, 1998, this thesisl2'l!l'20’21-M)
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The coprological analysis performed by our laboratory on the individuals in 
Chijipata Alta (1996) revealed the highest global intensities of eggs per gram (epg) of 
faeces is to be found in the Bolivian Altiplano. In a“typical” infection recorded in France 
or Portugal an average intensity of 1 to 4 epg is anticipated. The highest reported 
European incidence was recorded in Portugal, an estimated 2100 epg (Chen and Mott,
1990) but this egg count is not normally associated with a typical infection. In contrast, 
the intensities in Bolivia ranged between 24 epg to 4446 epg and the highest intensity 
reported was 5064 epg in Chijipata Alta. Therefore individuals in this region are either a) 
exposed to a higher level of infection, b) are genetically more susceptible to infection c) 
are immunologically more susceptible to infection as a result of concurrent infections or d) 
the parasite has evolved to survive within the human host.
Many individuals in the Bolivian Altiplano carrying acute or chronic fasciolosis are 
asymptomatic or present with ‘vague’ symptoms rendering clinical diagnosis problematic 
(Bjorland et ah, 1989). A significant number of individuals are in the latent stage of 
infection which can last from a period extending from several months to several years and 
clinical diagnosis is difficult during this stage. Accordingly, the development of a simple, 
sensitive and cost effective diagnostic assay which can identify individuals at all stages of 
disease is necessary. While coprological analysis may fulfill some of these requirements it 
has several disadvantages. Firstly, it provides a definitive parasitological diagnosis only 
when eggs are found in the patients faeces. Therefore, early infections cannot be detected 
using this method. An early diagnosis of fasciolosis is vital since it is the juvenile stages of 
the parasite which cause extensive damage to the liver tissue (perforations and 
haemorrhaging) as they migrate towards the bile ducts. Secondly misdiagnosis of
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individuals can occur since eggs are irregularly released with the bile juices into the 
intestines. Definitive coprological analysis requires the examination of at least two faecal 
samples taken at different times on consecutive days. In the 1986 survey of Cutusuma it 
was possible to obtain only a single faecal sample from each patient. This may explain 
why a higher proportion of individuals were coprologically negative but serologically 
positive in this region in comparison to surveys where two stool samples were obtained. 
Thirdly, the use of different methods of coprological analysis also may result in different 
estimates of the prevalence of infection (Munoz et al., 1987). A significant variation was 
observed between the sedimentation method and the Kato-Katz technique (Chapter 4). 
This is particularly important when diagnosing patients with low intensity infections since 
only 2-3 epg may found in the faecal sample. Finally applying this method in the field may 
be difficult as children are reluctant to provide stool samples. In the Cutusuma 1997 
survey we suspected that some children may have provided us with stool samples which 
they had obtained from other children.
The CLl/IgG4-ELISA was shown to be a useful tool in diagnosing human 
fasciolosis and is both highly sensitive and specific. This immunological assay eliminates 
many of the problems associated with coprological analysis. One sample of blood is 
required for diagnosis and this sample is taken directly from the subject participating in the 
study. ELISA can diagnose infection in both the acute and chronic stages of disease. 
Using our IgG4/CLl assay large numbers of samples can be analysed within a relatively 
short time. Provision of diagnostic laboratories with purified cathepsin L would 
standardise the assay thus facilitating comparison of results throughout the Altiplano and
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in other regions where fasciolosis is endemic. If  3 mg of recombinant protein is given to 
the INLASA by our laboratory approximately 2000 individuals can be tested.
Using out newly developed ELISA the present report reveals that human 
fasciolosis has been endemic in the Bolivian Altipiano for at least a decade and a total of 
44.3% of individuals from 361 surveyed were infected with human fasciolosis. There are 
approximately 1.5 million people resident in the Bolivian Altipiano with approximately 
100,000 individuals at risk to infection. If our study reflects the overall incidence in this 
region then approximately 44,300 individuals are infected. A more comprehensive study 
of fasciolosis, in humans in the Altipiano, is therefore essential to determine the full extent 
of infection, the limits to which it extends and the epidemiological factors that influence 
transmission.
Some of the factors which contribute to the high incidence of human fasciolosis 
include living in close proximity to their livestock, the consumption of aquatic plant and 
contaminated water, the outdoor defaecation habits and the underdeveloped health care 
system. The majority of individuals residing in the Bolivian Altipiano are subsistence 
farmers relying on the land and their livestock to survive. Animals are primarily fed on 
aquatic plants and algae which may be contaminated with F. hepatica metacercarial cysts. 
In some regions of the Altipiano pasturing is free or mixed and the absence of pasturing 
zones leads to contaminated pastures. Transmission in humans is promoted by animal 
reservoirs such as sheep, cattle (Hillyer, 1996), pigs (Apt, 1993), llamas and alpacas 
(Ueno, 1975) because of the high prevalence of fasciolosis in livestock in this region. Fig. 
9.2 highlights the prevalence of Bovine fasciolosis. Similar to the studies performed in 
humans the incidence of infection is high in the Pucarani and Tambillo region. However,
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the incidence is also high in other regions that have not been surveyed for human 
fasciolosis. Similar to humans the incidence of bovine fasciolosis is low in the south of La 
Paz and in the Tiwanaku corridor. These result would support the close association of 
bovine and human fasciolosis (Buchon et al., 1997).
Transmission in humans is believed to occur because of their dietary habits. 
Individuals supplement their diet with aquatic plants during daily animal husbandry. The 
main types of aquatic plants are “berro berro” (watercress), “algas” (algae), kjosco and 
totora (Bjorland et al., 1995; Angles, personal communication, 1996). Whilst drinking 
water is not believed to be associated with infection, the consumption of surface water 
while working in the fields is believed to be a source of infection. Caceres Vegas (1989) 
was the first author to suggest that drinking untreated water may be a source of infection. 
He suggested that the strain of F. hepatica had evolved to produce free floating 
metacercarial cysts. Vegetables washed in contaminated water may also become a source 
of infection. The incidence of infection is almost inevitably aggregated within familial 
groups which share contaminated food and drink from a common water source (Bjorland 
et al., 1995).
The data collated by this laboratories and by others in collaboration with INLASA 
have underlined the extent of human fasciolosis in this region. Presently the Bolivian 
government are seeking to address this problem with the formation of a committee, tasked 
with the development o f a health care policy specific to this region. Although it is 
apparent that this disease is endemic to this region, it should be possible with the 
combination of an extensive regional survey and the provision of primary preventive health 
care to eradicate this disease. Firstly, the incidence of infection throughout the entire
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region should be determined. This is to identify specific target areas. The use of our IgG4 
ELISA would provide a cheap simple and quick diagnostic method to do this. The 
provision of recombinant protein would standardise this assay making it possible to 
directly compare data from different regions. In this study individuals were reluctant to 
provide blood samples. However, the method of collecting blood onto filter paper makes 
a large epidemiological survey possible. This method would also allow us to obtain a 
large number of samples within a relatively short period of time. It is vital that once 
individuals are drug treated primary preventive steps are introduced to curtail re-infection. 
The installation of a number of water pumps throughout the region are vital to stop the 
consumption of contaminated water. In addition, drinking water should be filtered or 
boiled. This would not only limit the spread of infections such as liver fluke disease but 
also other infections that are transmitted through water contamination.
If feasible cattle should be provided with water from troughs which are supplied 
with pumped water. This innovation, coupled with the herding of cattle into areas 
divorced from the water sources, prevents the consumption of pond algae, would protect 
the cattle by controlling consumption, it would have the further advantage of preventing 
pollution of the water source by ruminants defecating directly into the system. This would 
prevent transmission of the life cycle.
Health education programmes in schools are essential as we and others (Mas- 
Coma et al., 1997) have shown that children have a higher risk of infection. Children 
should be aware of the F. hepatica life cycle and the mode of transmission and be 
encouraged to use toilets or latrines away from water source. F. hepatica infection in 
children may be related to an increased exposure to infection as children commonly work
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in the fields minding livestock where the intensity of transmission would be expected to be 
higher. Children are more likely to consume the aquatic plants. If algae is used as a 
supplement to their diet it should be washed and the eating of algae directly from the 
ponds or rivers should be discouraged.
It is possible that the higher incidence of infection in children observed in this study 
may indicate the existence of an age related immunological resistance to infection by F. 
hepatica in operation, a phenomenon that is well documented for the related digenetic 
trematode of the spp. Schistosoma. Studies performed by Hagan et al. (1991) 
demonstrated age-related resistance to schistosomiasis haematobium in Kenya. The 
intensity o f schistosomiasis peaked in the second decade of life and fell to lower levels as 
the subject aged. They also observed that after treatment with praziquantel the frequency 
and intensity of re-infection was greatest in children under 15 years of age compared to 
low frequency and intensity subjects older than 15 years. Contact with water was 
monitored during this study and it is apparent that some adults were as intensely exposed 
to possible infection as the children. Specific IgE antibody against adult worms was 
higher in the older age group whereas higher levels of IgG4 antibodies to either worm or 
egg antigens were present in the younger age group. It is thought that IgE and IgG4 
compete for the same antigenic sites where IgG4 blocks binding of the more specific IgE. 
It is apparent that as the subject ages a switch from IgG4 to IgE occurs. The development 
of high levels of specific IgE is associated with protection.
Immunological investigations were not logistically possible in the Bolivian 
Altiplano because of the reluctance of the Aymarans to provide blood samples. However, 
analysis o f the serum obtained from individuals o f all age groups showed that these elicited
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high titres of IgG4 but not IgGl iso type in response to infection. This result suggests that 
a type II immune response may be associated with human fasciolosis. Fundamental 
questions remain concerning the mechanisms of immunity to infection with F. hepatica in 
humans. To this end we employed the mouse as a model to gain some insight into the 
immunological mechanisms associated with infection. Although the Thl/Th2 cytokine 
network described for mice is not identical to that of humans the murine model provides a 
basis through which we can begin to understand these immune responses. In addition, 
information acquired in this study may also prove useful in understanding the 
immunological mechanisms in other animal models such as sheep and cattle since infection 
in these animals is a source of economic loss to farmers throughout the world.
The ability of helminth infected animals to determine the outcome of disease is 
dependent upon whether a type I or type II immune response is mounted for example, T. 
spiralis infection in resistant AKR mice is associated with a Thl cytokine profile whereas 
the susceptible B10.BR strain predominantly secretes IL-5. This suggests that a type I 
response is associated with protection (Pond et al. 1989). However, T-cells from 
susceptible strains of mice infected with T. muris secrete IFNy while resistant mice strains 
secrete the IL-5 cytokine suggesting that in this parasitic infection Th2 responses are 
protective (Pearce et al., 1990).
Schistosomiasis in mice induces a type II response which initiates the immune- 
mediated granulomatous reaction to entrapped eggs. Granuloma formation is associated 
with the gross pathology and manifests itself clinically by portal hypertension and 
extensive hepatic fibrosis. SCID mice infected with S. mansoni are unable to generate a 
granulomatous response and die rapidly from severe hepatitis as a result of eggs trapped in
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the hepatic tissue. Therefore, in murine schistosomiasis a type II response does not 
eliminate the worms but is important in limiting the immunopathology (Pearce el al.,
1996). In humans a more complex immunological phenomena occurs as a type II response 
is associated with both resistance and susceptibility to disease. However, differential type 
II antibody responses are associated with resistance and susceptibility; high levels of IgG4 
antibodies are associated with susceptibility whereas high levels of IgE antibodies are 
associated with resistance (Hagan et al., 1991).
B. malayi, the causative agent of lymphatic filariasis, is another important example 
of the balance that exists between the immune mediated expulsion of the parasite and the 
immunopathology associated with disease. Transmission of B. malayi occurs by the 
inoculation of the host with the infectious larvae (L3) via the intermediate host, the 
mosquito. The larvae migrates to the lymphatic system where mature male and female 
worms mate to produce microfilariae. Maizels et al. (1993) postulated that the Th2 
responses observed in the asymptomatic individuals ultimately results in the expulsion of 
the microfilariae. However, expulsion of the worms is associated with the induction of a 
Thl response which is believed to cause the immunopathology observed in elephantiasis.
The present study has clearly demonstrated that fasciolosis induces type II 
responses in mice. Antibody isotype responses in rats (Poitou et al., 1993), sheep (Sexton 
et al., 1994) and cattle (Clery et al., 1996) indicate that these species also develop type II 
responses to infection. Immunological studies investigating cytokine responses in animals 
infected with F. hepatica have been limited to a few studies which were predominantly 
performed in cattle. In a study by Brown et al. (1994) it was demonstrated that antigen 
specific T-cell clones isolated from cattle chronically infected with F. hepatica express
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ThO and Th2 CD4+ cells but not Thl CD4+ cells. Clery et al. (1996) measured mRNA 
from peripheral blood mononuclear cells (PBMC) lymphocytes of chronically infected 
cattle with F. hepatica. In this experiment it was demonstrated that cattle failed to 
produce IFNy but produced both IL-4 and IL-5 mRNA. The proliferation of peripheral 
blood lymphocytes correlated with IgGl titres to liver fluke antigen in infected cattle 
which confirms that a type II response is associated with F. hepatica infection.
Although type II responses appear to predominate in liver fluke infection it is not 
known whether this offers protection to the host or is responsible for the pathological 
sequale that is associated with disease. Various hosts have exhibited differences in their 
susceptibility to infection and in their ability to develop resistance. Although some studies 
have shown protection in mice (Lang et al., 1974), they are generally considered 
susceptible to infection as they fail to develop resistance to a challenge infection either 
following light infection or immunisation with F. hepatica antigens. Even drug 
abbreviated infections also fail to induce any significant resistance to re-infection 
(Chapman and Mitchell, 1982). Many studies have also demonstrated a lack of resistance 
in sheep to liver fluke infection (Ross 1967; Sinclair, 1962; 1970). In rats and cattle 
resistance to re-infection is observed (Hayes et al., 1973; Doyle et al., 1971). Recently, 
Clery et al. (1997) have shown that cattle are not resistant to recurrent infections. In 
contrast, rats appear to show resistance to recurrent infections and protection in rats was 
shown to occur at the level of the gut mucosa (Meussen and Brandon, 1994). In 
conclusion these studies would suggest that Th2 responses do not protect against liver 
fluke infection and that rats, unlike other infected animals, are somehow unique in their 
response.
174
Vaccine studies in cattle and sheep using purified F. hepatica antigens have been 
successfully employed in reducing worm burden and egg fecundity. There are several 
vaccine candidates which show potential for commercial use such as the fatty acid binding 
protein (FABP) (Hillyer et al., 1985; 1987) and the glutathione S-transferase (GST) 
vaccine (Sexton et al., 1990). The FABP antigen elicited 31-55% protection in cattle 
(Hillyer et al., 1985; 1987) while the GST vaccine elicited 18-69% protection in cattle 
(Morrison et al., 1996) and 57% protection in sheep, respectively (Sexton et al., 1990). 
The most successful vaccine to date which is presently undergoing vaccine trails was 
developed by this laboratory (Dalton et al., 1996; Mulcahy et al., 1998). This vaccine is 
composed of two molecules, cathepsin L2 and heme protein, which were purified from F. 
hepatica ES products (Smith et al., 1993; McGonigle and Dalton, 1995). The function of 
cysteine proteins in immunoevasion strategies, migration and feeding have already been 
discussed (section 1.6). The heme protein is believed to function in the aerobic respiration 
of immature flukes as they migrate within the liver mass (McGonigle and Dalton, 1995). 
The combination of these proteins elicited 72.4% protection in cattle. Moreover, 98% of 
eggs recovered from these infected cattle were non-viable thus preventing transmission of 
the life cycle.
In experiments carried out during these vaccine trials a positive correlation in non­
vaccinated animals between fluke-specific serum IgGl levels and fluke burden was 
observed. In contrast, a correlation was observed between IgG2 and low fluke burden. 
Cattle vaccinated with the combination cathepsin L heme protein vaccine exhibited > 8 
fold titre of IgGl and > 200 fold titre of IgG2 than non-vaccinated cattle. The Th-subset 
response in cattle has not been clearly defined but evidence suggests that IgGl is
175
associated with a type II immune response and IgG2 with a type 1 response. Both IgGl 
and IgG2 antibodies are observed in vaccinated cattle which indicates that a ThO cytokine 
response may be observed in these cattle. However, since IgG2 is only observed after 
vaccination and because there is a positive correlation between low fluke burden and IgG2 
tires it was concluded that a IgG2 confers protection in vaccinated cattle (Mulcahy et a l ,
1997). This would indicate that a type I response is associated with protection.
In this study we demonstrated that F. hepatica infection shifts the balance in the T- 
helper cytokine response towards a Th2 cytokine profile. This generalised Th-subset 
polarisation results in the down-regulating of Thl cytokines to a bystander antigen. 
Several other studies have also reported the immunomodulatory effects of F. hepatica 
infection. Oldam and Williams (1985) demonstrated that T-cell proliferation and IL-2 
production in cattle was suppressed by F. hepatica infection. Observations of 
immunosuppression were also made in studies performed in rats and sheep (Cervi and 
Masih, 1997; Chauvin et al, 1995). The suppression of Thl responses may make animals 
susceptible to infection that requires this arm of the immune system for protection. 
Moreover, this may also effect the efficacy of vaccines where the induction of a Thl 
responses is required for protection.
Polyparasitosis is common in developing countries. For example, in the Bolivian 
Altiplano Mas-Coma et a l (1999) found that besides being infected with liver fluke many 
patients also harboured infections such as Giardia intestinalis, Cryptosporidium sp., 
Ascaris lumhricoides and Trichuris trichiura. Moreover, they found a direct correlation 
between fluke infection and susceptibility to Giardia intestinalis. There is also a number 
of reports that have correlated the susceptibility o f individuals with schistosomiasis to
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other infections such as hepatitis B and septicaemia salmonella (Neues and Martin, 1967; 
Ghaffar et al. 1989; Bassily et al. 1992). These observations raise the question of how 
does the immune response directed to one infection influence the immune response to 
another. It is known, as demonstrated in the study by Neues and Martin (1967), that 
because helminths induce strong Th2 responses they cause a down-regulation o f Thl 
specific CTL responses. Accordingly, it is believed that this makes helminth-infected 
patients susceptible to infections that require CTL responses for protection. Indeed, it has 
been shown that the successful treatment of salmonella in schistosome-infected patients 
first requires the removal of the schistosome parasite with praziquantel (Butterworth,
1993).
Salmonella infection has also been associated with bovine schistosomiasis and in 
this case treatment of the schistosome parasite is required before the salmonella infection 
can be successfully treated (Butterworth, 1993). A parallel in fasciolosis may be infection 
with Clostridium novyi, known as black disease of the liver. It is well established that 
liver fluke-infected cattle are susceptible to this disease; one theory suggests that the 
parasite itself carries the bacterium into the liver while another suggests that the bacterium 
propagates in the necrotic tissues that result from damage caused by the liver flukes. In 
the light of the discussion above it would be interesting to determine whether the 
expression of black disease in liver fluke-infected cattle is associated with the down- 
regulation of Thl responses.
Recently, there has been much discussion on the similarity of the immune 
responses observed in helminth infections and in other hypersensivity states such as atopy 
(response to allergens, asthma). The clinical manifestations o f both include the production
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of high levels of IgE and appearance of eosinophilia which are clearly Th2 driven. To 
explain this similarity it has been suggested that the part of the immune system which 
evolved to tackle parasites, i.e. the type II responses, is now triggered by certain 
chemicals, proteins or particles in our environment (Cookson and Moffall, 1997). Of 
more fundamental relevance, the increase in atopic disorders in the developed world has 
now been attributed to the lack of exposure of individuals to Thl -inducing infections 
(Cookson and Moffall, 1997; Shirahawa et al. 1998). Cookson and Moffall (1997) 
believe that exposure to viral or bacterial infections during childhood is important in 
providing protection to atopy. There are several experimental findings that support this 
idea. Shaheen et al. (1996) showed that there was a 50% decrease in the number of 
positive atopy skin-tests during a measles epidemic in Guinea-Bissau. Skirakam et al. 
(1997) found and inverse relationship between immune response to Mycobacterium 
tuberculosis and atopy in children and Cookson and Moffal (1997) found that children 
with eczema underwent a spontaneous remission after severe bacterial or viral infectious. 
Wang and Rook (1998) also demonstrated that an established allergic response to 
ovalbumin in BALB/c mice was inhibited by an injection of Mycobacterium vaccae. 
Although it seems contradictory, it has also been indicated that helminth infections can 
protect children against asthma; however, it was suggested that the saturation of IgE 
binding sites on effector cells by parasite-induced IgE prevents them from reacting to 
aeroallergens (Cookson and Moffal, 1997).
Allergens are a heterogeneous class of molecules. One of the most common 
aeroallergen is Der p i which is found in the excrement of the house dust mice, 
Dermatophagoides pteronyssimus. Der p i is a 30 kDa cysteine proteinase which is
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involved in digestion in the mite. This molecule is thought to induce atopic immune 
responses by cleaving the surface molecules CD23 and CD25 on B cells and lymphocytes, 
respectively (Hewitt et al., 1995; Skakib et al, 1998). CD23 is involved in the regulation 
of IgE; the binding of IgE to this membrane-bound molecule results in the down- 
regulation of IgE secretion by B cells. However, when not occupied by IgE CD23 is 
cleaved releasing soluble-CD23 which can enhance IgE production. It is thought that Der 
pi up-regulates IgE by cleaving CD23 fromB cells (Hewitt et al, 1995). CD25 is a sub­
unit of the IL-2 receptor found on peripheral blood mononuclear cells which, following 
cleavage, results in diminished lymphocyte proliferation and IFNy secretion. Therefore, 
cleavage of this receptor by Der pi would block the proliferation of Thl cells and thereby 
facilitate the augmentation of Th2 responses (Shakib et a l,  1998).
In the context o f the above discussions the findings o f this study are o f particular 
interest. We have demonstrated that F. hepatica can induce Th2 responses that are strong 
enough to overcome the Thl responses induced by injection of an unrelated antigen, in 
this case B. pertussis whole cell vaccine. As mentioned above liver fluke infection could 
therefore influence the outcome of other infections. But, more importantly, liver fluke 
infection could negate the protection provided by Thl-inducing vaccines. Work is 
underway to test this hypothesis and data already obtained demonstrates that a concurrent 
infection of liver fluke inhibits the ability of mice to clear an active infection of B. pertussis 
(Brady T., O’Neill S.M., Dalton J.P. and Mills K.H.G., unpublished data).
Clearly, the mechanism by which F. hepatica induces the polarisation of the 
immune response to a Th2 type needs to be understood. We believe that the molecules 
responsible for this are most likely to be found in the ES products of the parasite.
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Accordingly, we demonstrated that an intravenous injection of ES products prior to 
vaccination with B. pertussis whole cells vaccine can down-regulate the Thl responses to 
the vaccine. Whilst the nature of the molecules that induce this down-regulation has yet to 
be established we suggest that they may well be the cathepsin L proteinases (CL1 and 
CL2) characterised by Smith et al. (1993) and Dowd et al. (1994) (and used in the first 
section of this thesis as immunodiagnostic reagents). These molecules play a digestive 
role in the fluke and together represent 80% of the total protein in ES products (Dowd et 
al., 1994). Most interestingly, the two enzymes are cysteine proteinases that are highly 
homologous to the dust mite cysteine proteinase Der p i. Other helminths such as 
schistosomes and hookworms also secrete cathepsin L cysteine proteinases (Brady et al. , 
1999; Hewitt et al., 1995). The obvious question therefore arises, could helminth cysteine 
proteinases be responsible for inducing atopic-like reactions (high lgE and eosinophilia) in 
a similar manner to Der pi i.e. the cleavage of CD23 and CD25 ? It is the intention of this 
laboratory to answer this question in the near future.
So how does F. hepatica - and indeed other helminths - drive a Th2 immune 
response ? Our findings suggest that the cytokines that are important in initiating the type 
II responses include IL-4, IL-5 and IL-10. The specific production of this IL-10 was 
induced when peritoneal exudate cells were stimulated with ES. Although the role of this 
cytokine in humans is less clear, in mice it is involved in blocking the synthesis of Thl 
cytokines. It is possible that juvenile flukes migrating through the peritoneal cavity of the 
host may induce the production of IL-10. At the same time secreted antigens (cysteine 
proteinases and/or other antigens) may then cleave surface-bound molecules like CD23
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and CD25 on B-cells and other lymphocytes triggering the production of IL-4 and IL-5 
which would then augment the type II response.
The experiments carried out in this thesis show that F. hepatica is a very useful 
model for the study of the immune responses to helminths. The advantages of this model 
include a) laboratory animals, such as mice and rats, can be easily infected, and many 
reagents are available for studying immunological responses in these hosts b) the 
molecules secreted from the liver fluke are easily obtained and purified for analysis o f their 
effects on the hosts immune effector mechanisms and c) unlike in schistosomiasis, liver 
fluke eggs are not trapped in the liver and hence we observe very polarised Th2 responses 
rather than a mixture o f responses. The knowledge gained from studies performed in 
laboratory animals can then be applied to the more relevant hosts like cattle, sheep and 
humans.
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In this study we have confirmed that human fasciolosis has been hyper-endemic in the 
Bolivian Altiplano for at least a decade. Prior to the planning of a health care programme 
a large scale regional survey is required to fully establish the distribution of the disease 
throughout the entire region. To this end our highly sensitive and specific standardised 
diagnostic assay could be employed. The reluctance of the indigenous population to 
provide blood samples makes studying human fasciolosis in this region very difficult. 
However, taking blood samples onto filter paper provided a means of overcoming this 
problem.
Due to the difficulty in obtaining sufficient blood samples to explore the 
immunological responses of humans to fasciolosis we employed the mouse as a model to 
investigate the immune response associated with fasciolosis. We have demonstrated that 
Fasciola hepatica generates a highly polarised type II immune response. In addition we 
showed that the molecules of ES products are involved in triggering type II immune 
responses and in down-regulating a type I immune response. Although some progress has 
been made towards understanding the immunology of fasciolosis in mice there are many 
fundamental questions which remain unanswered. In future experiments it is important 
that we a) identify the cytokines and cellular components involved in the production of 
type II cytokines by the molecules of the ES, b) identify the molecules of ES products and 
the regulatory cytokines involved in the suppression of Thl responses to the gram 
negative bacterial pathogen, B. pertussis and c) establish the role of these molecules in the 
molecular pathway resulting in the enhancement of type II responses or in the suppression 
of type I responses.
9.2 Conclusions and future prospects
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